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ABSTRACT 
Precise control of the uterine luminal fluid pH is important for a number of key 
reproductive events. We hypothesized that sex-steroid could participate in this control 
via affecting the expression of H
+ 
and HCO3
-
 transporters as well as the enzyme that is 
involved in their generation. In view of this, we investigate the expressions and 
functional activities of few membrane transporters including CFTR, SLC26A6, NBC 
and NHE as well as CA enzyme in the uterus.   Adult female WKY rats were divided 
into two main groups; (i) ovariectomized, steroid-replaced and (ii) intact rats at different 
phases of the oestrous cycle. The level of mRNA, the expression and distribution of 
proteins as well as the functional involvement of these transporters /enzyme were 
investigated. 
Our functional studies revealed that estrogen caused an increase in the pH, volume, Cl
-
, 
HCO3
-
 and Na
+
 content of this fluid while progesterone resulted in vice versa. The 
effects of estrogen were antagonized by glibenclamide (CFTR inhibitor), DIDS (anion-
exchanger inhibitor) and acetazolamide (CA inhibitor) while progesterone effects were 
inhibited by acetazolamide and EIPA (NHE inhibitor). A similar increase in the pH, 
volume, HCO3
-
, Cl
-
 and Na
+
 content were observed during estrus and proestrus stages, 
which were inhibited by glibenclamide, DIDS and acetazolamide. Meanwhile, 
acetazolamide and EIPA antagonized the reduction in pH, volume, Cl
-
, HCO3
-
 and Na
+
 
concentrations during diestrus. The mRNA and protein expression of CFTR, SLC26A6 
and NBC were increased following estrogen treatment while P treatment resulted in a 
decrease in these transporters expression. While NHE1 expression was up-regulated by 
P, NHE2 and NHE4 expressions were up-regulated by estrogen. Meanwhile, CAII and 
XII expressions were both stimulated by estrogen and progesterone although 
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progesterone treatment resulted in a lower expression of CA enzyme as compared to 
estrogen. 
A similar effect was observed at different phases of the oestrous cycle, during which the 
pH and volume of the fluid were both increased. This was associated with an increase in 
the expressions of CFTR, NBC and SLC26A6. At metestrus and diestrus however, an 
increased in NHE1 expression together with the reduction in CFTR, NBC and 
SLC26A6 could result in the lower luminal fluid pH and volume. 
Immunohistochemistry findings indicated that CFTR and SLC26A6 were expressed at 
the apical membrane, while NBC was bilaterally expressed with a higher intensity at the 
basolateral membrane under the estrogen effect and at estrus. NHE isoforms expression 
revealed bilateral localization of this protein’s isoforms with NHE1 distributed mainly 
on the apical membrane under the influence of progesterone and during diestrus while 
NHE2 and NHE4 were distributed mainly at the basolateral membrane under estrogen 
influence and at estrus. CA II was expressed exclusively in the glandular epithelia while 
CAXII was expressed at both the glandular and endometrial epithelia. 
In conclusion, the differential expression of these transporters/ enzyme by sex-steroids 
and at different phases of the oestrous cycle may explain the changes in the uterine fluid 
pH under these different conditions.  
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ABSTRAK 
Kawalan tepat pH cecair rongga rahim adalah penting bagi beberapa acara utama 
pembiakan. Kami menghipotesiskan bahawa seks steroid boleh menyertai dalam 
pengawalan cecair ini dengan mempengaruhi pengangkut H + dan HCO3- serta enzim 
yang terlibat di dalam penghasilan mereka. Berdasarkan pandangan ini, kami menyiasat 
expresi dan aktiviti fungsi beberapa pengangkut membran termasuk CFTR, SLC26A6, 
NBC dan NHE serta enzim CA di dalam rahim. Tikus WKY betina dewasa telah 
dibahagikan kepada dua kumpulan utama; (i) tikus yang yang ovariektomikan, serta 
dirawati dengan steroid dan (ii) tikus pada pelbagai fasa kitaran oestrous. Ekspresi 
mRNA dan protein/ enzim berserta penglibatan mereka di dalam fungsi pengangkutan 
ini telah disiasat. 
Kajian fungsi kami mendedahkan bahawa estrogen yang menyebabkan peningkatan di 
dalam pH, isipadu serta kandungan Cl
-
, HCO3
-
 dan Na
+
 cecair ini manakala progesteron 
menyebabkan sebaliknya. Kesan estrogen telah dihalang oleh glibenclamide (perencat 
CFTR) dan DIDS (perencat anion-penukar) dan acetazolamide (perencat CA) manakala 
kesan progesteron dihalang oleh acetazolamide  dan EIPA (perencat NHE). Peningkatan 
yang sama di dalam pH, isipadu serta kandungan HCO3
-
, Cl
-
 dan Na
+
 telah diperhatikan 
semasa peringkat estrus dan proestrus, yang direncat oleh glibenclamide, DIDS dan 
acetazolamide. Sementara itu, acetazolamide dan EIPA menghalang pengurangan pH, 
isipadu serta peningkatan kepekatan Cl
-
, HCO3
-
dan Na
+
 semasa peringkat diestrus. 
Ekspresi mRNA dan protein bagi CFTR, SLC26A6 dan NBC telah meningkat berikutan 
rawatan E manakala rawatan P mengakibatkan penurunan di dalam ekspresi 
pengangkut-pengangkut ini. Walaupun ekspresi NHE1 dikawal oleh P, ekspresi NHE2 
dan NHE4 dikawal oleh estrogen. Sementara itu, ekspresi CAII dan XII kedua-duanya 
dirangsang oleh estrogen dan progesteron walaupun rawatan progesteron menyebabkan 
ekspresi enzim CA yang lebih rendah berbanding rawatan estrogen. 
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Satu kesan yang sama telah diperhatikan pada fasa yang berbeza kitaran oestrous, di 
mana pH dan isipadu cecair pada kedua-dua fasa meningkat. Ini telah dikaitkan dengan 
peningkatan di dalam ekspresi CFTR, NBC dan SLC26A6. Pada fasa metestrus dan 
diestrus bagaimanapun, peningkatan di dalam ekspresi NHE1 bersama dengan 
pengurangan di dalam CFTR, NBC dan SLC26A6 menyebabkan pH cecair berongga 
lebih rendah. 
Penemuan immunohistokimia menunjukkan bahawa CFTR dan SLC26A6 telah 
diagihkan pada membran apikal, manakala NBC diaagihkan pada kedua-dua membran 
dengan intensiti yang lebih tinggi pada membran basolateral di bawah kesan estrogen 
serta pada fasa estrus. Ekspresi isoforms NHE mendedahkan pengagihan dua hala 
isoforms ini dengan protein NHE1 diagihkan terutamanya pada membran apikal di 
bawah pengaruh progesteron dan semasa fasa diestrus manakala NHE2 dan NHE4 
diagihkan terutamanya pada membran basolateral bawah pengaruh E dan pada fasa 
estrus. CA II telah diekspresi secara eksklusif di dalam epithelia kelenjar rahim 
sementara CAXII telah diagihkan di kedua-dua epithelia kelenjar rahim serta lapisan 
endometrium. 
Kesimpulannya, ekspresi berbeza pengangkut / enzim oleh seks steroid dan pada 
pelbagai fasa kitaran oestrous boleh menjelaskan perubahan di dalam pH bendalir rahim 
di bawah pengaruh hormon yang berbeza. 
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Chapter 1 
INTRODUCTION 
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1.1 Introduction 
The precise regulation of uterine fluid pH is important for a number of key reproductive 
events including sperm transport and capacitation, fertilization, embryo transport and 
implantation (Aguilar & Reyley, 2005; Boatman, 1997). The exact pH of the uterine 
fluid at different phases of the rodent’s oestrous cycle is currently unknown; however, 
limited data indicate that the pH is high at around the time of ovulation (Blandau, et al., 
1958). Sex-steroids in particular estrogen (E) and progesterone (P) may be involved in 
the regulation of uterine fluid pH since they have found to affect other uterine fluid 
parameters such as volume and electrolyte content (Naftalin, et al., 2002; Salleh, et al., 
2005). The evidence that sex-steroid may affect uterine fluid pH comes from an 
observation that the uterine fluid HCO3
-
 content is high under the influence of E 
(Murdoch & White, 1971; Vishwakarma, 1962).  
HCO3
-
 and H
+
 are the two most important determinants of body fluid pH. Factors 
affecting their secretion or generation can thus affect the pH of body fluid. HCO3
-
 
secretion may involve multiple membrane proteins including cystic fibrosis 
transmembrane conductance regulator (CFTR) (Wang, et al., 2003a), sodium 
bicarbonate cotransporter (NBC) (Wang, et al., 2002)  and Cl
-
/HCO3
-
 exchanger 
(SLC26A6) (Jensen, et al., 1999b) while H
+
 secretion may involve the sodium proton 
exchanger (NHE)  (Bagnis, et al., 2001)  and H
+
-ATPase pump (Herak-Kramberger, et 
al., 2001). In addition, the carbonic anhydrase (CA) enzyme may participate in HCO3
-
 
and H
+
 synthesis (Lutwak-Mann, 1955). Apart from the well documented involvement 
of CFTR in mediating endometrial HCO3
-
 secretion (Chan, et al., 2002; Salleh, et al., 
2005), the participation of other endometrial proteins in uterine fluid pH regulation have 
not been well documented.  
CFTR is a Cl
-
 channel expressed in the apical membrane of the epithelia and responds 
to an increase level of intracellular cyclic AMP (cAMP) by secreting Cl
-
 (Bargon, et al; 
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1992). Additionally, CFTR has also been shown to mediate cAMP dependent HCO3
- 
secretion in the endometrial epithelia (Wang, et al., 2003a).  Its expression is up-
regulated by E and at proestrus and estrus phases of the oestrous cycle (Chan, et al., 
2007; Rochwerger & Buchwald, 1993)  and down-regulated by P (Mularoni, et al., 
1995).  
SLC26A6, from the Cl
-
/ HCO3
- 
exchanger family, is expressed on the luminal 
membrane of secretory epithelia. SLC26A6 has been reported to be involved in the 
regulation of intracellular fluid pH and cell volume via extrusion of HCO3
-  
into the 
lumen in exchange for Cl
-
 (Jensen, et al., 1999b). The effect of sex-steroids on its 
expression and functional activities is not fully understood.  
NHE, on the other hand consists of nine isoforms, NHE1-9 (Orlowski & Grinstein, 
2004) and is involved in pH regulation of by extruding H
+
 in exchange for Na
+
 
(Dunham, et al., 2004). It is involved in intracellular pH homeostasis (Wang, et al., 
2003b). The involvement of NHE in intracellular pH regulation has been reported in the 
epididymis (Kaunisto & Rajaniemi, 2002) and pancreas (Brown, et al., 2003). NHE 
expression has been reported in the endometrium (Salleh, et al., 2011), however the 
changes in its expression and functional activity under the influence of sex-steroid has 
not been reported.  
In addition to NHE that regulates the intracellular pH (pHi), Fong  (1998b) has shown 
that HCO3
-
 secretion depends substantially on basolaterally situated Na
+
-HCO3
-
 
cotransporter (NBC). NBC has been implicated in the regulation of intracellular pH and 
epithelial HCO3
-
 secretion (Yamaguchi & Ishikawa, 2008). Functional studies by Wang 
et al, (2002) has revealed that  the pHi recovery was observed only when both Na
+ 
and 
HCO3
-
 were present
 
in the basolateral compartment which suggested that HCO3
-
 influx 
 
through the basolateral membrane requires the presence of Na
+
.
 
These results point to
 
the involvement of NBC in cellular pH content. The presence of NBC in the mouse 
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endometrial epithelium was furthermore, confirmed by the results of RT-PCR (Wang, et 
al., 2002). Despite this information the pattern of NBC protein and mRNA expression at 
different stages of the estrous cycle and under the effect of exogenous steroid remains 
unknown. 
CA, a zinc containing metalloenzyme  with 16 isoforms, is involved in the synthesis of 
H
+
 and HCO3
- 
via reversible hydration of CO2 (Boron, 2010). It is the main enzyme that 
contributes to acidification of epididymal fluid and urine (Breton, et al., 1996), and 
alkalinization of the pancreatic fluid (Sly & Hu, 1995). The expression of different CA 
isoforms has been reported in human, rat and mouse endometrium (Ge & Spicer, 1988; 
Sly & Hu, 1995). The effect of sex-steroids on CA expression and functional activity is 
still unknown.  
It is hypothesized that uterine fluid pH fluctuates throughout the oestrous cycle and it is 
under the control of sex-steroids. We further hypothesize that the effect of sex-steroids 
on the pH changes is mediated via multiple endometrial proteins such as CFTR, 
SLC26A6, NHE, NBC and CA.  In view of this, the aim of the study was to investigate 
the involvement of these proteins in uterine fluid pH changes under the influence of 
sex-steroids and at different phases of the oestrous cycle. In parallel, the changes in 
other parameters such as uterine fluid volume and electrolytes (HCO3
-
, Cl
-
 & Na
+
) 
content were also investigated under a similar hormonal condition.   
The general objective of this study is to investigate the influence of ovarian hormones in 
the changes of uterine milieu. 
The specific objectives of the study are: 
1- To investigate the effect of E and P on uterine fluid pH, volume and ionic content in 
steroid replaced ovariectomized rats and at different stages of the oestrous cycle. 
2- To evaluate the role of CA in uterine fluid changes by the application of 
acetazolamide in uterine perfusion in various experimental groups. 
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3- To assess the contribution of CFTR to uterine fluid content by introduction of 
glibenclamide.  
4- To assess the involvement of other bicarbonate transporters via inhibitory effect of 
DIDS on uterine fluid. 
5- To investigate the importance of NHE in uterine fluid changes by the application of 
EIPA. 
6- To evaluate the mRNA level, protein expression and localization of CAs, CFTR, 
NHEs, SLC26A6 and NBC in steroid treated rats and throughout the oestrous cycle. 
 
 
 
 
 
 
 
 
 
 
  
Chapter 2 
Literature review 
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2.1 Endometrium 
 The uterus plays a major role in reproductive biology of mammals by providing a 
suitable environment for the embryo and fetal development. The uterus achieves this 
important function by synthesis and secretion of different products through uterine 
endometrium (Davis & Blair, 1993) (Figure 1). 
The endometrium is uterine epithelia which is exposed to E and P cyclically and 
undergoes different changes consisting of proliferation, differentiation and menstruation 
in human and some mammals. The endometrium is capable of shedding and 
regeneration in the absence of pregnancy; hence it can be considered a site of 
physiological injury and repair (Ollo, 1991).   
2.1.2 Endometrial structure 
The endometrium consists of two layers: upper functional layer of columnar epithelia, 
which is shed at menstruation and an underlying thick connective tissue, stroma 
responsible for regeneration of the endometrium, and vary in thickness according to 
hormonal influence (Lutz, 2009). The endometrium consists of different cell types, 
luminal and glandular epithelium and endometrial stroma (Beier & Beier-Hellwig, 
1998; Davis & Blair, 1993), (Figure 1.c).  
 Before puberty endometrium consist of tubular gland, dense fibroblast in stroma and 
thin blood vessels. Upon activation of the hypothalamus-pituitary-gonadal axis, the 
endometrium undergoes cyclic morphological changes. Under E dominance, 
endometrium proliferates. The endometrial glands grow and become tortuous 
(proliferative phase). After ovulation, P secretion inhibits the proliferation and induces a 
complex of secretory activity. These secretory changes occur in the E primed 
endometrium (Deligdisch, 2000). 
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Figure 2. 1 Human uterine structure and histology in (a) which shows endometrium, myometrium and 
perimetrium. In rat, uterus formed of two horn (b) and endometrium, myometrium and perimetrium can 
be seen in horizontal section of rat uterus under microscope (c). 
                                                                         
                                                     Source: a (Kim, et al., 2009),  and b (Osol & Mandala, 2009) 
 
2.1.3 Endometrium changes under the effect of ovarian hormone 
The effect of sex-steroid on the uterus is via their respective hormone receptors that 
initiate a cascade of gene expression involved in implantation and early pregnancy. E is 
responsible for proliferative changes during follicular phase of the ovarian cycle, while 
P leads to differentiation during the luteal phase. The effect of P relies on the existence 
of progesterone receptor (PR), while the presence of PR is depends on prior exposure of 
the endometrium to E. In rodents, E leads to several morphological changes such as 
increased depth of tight junction, flattening of microvilli and alteration in the apical 
cytoskeleton during embryo attachment (Nimbkar-Joshi, et al., 2012). Concurrently 
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studies in monkey shows that these changes are probably mediated by up regulation of 
estrogen receptors α (ERα) and down regulation of ERβ (Nimbkar-Joshi, et al., 2012). 
2.1.4 Expression of steroid receptor in endometrium 
Different protein receptors are expressed in the endometrium such as ER α and β; G 
protein coupled ER, known as G protein coupled receptor 30 (GPR 30), a non-nuclear 
receptor with high affinity binding site for E (Samartzis, et al., 2012).  
 PR, includes two isoform PRA and PRB which is encoded by the same gene (Conneely 
& Lydon, 2000). The endometrium also expresses androgen receptor (AR), hence it 
either acts directly via its receptor or indirectly through ER after aromatization to E 
(Horie, et al., 1992) and it is involved in anti-proliferative effect induced by anti-
progestin (Brenner, et al., 2002;  2003), (Table 1).           
 
 
 
 
 
 
 
 
 
 
 
 
                        
 
  
               
               
. 
 
  
   
                  Table 2. 1 Expression of steroid receptor in endometrium. (Adapted from Brenner, et al., 2002; Horie, et al., 1992; Henderson, et al., 2003) 
 
 
 
 
 
 
 
 
Estrogen receptor (ER) 
Progesterone receptor 
(PR) 
Androgen receptor 
(AR) 
Glucocorticoid receptor 
(GR) ERα ERβ 
 
 
Endometrium 
Functional layer 
Upper zone 
 
 
 
 
 
 
 
 
- Increase in glandular  
and stroma in 
proliferative phase 
- Decrease in secretory 
phase (due to 
progesterone) 
 
 
Decline in late 
secretory phase 
Reduce in gland during 
transition from 
proliferative to secretory 
phase, highly express in 
stroma 
- Up regulated in 
estrogen proliferative 
phase  
- Down regulated in 
secretory phase 
-Minimal expression in 
gland. 
Mostly in Stroma  
-Expressed throughout the 
cycle 
The function is not clear  
 
Endometrium 
Basal layer 
In glandular and 
stroma across the cycle 
 
In glandular and stroma 
express throughout the 
cycle 
 
  
11 
 
2.2 Uterine fluid 
The endometrium plays an important role in the early stages of embryonic life, embryo 
relationship with mother, and in pregnancy through the secretion of uterine fluid 
(Bauersachs, et al., 2005). This fluid of the uterine lumen is essential for sperm and 
embryo transport, development and implantation. Even though the surface epithelial 
cells are capable of producing fluid but, the main source of the fluid in the endometrium 
are the glandular cells. 
Uterine fluid contains hormones, prostaglandin (PG), enzymes, energy substrates, ions, 
vitamins, amino acids, peptides, serum proteins and uterine proteins. These are essential 
for oocyte and spermatozoa movement, capacitation of the spermatozoa and 
implantation (Yang, et al., 2004), early embryonic development (Aguilar & Reyley, 
2005; Wang, et al., 2003a), and embryo viability (Shixiong, 2000). The protein pattern, 
ionic composition and volume of this fluid varies during the stages of the cycle 
(Abuladze, et al., 1998; Casslén & Nilsson, 1984). The exchange rate of the fluid 
between vascular and extra vascular fluid is determined by the uterine blood barrier; 
whereby extra vascular fluid is divided into vascular, endometrial extracellular and 
luminal extracellular fluid (McRae, 1988; McRae & Heap, 1988). 
2.2.1 Uterine fluid composition 
2.2.1.1 Amino acids and proteins 
 There are 25 amino acids in the tubal fluid of cows, ewes, pigs, rabbits and mice. 
Among all the amino acid glycine has the highest concentration in all species. It protects 
preimplantation of mouse embryos against the detrimental effect of inorganic ions (Van 
Winkle, et al., 1990). Free amino acids are important for the survival of gamete and 
embryo, and are varied between species and during stages of the oestrous cycle (Aguilar 
& Reyley, 2005). Protein in tubal fluid is lower than protein in plasma and its content is 
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about 10-15% of serum protein content. Most of it consists of albumin and 
immunoglobulin G derived from blood serum. Total protein concentration of uterine 
fluid is associated with ovarian hormone cycle, for example in the bovine uterus, protein 
profile changes during the oestrous cycle in term of quality and quantity, and may 
prepare the uterus for the physiologic events (Alavi-Shoushtari, et al., 2008). The 
amount of tubal glycoprotein is affected by stages of the oestrous cycle (Abe & Abe, 
1993; Aguilar & Reyley, 2005; Kapur, 1988), and has the highest level during the 
periovulatory period (Abe, et al., 1998; Aguilar & Reyley, 2005; Leese, 2001). 
Moreover, it has been proved that E induces the synthesis and secretion of oviduct-
specific glycoprotein in the golden hamster while P has a lesser effect (Abe, et al., 
1998; Aguilar & Reyley, 2005; Leese, 2001; Sun, et al., 1997).  
2.2.1.2 Prostaglandins  
PG level in the uterus is under the influence of ovarian hormones and it fluctuates 
throughout the stages of the oestrous cycle. In pigs, for example, the highest amount of 
PGF2α was detected on the second day of standing heat (Rodriguez-Martinez, et al., 
1983). In rabbit PGE and F significantly increases before ovulation which could be 
related to ovum capture (McComb, 1985). In human, PG level varies at different region 
of the oviduct and at different stages of the cycle. Lower level of PGE and PGF is 
detected at the utero-tubal junction, while the highest amount is in fimbriae. At luteal 
phase their concentration is two times more than in the follicular phase (Nieder & 
Augustin, 1986). Furthermore, in human tubes the number of binding sites for PGE2 
and F2 are greater in the isthmus and in the luteal phase (Sato, 1988). 
2.2.1.3 Growth factors  
Several growth factors participates in early embryogenesis, trophoblast growth, 
endometrial cell differentiation, conceptus invasiveness and regulation of 
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steroidogenesis (Simmen & Simmen, 1991). In addition, growth factor levels vary 
during the cycle; in pig, for instance, IGF-I and II are in greater amount at estrus than 
pre- or postestrus, even though their concentration is similar at both stages (Wiseman, et 
al., 1992).  
2.2.1.4 Ionic content of the uterine fluid 
Ions are involved in different biochemical functions in the reproductive system. In vitro 
studies have revealed that cations  contribute to acrosome reaction, sperm motility, 
capacitation and fertilization (Grippo, et al., 1992). Ca
+2
 for instance has a major role in 
sperm capacitation, while Na
+
 and K
+
 are necessary for zona-induced acrosome reaction 
(Grippo, et al., 1992).  
In the female reproductive tract, ionic composition is similar to that of serum, and it 
may be affected by stages of the reproductive cycle (Deachapunya & O’Grady, 1998; 
Matthews, et al., 1998; Nichol, et al., 1992). In addition steroids can regulate the ion 
flow through the oviductal epithelium similar to the regulation of ions flow in  trachea 
cells (Leese, 2001; Zeitlin 1989) and in kidney tubule (Leese, 2001; Verlander, 1998). 
 K
+
 content in human oviduct and uterus, and bovine oviduct is higher than in plasma 
(Deachapunya & O'Grady, 1998; Matthews, et al., 1998; Schul, et al., 1971). However, 
Ca
+2
 and Na
+
 in cow and human are in lower concentration in the uterus than blood 
(Matthews, et al., 1998; Schul, et al., 1971). Ca
+2
 concentration increases during 
ovulation in the isthmus region of cow oviduct and is more than Ca
+2
 concentration in 
plasma (Grippo, et al., 1995). In cow, Mg
+2
 concentration is significantly affected by 
different stages of the oestrous cycle, and it is lower than plasma level. In mare however 
Mg
+2
 is 2-5 times higher than its plasma concentration which is also much more higher 
than what is measured in other species (Aguilar & Reyley, 2005; Grippo, et al., 1992). 
Table 2.2 shows the concentration of ions in the tubal fluid in some species.  
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          Table 2. 2 Ionic concentration of uterine fluid in different species from different                          
studies has reviewed by  Aguilar et al. ( Adapted from Aguilar & Reyley, 2005). 
 Cow Rabbit Rabbit Human Human Mare 
Na
+
 86.1 127.8 189.7 130 145 129.5 
Cl
-
 112.7 115.4 332.2 132 119.5  
K
+
 65.7 5.6 16.8 21.1 6.7 7.9 
Ca
+2
 3.19 7.98 2.71 1.13  2.28 
Mg+2  0.141 0.473 1.42  4.59 
S    123   
P 3 0.193  8.69  0.366 
Zn  0.099 0.0046    
HCO3
-
   16.55    
 
In spite of the high K
+
 concentration of tubal fluid, the total cation concentration in the 
uterine fluid is less than the serum cation concentration (Casslen & Nilsson, 1984; 
Matthews, et al., 1998) due to active  absorption of Na
+
 and Ca
+2
 and passive K
+
 
secretion. This phenomena have occurred in primary monolayer of human endometrial 
epithelium (Matthews, et al., 1998) and in the uterus of immature pig  (Chan, et al., 
1997; Fong, et al., 1998; Vetter & O’Gary, 1996). Thus, there is a high K+: Na+ ratio 
(K
+
 20mM and Na
+
130mM) in rat  and human uterine fluid under the influence of 
ovarian steroid hormones (Casslen & Nilsson, 1984; Clemeston, et al., 1970). 
It has been reported that Cl
-
 concentration is not significantly different from serum 
concentration (Casslen & Nilsson, 1984), but the bicarbonate concentration was found 
to be two- to four fold higher than plasma (Murdoch & White, 1968, 1971). Moreover, 
HCO3
-
 concentration not only changes along the tract and depends on reproductive 
events  but varies at different stages of the cycle and pregnancy, (Chan, et al., 2006). 
This indicates that active bicarbonate transport across endometrium (Wang, et al., 
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2003a) is presumably by NBC in the basal membrane (Wang, et al., 2002), or CFTR 
and Cl
-
/HCO3
-
 exchanger in the apical membrane (Wang, et al., 2003a).  
In spite of the above mentioned studies, Hugentobler, et al (2007)  reported that there is 
no association between the ionic concentration in bovine oviduct and  uterus with E and 
P levels. Differential regulation of ion secretion accounts for different concentration 
during the reproductive cycle. 
2.2.2 Secretion of uterine fluid 
The ionic concentration of the uterus (Chan, et al., 1997; Nordenvall, et al., 
1989), and fluid volume (Parmar, et al., 2008), are under the influence of 
steroid hormones. The highest amount of fluid accumulates during the 
proestrus phase of the rodent reproductive cycle (Huang, et al., 1999). E 
predominantly stimulates tubal fluid secretion while P inhibits it (Aguilar & 
Reyley, 2005; Clemeston, et al., 1970). Hence, fluid secretion increases at 
estrus and declines at diestrus and pseudopregnancy (Aguilar & Reyley, 2005; 
Dickens & Leese, 1994). In the rabbit amount of fluid production is higher in 
estrus than pseudopregnancy (Downing, et al., 1997); whereas in monkey, fluid 
secretion is at its peak at ovulation (Brenner & West, 1975). In cows, the rate 
of oviductal fluid production are approximately 0.2ml and 2.0 ml per day at 
diestrus and estrus respectively (Schul, et al., 1971). This means at estrus the 
oviduct presents the highest volume of fluid (Aguilar & Reyley, 2005; Leese, 
2001). It has been reported that secretory rate of oviduct in ovariectomized ewe 
and rat is lower than the constant state at the luteal phase (Leese, 2001; 
Perkins, 1974). There is a great increase in secretion in ovariectomized ewe 
after treatment with E (Leese, 2001; Murray, 1995). However, the mechanism 
underlying this effect of ovarian steroid hormones  has not been completely 
resolved (Leese, 2001).  
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2.2.3 Mechanism of fluid secretion 
 It is likely that fluid secretion is related to ionic flow,  and ionic flow occurs prior to 
fluid movement in the epithelial cells (Chan, et al., 2002). In secretory epithelia, the 
driving force for water movement is Cl
-
 ion flow from the basal to the apical side 
(Downing, 1997; Leese, 2001; Quinton, 1990). In the apical membrane of epithelium, 
fluid absorption and secretion is dependent on Na
+
 and Cl
-
 conductance. Active Na
+
 
absorption leads to Cl
-
 and fluid efflux from the lumen into the blood, while active 
secretion of Cl
-
 results in Na
+
 and fluid flow into the lumen (Chan, et al., 2002).  The 
Na
+–K+ATPase, are responsible for the lower concentration of intracellular Na+, and at 
the basolateral membrane the Na
+
-K
+
-Cl
–
 cotransporter are responsible for the uptake of 
Cl
-
,  and due to the permeability of apical surface to Cl
-
,  anion  moves down the 
electrochemical gradient into the lumen. Ion flow produces an electrical force that 
drives Na
+
 paracellularly through the tight junctions between the cells. It is assumed that 
in secretory epithelia, localized accumulation of ions in the intracellular space causes 
high osmotic pressure. Water movement occurs to balance the osmotic equilibrium so 
that fluid accumulates in the lumen (Leese, 2001; Quinton, 1990).  
At estrus, the height of epithelial cells increase to enhance the area of intercellular space 
available for localized accumulation of ions (Leese, 2001; Murray, 1995) and fluid 
production is at maximal level. Moreover, during estrus, glycoprotein production and 
secretion increases, which in turn enhances the viscosity of luminal fluid. It may also 
prevent rapid diffusion by accumulation of ions into microenvironments with high 
osmolarity  (Hunter, 1994; Leese, 2001).  
In the uterus, fluid absorption is under the influence of P via an amiloride sensitive 
channel (Salleh, et al., 2005). It has been suggested that epithelial Na
+
 channel (ENaC) 
is involved in fluid absorption, as the expression of ENaC subunits are stimulated by P. 
The level of ENaC mRNA in the uterus vary at different stages of the oestrous cycle 
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(Chan, et al., 2002) and the highest expression is around the time of implantation  
(Yang, et al., 2004).  Thus due to the activity of ENaC and CFTR in the female 
reproductive tract, the ovary and oviduct are involved in fluid secretion while vagina 
and cervix contribute to fluid absorption. In the uterus both absorptive and secretory 
activities have been detected (Chan, et al., 2002). 
2.2.3.1 Aquaporin (AQP) role in fluid secretion 
Transepithelial osmotic water flow results from transcellular ion secretion. 
Water crosses the membrane through the membrane lipid bilayer and 
paracellular junction. In addition water channels, the aquaporins (AQP) 
facilitate water flux. The AQP family consists of 13 members (Lee, et al., 
2012) and some of these AQP are expressed in the uterus.  
 AQP 1 that has been detected in the myometrium of mouse uterus is regulated 
by ovarian hormones. E in epithelial cell and myometrium stimulate AQP2 
expression. AQP3 is expressed at low level in epithelial cells and myometrium. 
Water flux into the mouse uterine lumen is facilitated by both AQP2 and AQP3 
(Jablonski, et al., 2003). 
2.2.4 Effect of growth factor and adrenaline on uterine fluids 
Ovarian steroid hormones exert many of their actions through growth factors 
(such as IGF-1) and cytokines in the uterus. Katagiri, et al (1997) has reported 
that hyperestrogenemia due to superovulation increased the total cation content 
and uterine fluid volume by more than twofold. Percentages of K
+
 and HCO3
-
 
content to total cations or anions were enhanced by 27% and 16%, 
respectively, and Na
+
 and Cl
-
 content were attenuated by 26% and 15% 
respectively after superovulation. In this condition IGF-1 is an E mediator.  
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The effect of other factors such as adrenaline on uterine fluid composition has 
been studied before. Anion secretion in cultured mouse endometrial epithelium 
(Fong, et al., 1998b) and in rat (Levin & Phillips, 1983) can be regulated by 
adrenaline via β adrenoceptors through a pathway that involves cAMP (Fong, 
et al., 1998b). The effect of adrenaline could be inhibited by Cl
-
 inhibitor, 
Diphenylamine-2, 2'-dicarboxylic acid, glibenclamide (Fong, et al., 1998b) and 
DIDS, which are also inhibitors of Ca
+2
 activated Cl
-
 channels (Chan, et al., 
1997; Fuller & Benos, 1992). Replacement of external Cl
-
 and HCO3
-
 but not 
amiloride or Na
+
 replacement in apical solution is also able to inhibit the 
adrenaline effect. In spite of this, Levin and Scragill (1987) reported that only 
HCO3
-
 secretion is under adrenaline stimulation. In the inner medullary 
collecting duct cells (in kidney) of rat, cAMP induced cell acidification via 
anion secretion that is independent of acid secretion and is the result of 
activation of one or more HCO3
-
 exit pathways (Zhang, et al., 1996).  
The influence of cAMP on HCO3
-
  secretion across the endometrial epithelium, 
and dependence of some neurohormonal regulatory pathway on cAMP, 
suggests that probably HCO3
-
  content of the uterine is under precise 
neurohormonal regulation (Wang, et al., 2002). 
PGF2α stimulates Na
+
 absorption and K
+
 secretion in the intact endometrium of 
pig (Chan, et al., 1997; Vetter & O'Gary, 1996), however it has been 
previously reported that endometrium active secretion of K
+
 and anion along 
with Na
+
 absorption occurs in pigs (Chan, et al., 1997; Deachapunya & 
O'Grady, 1998). 
2.2.5 The role of HCO3
-
 in uterine fluid  
Bicarbonate is a biologic pH buffer that maintains acid-base homeostasis and protects 
the body against toxic flow from intra and extracellular pH fluctuation. In addition it 
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facilitates solubilisation of macromolecule such as mucin (Park & Lee, 2012; Roos & 
Boron, 1982). HCO3
-
 is involved in different physiologic events in the reproductive 
system. In the male reproductive tract, for example,  low HCO3
-
 is the main reason of 
sperm being immotile, whereby during ejaculation high HCO3
-
 content of seminal 
plasma enhances sperm motility (Ekstedt, et al., 2004) via activation of adenylate 
cyclase (Okamura, et al., 1985). In the female reproductive tract HCO3
-
 contributes to 
capacitation and acrosome reaction. Furthermore, zone penetration by spermatozoa 
increase in comparison with bicarbonate free media (Amitabha & Yanagimachi, 1988). 
Bicarbonate  participates  in cleavage, embryonic formation particularly in blastocyst 
stage, and may be involved in pH regulation whereby low pH is harmful such as in 
hydrosalpinx (Karhumaa, 2002) . 
CO2/HCO3
-
 is the major physiological buffer that is responsible for pHi regulation. In 
this system, CO2 usually can cross the membrane without involvement of protein 
transporters although aquaporin is able to enhance CO2 movement. However CO2 flux 
must be matched with HCO3
-
, thus the role of bicarbonate transporter is inevitable 
(Swietach, et al., 2010).  
2.2.6 Uterine fluid pH  
Bicarbonate is the main ion involved in pH alteration. The main function of the vaginal 
and cervical epithelial cells is to regulate pH in the lumen of lower genital tract in 
female. pH is maintained between 4.5 and 6 during premenopausal years with mild 
alkalinization to about 6.5 before ovulation (Gorodeski, 2004).  
pH in the female reproductive tract is affected by location and stages of the menstrual 
cycle.  In the human vagina, for example, pH is acidic during the whole menstrual 
cycle, and seminal plasma increases vaginal pH form 4.3 to 7.2. This is due to high 
bicarbonate concentration. However in cervical mucus (6.5-7.5) and oviduct (7.0-8.0), 
pH is affected by stages of the cycle and the highest amount has been recorded at 
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ovulation in the cervix (Macdonald & Lumley, 1970). The pH of the uterus is unknown, 
thus it will be evaluated in this study in rat uterus as an animal model. 
2.2.6.1 Physiologic role of uterine fluid pH  
The pH of uterine fluid is important for gamete transportation, sperm capacitation, and 
embryo development. It has been shown that culture of early bovine embryos at pH 
values less than 7
 
reduces cleavage rates and development to the blastocyt stage (Ocon 
& Hansen, 2003). Furthermore, pHi is the main parameter in cell homeostasis and 
contributes to a wide range of process such as biochemical reaction, channel/transport 
function and protein- protein interaction (Boron, 2010). 
2.2.6.2 pH regulation 
 Nichol, et al (1997)  reported that the pH of oviductal fluid is controlled by both 
systemic and local mechanisms, and in pig the ipsilateral ovary and (or) embryonic 
factors influence the pH profile of the oviduct. In dairy cows, a short time increase in 
plasma urea nitrogen can decrease the pH in uterus (Rhoads, 2004).  
The pH may change under the influence of steroid hormones (Pybus & Onderdonk, 
1999). In rat or mouse pH is higher in the E replaced animal in comparison with control 
animals (He, et al., 2010; Salleh, et al., 2011). In addition in women, oral administration 
of E lead to a subtle alkalinization of the cervical mucus (Eggert-Kruse, 1993). E 
replacement after menopause decreases vaginal luminal pH from 6.5-7 to 5.5 which is 
due to active proton secretion into the vaginal lumen by vaginal ectocervical cells or  
presence of lactobacillus (Gorodeski, 2004).  It seems that E has a different role in 
vagina in respect to other part of female genital tract.  
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2.2.7 Channels involved in HCO3
-
 transport  
Accumulation of luminal HCO3
-
 in body cavities is mediated by basolateral membrane 
transporters that absorb HCO3
-
 from the blood; and apical membrane transporter that 
secrete HCO3
-
 into the luminal space.  
Carbonic anhydrase (Cohen, et al., 1976; Goyal, et al., 1980), apical NHE3 (Bagnis, et 
al., 2001; Kaunisto & Rajaniemi, 2002), cytoplasmic H
+
/ATPase (Herak-Kramberger, et 
al., 2001) in addition to basolateral Cl
-
/ HCO3
-
 exchanger (AE2) (Jensen, et al., 1999b) 
are involved in the regulation of pH in male reproductive tract.  
In kidney proximal tubules, net HCO3
-
 reabsorption is achieved through apical H
+
 
secretion into the lumen via NHE3 and proton pump (PP). Then H
+
 combines with 
HCO3
-
 via CA IV and produces CO2 that later diffuses into the cell and it is converted to 
H
+
 and HCO3
-
 by application of CAII. HCO3
-
 diffuses passively through the basolateral 
NBC. In the thick ascending limb HCO3
- 
reabsorption is mediated by Cl
-
/ HCO3
-
 
exchanger (AE1) (Breton, 2001). 
It has been suggested that these channels contribute to changes in uterine fluid pH. This 
fact is observed through regulation of uterine intracellular pH (pHi) by NHE, Na
+
, 
HCO3
-
/Cl
-
 exchanger and Cl
-
/ HCO3
-
exchanger, whereby the first two channels increase 
pHi whereas the latter decreases it (Dale, et al., 1998). 
The activity of these channels is under the influence of sex-steroid. Steroids influence 
the kinetic properties of both anion and cation channels (Ashvani, et al., 2000) and the 
expression of these epithelial channel are regulated by estrogenic hormone (Rochwerger 
& Buchwald, 1993). The expression of the different protein channel along with CA will 
be discussed in the endometrium. 
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2.2.7.1 Carbonic Anhydrase (CA)  
CA is a metalloenzyme which belongs to  α CA family, that contain zinc ion and 
enclosed by histidine residues and one water molecule (Karhumaa, 2002). CA is 
involved in H
+
 and HCO3
-
 production (Sly & Hu, 1995) and transportation (Wu, et al., 
1997) via reversible hydration of CO2. This can influence the environment's acidity 
(Barnett, et al., 2008), and facilitate CO2 transport across the membrane (Hynninen, et 
al., 2004). CA is the main enzyme involved in the transport and metabolic process at the 
cellular level (Henry, 1996).  Sixteen different isoenzymes for CA have been identified 
in mammals (Liao, et al., 2009). These are participated in a wide range of physiological 
events such as respiration, acid-base balance, ion transport, bone absorption, renal 
acidification, gluconeogenesis, and ureagenesis, formation of aqueous humor, 
cerebrospinal fluid, saliva, and gastric acid (Henry, 1996).  
CA is involved in different reproductive process including capacitation and sperm 
maturation via the HCO3
- 
secretion pathway (Boatman, 1997; Hu & Spencer, 2005). 
Furthermore, CA contributes to development of neonatal mouse uterus gland (Hu & 
Spencer, 2005). CA may be involved in the changes of uterine fluid pH through 
bicarbonate production (Hynninen, et al., 2004). Participation of CA in uterine HCO3
-
 
production has been reported, whereby application of acetazolamide (ACTZ, a CA 
inhibitor), to the basolateral side of cultured mouse endometrial reduced current in 
normal and Cl
-
 free buffer. However HCO3
-
 free buffer had no effect, indicating low 
contribution of CA in HCO3
-
  production (Fong, et al., 1998b) 
Furthermore, application of ACTZ reduced spermatozoa volume in fowl and decreased 
rate of testicular fluid secretion. It also inhibited the acidification of epididymal fluid 
(Breton, et al., 1996). In rabbit, ACTZ leads to lower numbers of implantation. It 
further terminates pregnancy after direct administration into the uterus (Pincus & Bialy, 
1963). However, Chiang, et al  (2004) reported that the CA inhibitor sulphonamide 
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when administered on day 2.5 of pregnancy  has a small effect on implantation in mice. 
He suggested that cytosolic CA is a negative regulator of decidualized uterine tissue 
stability that is involved in acid-base balance in the uterus and creates a 
microenvironment conducive to cell growth and spread.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 2 Molecular structures and sub cellular localization of CA isoenzyme.  CA  isoenzyme are intra 
cellular such as CAII and  VII ( high activity enzyme), CA XIII (medium activity) , CA  I and III (low 
activity) , CA VIII, X and XI (no activity) and CA V (mitocondrial ) or extra cellular  such as CA  IX and 
XII ( high activity),  CA IV and XIV (medium activity). CA: carbonic anhydrase, GPI: glycosyl 
phosphatidyl inositol, PG: proteoglycan like domain, TM: transmembrane domain, IC: intracytoplasmic 
tail. (Adapted from Nishimori & Onishi, 2001). 
                                                                  
                                                                                                 
CA expression and activity is under the influence of ovarian hormones (Lutwak-Mann, 
1955) and its expression varies in different species. Unique isoenzymes of CA are 
induced by P
 
in human or rabbit uterus (Hodgen & Falk, 1971),
 
 and in some species 
such as guinea pig estrus stimulate CA activity (Lutwak-Mann, 1955). In lactating cows 
CA increased between estrus and day nine of the oestrous cycle (Elrod, et al., 1993) . 
Down regulation of cytosolic CA (CAII) during implantation that can lead to 
acidification and enhance cell proliferation has been observed.  In view of this, Chiang, 
et al (2004) showed that in mice abortion induced by substance P (neuropeptide), 
resulted in significant expression of cytosolic CA and decreased the number of 
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embryos. In rat prostate and seminal vesicle, CA activity is regulated by androgen 
(Pincus & Bialy, 1963). However in sheep CA is free from ovarian hormone influences 
(Lutwak-Mann, 1955).   
CA has been detected in ovarian epithelium, granulosa cell of maturating follicle, and 
oviduct smooth muscle (Ge & Spicer, 1988). Endometrial CA activity has been detected 
by histochemical  studies 30 years ago and later different isozyme have been identified 
(Karhumaa, et al., 2000). For example, expression of CAXII in human basolateral 
membrane of endometrium  (Karhumaa, et al., 2000), CAXIII in mouse endometrium  
 has been detected in deeper endometrial glands whereas CAIX signal is very weak 
(Hynninen, et al., 2004). CAII has been found in human endometrial capillaries, 
whereby this high activity isoenzyme is abundantly expressed in the cytoplasm and 
epithelial cell membrane of the mouse endometrium (Hynninen, et al., 2004). Since the 
presence of CAII in mice endometrium, and CAXII in human endometrium has been 
reported; in this study the expression of these isoenzymes under the influence of ovarian 
hormone was evaluated. 
2.2.7.1.a CAII  
CAII is located on chromosome 8q22 in human, and generates a protein with 29kDa 
(Venta, et al., 1991). CAII is a very active isozyme with the maximum turnover rate for 
CO2 hydration. It can be detected in almost all cells such as osteoclasts in bone, 
oligodendrocytes in brain, epithelium of the choroid plexus (brain) and the ciliary body 
(eye), lens, miller cells in retina, liver (mainly perivenous hepatocytes), kidney acinar 
cells in salivary glands, pancreatic duct cells, gastric parietal cells, endometrium of the 
uterus, endothelial cells, epithelial cells of seminal vesicle and ductus deferens, 
spermatozoa, erythrocytes, and platelets. It has also been reported in neutrophils, type II 
epithelial cells of lung, endothelial cells and epithelial cells of duodenum, intestine, and 
colon, and zona glomerulosa cells of the adrenal (Sly & Hu, 1995).  
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The role of CA II varies in different organs. In gastric parietal cells and renal tubular, it 
is involved in fluid acidification. However, in pancreatic duct, choroid plexus and 
salivary gland, HCO3
-
 secretion is attributed to CAII activity. Due to its role in H
+
 and 
HCO3
-
 absorption and secretion, CA promotes water and NaCl absorption in the large 
intestine, gallbladder, in erythrocytes, lungs  and kidneys (Sly & Hu, 1995).  
2.2.7.1.b CAXII 
CAXII is mapped to chromosome 15q22 in human and produces type 1 membrane 
protein which is 43-44kDa in size (Türeci, et al., 1998). CAXII is an active isoenzyme 
and its mRNA is expressed in efferent ducts, prostate gland, testis, ovary, pancreas 
lungs and brain (Ivanov, et al., 2001). It is over expressed in some cancer tissues and 
cell lines (Ivanov, et al., 2001; Parkkila, et al., 2000). However CAXII protein has only 
been detected in endometrium, colon and kidney (Karhumaa, 2002; Parkkila, et al., 
2000). Liao, et al (2009) has reported the expression of CAXII  occurs in cells derived 
from the mesonephric duct or cells that involved in  secretion and proton pumping-pH 
regulation. CAXII is probably related to water and HCO3
-
 absorption in different 
epithelial cells such as in the efferent duct and kidney. This has been confirmed by 
simultaneous expression of CAXII and AQP in these cells (Karhumaa, et al., 2001b; 
Parkkila, et al., 2000). Moreover, inhibition of basolateral CA in kidney proximal tubule 
decreases the HCO3
-
 and fluid absorption.  The presence of CAXII in the endometrium 
is related to CAXII activity in a pH dependent event that is involved in fertilization 
(Chiang, et al., 2004; Karhumaa, et al., 2000). It is also responsible for acidification of 
luminal epididymal fluid in apical mitochondria-rich cells (AMRC) and in tumours 
(Ivanov, et al., 1998; Karhumaa, 2002). Expression of CAXII in the male reproductive 
system lead to morphological changes in ER α in knockout mice, whereby this receptor 
is essential for fluid reabsorption in the efferent duct (Zhou, et al., 2001). In human 
breast tumour, and in mouse uterus, expression of CAXII is under the stimulatory effect 
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of E (Barnett, et al., 2008). Involvement of CAXII in cell proliferation and oncogenesis 
has been reported (Breton, 2001). 
2.2.7.1.c CA deficiency 
Among CA family member only deficiency in CA II leads to known disease, including 
osteopetrosis, renal tubular acidosis, and cerebral acidification (Sly & Hu, 1995). 
2.2.7.2 Bicarbonate transporter 
The uterine HCO3
-
 content is higher than plasma indicating active HCO3
- 
transport 
across the endometrium (Wang, et al., 2003b). The HCO3
- 
transporter contributes in 
regulation of pHi, cell volume changes along with  acid-base equivalent and CO2 flux 
across the cell membrane (Boron & Boulpaep, 1989). The following discussion 
continues on the HCO3
-
 transporter that may involve in the regulation of uterine HCO3
- 
content. 
The bicarbonate transporter super family includes NBC, Cl
-
/ HCO3
- 
exchanger, and Na
+
 
driven Cl
-
/ HCO3
-
exchanger (Figure 2.3) (Kurtz, et al., 2004). There are a few 
differences between NBC and other transporters: NBC is not Cl
-
 dependent, and the 
presence of HCO3
-
 stimulates NBC (Abuladze, et al., 1998). However all of mentioned 
transporter were inhibited by stilbenes such as DIDS (Boron & Boulpaep, 1989). CFTR 
is also considered a HCO3
-
 transporter that is activated by cAMP in different epithelial 
cells (Choi, et al., 2001). 
Acid- base transporter can be divided into" acid loader", which brings net acid into the 
cell or "acid extruder" that remove net acid from the cell (Roussa, 2011) (Figure 2.4). 
Acid extruders include NHEs from the SLC9 family, proton channels, and proton 
pumps. In addition Na
+
-coupled HCO3
-
 transporters (Figure 2.3) and the electrogenic 
NBCe1/-e2 (with a stoichiometry of 1Na
+
:2HCO3
-
) from SLC4 family are acid 
extruders. Acid loaders consist of NBCe1/e2 (with a stoichiometry of 1Na
+
:3HCO3
-
)
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HCO3
-
Transporter
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(Na + coupled HCO3-
transporter)
Na+ independent
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electrogenic
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NBCe1 (SLC4A4)
NBCe2
NBCn1
NBCn2
NDCBE (Na+ driven Cl-/HCO3- exchanger)
AE1
AE2
AE3
Cl-/HCO3
- exchanger
and the anion exchangers from the SLC4 family, SLC26 family and HCO3
-
 permeable 
channels like CFTR. 
Nevertheless, the direction of ion flux via a transporter might change in different 
tissues/cells depending on the local electrochemical driving force existing across the 
plasma membrane. pH homeostasis relies on balanced activities of the acid extruders 
and acid loaders.  
                                             Figure 2. 3  Different bicarbonate transporter. 
2.2.7.3 Cystic fibrosis transmembrane conductance regulator (CFTR)  
CFTR is a transmembrane protein (Figure 2.5) and member of the ATP binding 
cassette transporter family (Chan, et al., 2006) located on the chromosome 7 
with 27 exon and 250kbp (Bargon, et al., 1992).  
CFTR is mostly expressed in the epithelial cell, although it is found in some 
non-epithelial tissue like cardiac myocytes (Bargon, et al., 1992; Hwang & 
Sheppard, 1999).  
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         Figure 2. 4 Ion transport modes of acid-base transporters.  IN, intracellular; OUT,   extracellular.                                                                                      
Source: (Liu, et al., 2012) 
 
CFTR is distributed in wide variety of systems as well as reproductive organs (Fiedler, 
et al., 1992; Snouwaert, et al., 1992). In the female, CFTR expression in the luminal 
and glandular epithelium of the uterus, ovary, oviduct, cervix and vagina has been 
reported where its regulation is steroid dependent (Trezise, et al., 1993). It has been 
reported that the expression of CFTR in uterine epithelial cell line (UTT 1.16), is E 
dependent, and CFTR mRNA has been observed in the presence of E. Furthermore E up 
regulated CFTR expression in immature and ovariectomized mature rat (Rochwerger & 
Buchwald, 1993; Rochwerger, et al., 1994). Chan, et al (2002) has reported maximal 
expression of CFTR occurs at proestrus in the cervical and vaginal epithelia although in 
uterine epithelium CFTR mRNA was only detected at early estrus. In addition there is 
large amount of CFTR in ovary and oviduct throughout the oestrous cycle. CFTR 
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however is down-regulated by P in mouse endometrium (Tsang, et al., 2001). In fetal 
rat lung, androgen increases while E decrease CFTR functional activity (Sweezey, et al., 
1997) 
 CFTR responds to increased levels of intracellular cyclic AMP (cAMP) by 
elevating secretion of Cl
-
 from cells (Bargon, et al., 1992), thus regulating the 
rate of transepithelial salt and water transport (Hwang & Sheppard, 1999). 
PKA activates CFTR via phosphorylation (Zhang, et al., 2000). However 
CFTR is also implicated in cAMP dependent HCO3
-
 secretion in the apical face 
of the endometrial epithelium in mice. Furthermore, CFTR participates in 
HCO3
-
 conductance  in airway, intestine and pancreas (Wang, et al., 2003a).  
Different CFTR regulators including cAMP, tumour necrosis factor, phorbol 
ester, divalent cations ionofor and E have been reported (Rochwerger, et al., 
1994).  
Increased activity of the CFTR Cl
-
 channel, may be involved in different 
diseases such as poly cystic kidney diseases and secretory diarrhoea (Hwang & 
Sheppard, 1999). Mutations in the gene encoding CFTR lead to lethal 
autosomal recessive disorder cystic fibrosis (CF). CF patients are affected by 
chronic obstructive lung disease, pancreatic insufficiency, intestinal 
malabsorption and obstruction, and have elevated levels of sweat electrolytes, 
due to atypical regulation of electrolyte transport in affected organs. It has 
documented that in CF patients, reproductive organs are affected in both 
genders. In the male anatomical abnormality in the epididym, in the female 
endocervicitis, uterine polyp, thick cervical mucus, alteration in cervical mucus 
content and failure in sperm capacitation has been reported without any 
anatomical deficiency (Bargon, et al., 1992; Rochwerger, et al., 1994; Wang, et 
al., 2003a) . 
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Figure 2. 5 CFTR molecule contain two non identical halves, each part has six transmembrane spanning 
domain, that connected to nucleotide binding domain (NBD) in each side, NBD1 and NBD2 attached to 
the regulatory domain (R)(Zhang, et al., 2000). Some CFTR stimulator , interact with NBD that control 
channel gating, whereas CFTR inhibitors bind to channel pore and prevent Cl- permeation.                                                                                                      
                                                                                          Source: (Toony, 2008) 
2.2.7.4 Chloride/bicarbonate exchanger  
Three main members of Cl
-
/ HCO3
- 
exchangers, group of AE: AE1, AE2 and AE3, are 
encoded by three different genes in mammals. The protein is homologous to band 3 in 
erythrocyte which functions as a Cl
-
/HCO3
-
exchanger. The Cl
-
/HCO3
- 
exchanger 
participates in various physiological process including regulation of pHi, cell volume 
and acid/base transport in a wide range of epithelial cells (Jensen, et al., 1999b). While 
three families encode different polypeptides in different cells and their exchanger 
activity and probably their regulatory mechanism vary in distinct cells (Zhao & Baltz, 
1996). They all mediate Cl
-
/ HCO3
-
 exchanger and their anion specificity is similar. The 
Cl
-
/ HCO3
-
 exchanger might respond to different physiologic stimulus and contributes in 
different physiologic functions. As an example it takes part in net acid or net base 
secretion in type A or type B intercalated cells respectively. In the medullary thick 
ascending limb ok kidney Cl
-
/ HCO3
-
 exchanger is involved in volume regulation 
(Jensen, et al., 1999b). 
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The AE family contains two main types of exchangers, Na
+
 dependent and Na
+
 
independent. Na
+
 dependent exchanger known as acid extruder (Figure 2.4), relies on 
the presence of Na
+
, the Na
+
 gradient drives HCO3
-
 inside the cell and increase pHi. The 
second type is Na
+
-independent exchanger, which known as band 3 in red blood cells. It 
is involved in Cl
-
 shift and mediate a HCO3
-
 efflux, thereby reduce the intracellular pH 
(Boron & Boulpaep, 1989)  
AE has been detected in the luminal membrane of secretory epithelia (Dorwart, et al., 
2008), during preimplantation stages in mice embryo, and is involved in pHi and cell 
volume regulation (Zhao & Baltz, 1996)  
The AE member of the uterus is SLC26A6, and it is located in the luminal membrane of 
secretory epithelia. It plays a role in Cl
-
 absorption and HCO3
-
 secretion and function as 
a Cl
-
/HCO3
-
 exchanger with a stoichiometry 1Cl
-
/2HCO3
-
. This role is crucial in 
production of high HCO3
-
 fluid in varies epithelia such as pancreatic duct (Dorwart, et 
al., 2008; Melvin, et al., 1999). 
There are different regulatory mechanisms for the SLC26 family, including 
transcriptional, protein trafficking and post translational modification (Lee, et al., 2003). 
Additionally PGE2 stimulate SLC26A6 activity (Dorwart, et al., 2008). 
There is an association between CFTR and Cl
-
/HCO3
-
 exchanger activity in the 
regulation of fluid secretion in pancreatic duct, in which SLC26A6 inhibit activity of 
CFTR in resting state and in stimulated state it raises the Cl
-
 channel activity of CFTR 
(Dorwart, et al., 2008). However there is lack of information about the expression of 
SLC26A6 under the influence of ovarian hormone, thus in this study it will evaluated. 
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 Figure 2. 6 Regulatory interaction between SLC26 transporters and CFTR regulates resting and 
stimulated fluid and electrolytes secretion.A PDZ domain-containing scaffolding protein assembles 
luminal membrane complexes of CFTR and the SLC26 transporters.To avoid unnecessary secretion in the 
resting state, the nonphosphorylated R domain interacts with NBD1 to prevent its interaction with NBD2 
and activation of CFTR Cl– channel activity . This interaction and inhibition of the spontaneous activity 
of CFTR is stabilized by SLC26A6 , by as yet unknown mechanism, to inhibit fluid and electrolyte 
secretion in the resting state. Activation of PKA phosphorylates the R domain to alter its binding to 
NBD1 and at the same time enhances its binding to the STAS domain . This results in the mutual 
activation of CFTR and the SLC26 transporters and activation of fluid and electrolyte secretion . This 
form of regulatory interaction has been demonstrated so far for slc26a3, SLC26A4, and slc26a6 but is 
likely to operate with other SLC26 .                                                 Source: (Dorwart, et al., 2008)  
 
2.2.7.5 Sodium- bicarbonate transporter  
NBC is involved in concomitant Na
+ 
and HCO3
-
 movement across the cell membrane of 
many cells (Boron & Boulpaep, 1989) and the direction of ions flux is cell dependent 
(Gross, et al., 2003). This coupled transport contributes to HCO3
-
 secretion/absorption 
and pHi regulation (Jensen, et al., 1999a) and extracellular acid–base regulation (Kurtz, 
et al., 2004). The stoichiometry of ions flux varies between cells and is 3HCO3
-
/1Na
+
  
(HCO3
- 
efflux) or 2 HCO3
-
/1Na
+
  (HCO3
- 
influx) in kidney and pancreatic duct 
respectively (Gross, et al., 2001). The stoichiometry of NBC is regulated by cell 
specific factor and PKA is able to switch between these two modes (Gross, et al., 2003). 
Two well-known NBC1 member are located in pancreas (pNBC) and kidney (kNBC) 
(Abuladze, et al., 1998) and are from the SLC4A4. There are 994 amino acid 
similarities in their C-terminal, while they differ in N-terminal. kNBC is specific to 
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kidney but pNBC has been detected in other organ such as brain, spinal cord,  colon, 
kidney, liver, prostate, stomach and thyroid (Abuladze, et al., 1998). Another NBC1 
variant that differs in the COOH terminal has been identified in rat brain (Roussa, 
2011).  In kidney NBC is located on the basolateral membrane of proximal tubule and is 
involved in electrogenic HCO3
-
 flux (Abuladze, et al., 1998; Yoshitomi, et al., 1985). In 
pancreas basolaterally located NBC contributes to 75% of HCO3
-
  uptake during apical 
HCO3
-
 secretion, whereby the Cl
-
/base exchanger and CFTR secrete HCO3
-
  into the 
lumen and provide HCO3
-
  rich fluid (Abuladze, et al., 1998; Ishiguro, et al., 1996a; 
Ishiguro, et al., 1996b). The basolateral application of H2DIDS (an NBC inhibitor), lead 
to 80% reduction in HCO3
-
 secretion, indicating involvement of NBC in HCO3
-
 uptake 
from the basolateral side of mouse endometrium (Fong, et al., 1998b; Wang, et al., 
2002).  
NBC activity is dependent on internal pH sensitive site of the protein that inhibits its 
activity in alkaline pH and affects Na
+
 and HCO3
-
 flux (Gross & Hopfer, 1999; 
Soleimani, et al., 1991).  
NBC activity is associated with the CAII and the Cl
-
/HCO3
-
 exchanger. There is close 
interaction between C-terminal of AE1 and amino-terminal of CAII. CAII stimulates 
AE activity, thus inhibition of CAII by ACTZ reduces AE function. NBC1/AE1 share 
the homologues region at C-terminal and the C-terminal of kNBC1 has interaction with 
CAII (Gross, et al., 2001, 2002, &2003).  
Phosphorylation of kNBC or pNBC following PKA activation lead to dissociation of 
CAII  from the transporter and decreases the effect of CAII inhibition (Gross, et al., 
2003; Sterling, et al., 2001a, 2001b; Vince & Reithmeier, 1998),  and thus can influence 
both NBC and AE.   
NBC expression and functional activity has been reported to be regulated by multiple 
factors including hormones and paracrine agents. Parathyroid hormone has been 
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reported to induce basolateral membrane NBCe1 expression, thus increasing intestinal 
HCO3
-
 secretion, particularly in the ileum (Charoenphandhu, et al., 2011). Secretin has 
been reported to increase basolateral HCO3
-
 uptake in the pancreatic duct (Futakuchi, et 
al., 2009). Angiotensin II has been reported to inhibit the electrogenic NBC activities in 
cardiac myocyte (De Giusti, et al., 2010). As the female reproductive tissues usually 
bear E and P receptors (ER & PR) and are sensitive to the influence of sex-steroids 
(Samartzis, et al., 2012), uterine NBC expression and activities would probably be 
influence by these two hormones. In view of this, this study was conducted to 
investigate the changes in the expression as well as functional activity of this protein 
SLC4A4 under the influence of sex-steroid hormones and at different stages of the 
oestrous cycle in a rodent model. 
2.2.7.6 Sodium-Hydrogen exchanger  
NHE isoforms are integrated plasma membrane protein that exchange intracellular H
+
 
with external Na
+
 with stoichiometry of 1H
+
: 1Na
+
, according their concentration 
gradient and in reversible fashion. They belong to the solute carrier family9 of 
exchanger, (SLC9) (Chavez, et al., 2011; Yun, et al., 1995b). Mammalian NHE consists 
9 member (NHE1-9), and are present in almost all living cells (Dunham, et al., 2004; 
Orlowski & Grinstein, 2004). NHE is involved in cell volume changes, pHi regulation 
and acid-base balance (Praetorius, et al., 2000; Wang, et al., 1993). Its activity 
facilitates cellular adhesion, migration and proliferation. NHE is one of the major non-
nutritive Na
+
 absorptive pathway in intestine and rat kidney (Praetorius, et al., 2000). 
NHE family genes encode proteins with 25-70% identity, although they share secondary 
structure that consist 12 conserved membrane spanning region at the amino terminal 
and divergent cytoplasmic carboxy terminal segment (Orlowski & Grinstein, 2004). The 
expression pattern and membrane localization vary among different isoforms. 
Furthermore, they differ in kinetic properties and sensitivity to inhibitors, and probably 
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they vary in hormonal regulation, mechanical stimulation and responses to growth 
factor and protein kinase (Orlowski & Grinstein, 2004; Yun, et al., 1995a).  
Wide variety of molecular signal are able to effect the NHE activity such as 
neurotransmitter, growth factor, peptide hormone, phorbel ester, cAMP, chemotactic 
factors, glucocorticoid and thyroid hormone (Kandasamy & Orlowski, 1996) 
NHE exchange extracellular Na
+
 with intracellular H
+
, leads to acid extrusion that 
accumulates during cell metabolism; hence NHE along with HCO3
-
 transporter 
contributes to the regulation of pHi (Orlowski & Grinstein, 2004). 
 NHE probably is involved in HCO3
-
 absorption from the epithelial cell, for example, 
15% of HCO3
-
 absorption in thick ascending Henle’s loop is dependent to luminal NHE 
(Good, 1985). Furthermore in epididymis NHE2 and NHE3 are contributed in HCO3
-
 
transport that resulted in luminal acidification (Bagnis, et al., 2001). In salivary gland 
NHE involved in both fluid absorption and secretion activity (Martinez & Cassity, 
1985). The presence of three NHE isoform in uterus has been reported, NHE1,2 and 
4(Wang, et al., 2003b). 
2.2.7.6.a NHE1 
 NHE1 widely present in almost all mammalian cell such as intestine, kidney, red blood 
cell, brain and male reproductive tract (Chew, et al., 2000; Douglas, et al., 2001; 
Dunham, et al., 2004). It has a house keeping role and is involved in the pHi and cell 
volume homeostasis by extruding H
+
 out and Na
+
 into the cell (Baumgartner, et al., 
2004; Bookstein, et al., 1994; Praetorius, et al., 2000). NHE1 consists of 500 amino 
acid transport domain that extend into the cytoplasm and contain 12 membrane 
spanning domain (Wang, et al., 2003b). NHE1 activity is regulated by pHi, and 
intracellular acidosis increase NHE1 activity through the interaction between H
+
 and 
pHi sensor of NHE (Haworth, et al., 2003). NHE1 in parallel with Cl
-
/HCO3
-
 exchanger 
facilitated NaCl and water flux, thus they involved in cell volume regulation in red 
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blood cell (Dunham, et al., 2004). The interaction of NHE1 with Cl
-
/HCO3
-
 exchanger 
and NBC maintains cytoplasmic pH and acid-base balance. NHE1 participates in fluid 
absorption in male reproductive tract, in which amiloride reduced fluid absorption in the 
epididymis (Karhumaa, 2002).  NHE1 is involved in cell morphology, adhesion and 
migration, probably via remodeling the cortical actin cytoskeleton (Orlowski & 
Grinstein, 2004).  NHE1 contain a relatively conserved N-terminal, transmembrane ion 
translocation domain and a cytoplasmic regulatory C-terminal domain that serve as a 
target for a different regulator factor (Orlowski & Grinstein, 2004).  
2.2.7.6.b NHE2 
 NHE2 has been detected in intestine, gastrointestinal tract, lungs and skeletal muscles 
(Bookstein, et al., 1997; Chambrey, et al., 1998; Hoogerwerf, et al., 1996; Wang, et al., 
1993). HCO3
-
 reabsorption in the distal convoluted tubule is regulated by H
+
 secretion 
via NHE2 (Malakooti, et al., 1999; Orlowski & Grinstein, 2004; Orlowski, et al., 1992). 
NHE2 is involved in net Na
+
 and H
+
 transepithelial transport in several absorptive 
epithelia (Bagnis, et al., 2001). It has 42% similarity to NHE1 (55% in N- terminal 
transmembrane domain and 25% in C-terminal cytoplasmic domain), while NHE2 and 
NHE3 have 36%  in common in which 48% similarity is in transmembrane domain and 
21% similarity for cytoplasmic region. Similarity of NHE2 with NHE4 is approximately 
57% (63% for transmembrane and 46% cytoplasmic region).  
2.2.7.6.c NHE4 
In the kidney NHE4 is located on  the basolateral side of renal epithelia, where its 
function may overlap with NHE1 (Orlowski & Grinstein, 2004). It is also detected in 
cortical collecting duct, macula densa (Peti-Peterd, et al., 2000) and intestine (Bagnis, et 
al., 2001). NHE4 has been reported to be active under hypertonic condition and thus 
involved in cell volume regulation (Bagnis, et al., 2001). 
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NHE4 basolateral location is not affected by acids –base disturbances (Oehlke, et al., 
2006). It has been reported that NHE4 is not active under most physiological condition 
(Bookstein, et al., 1997) 
2.3 Interaction between CA and other transporters in different 
epithelial cells  
It has been suggested that CAII and CAIV (an active, membrane enzyme), form an 
active metabolon with AE isoforms and NHE1 (Breton, 2001; Hynninen, et al., 2004). 
In epididym CAIV involved in HCO3
-
 reabsorption while CAII supplying H
+
 for 
secretion mediated by different ion transporters (Kaunisto, et al., 1995). CA II along 
with PP contributes to epididymal luminal acidification which is dependent on the 
HCO3
-
 (Breton, et al., 1998). In addition to CA, epididymal luminal acidification, is Na
+
 
independent in proximal vas deferens, while in cauda epididym is Na
+
 dependent that 
indicating that NHE has a role (Au  & Wong, 1980; Jensen, et al., 1999a). 
In pancreatic duct, CAs contributes in self-defense mechanism against luminal 
acidification. Under acidic condition, CAs catalyze H
+
 + HCO3
-
  CO2 + H2O, thus 
removing extra acid from the lumen while CO2 passing through the membrane and enter 
the blood or renters the HCO3
- 
cycle (Nishimori & Onishi, 2001).  CO2 is only 
responsible for 50% of HCO3
-
 in pancreatic juice, and the high HCO3
-
 level is 
accumulated by Cl
-
/ HCO3
-
exchanger along with CFTR and NBCe1 activity in the 
apical membrane and HCO3
-
 uptake in the basolateral membrane through NBC or Na
+
 
dependent Cl
-
/ HCO3
-
exchanger (Gross, et al., 2001; Gross, et al., 2002; Ishiguro, et al., 
1996a). Furthermore in pancreas, CFTR act as a key regulator of different protein 
channels such as NBC, SLC26A6 and NHE3 (Steward & Ishiguro, 2009). 
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In colon, CA contributes in electroneutral NaCl absorption via synchronous operation of 
apical NHE and Cl
-
/ HCO3
- 
exchanger. Thus by supplying HCO3
- 
to Cl
-
/ HCO3
-
exchanger, CA involved in alkalization of luminal content (Halmi, et al., 2004).  
Net HCO3
- 
absorption in kidney results from H
+
 secretion into the lumen by NHE3 and 
PP. Then in the lumen, H
+
 combines with filtered HCO3
- 
by CAIV and produce CO2. 
CO2 across the membrane and in the cytoplasm converted to HCO3
- 
via CAII, which 
exit from the cell by basolateral NBC (Seki, et al., 1996). 
It has been reported that in non-pigmented ciliary epithelium in pig,  CAII and CA IV in 
coordination with AE2 are involved in aqueous humour secretion through affecting 
HCO3
- 
transport into the eye (Shahidullah, et al., 2009). 
In salivary gland, NHE activity coupled with Cl
-
/ HCO3
- 
exchanger is associated with 
pH regulation. In acinar cells NHE and CAII activity might enhance the Cl
-
/ HCO3
- 
exchanger activity via accumulation of HCO3
-
. Application of acetazolamide reduces 
the Cl
-
/ HCO3
- 
exchanger activity (Nguyen, et al., 2004). 
Taken together this indicates that close interaction exists in among different transporter 
that influence net H
+
 and HCO3
-
 transport. 
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3- Methodology 
3.1 Chemicals and consumables 
4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), acetazolamide, N-ethyl-N- 
isopropyl amiloride (EIPA), 17 beta-oestradiol, progesterone, glibenclamide, 
acetazolamide and ammonium persulfate  (Sigma, St. Louis, USA).  
Pro-Prep protein extraction solution (Intron Biotechnology, Korea). Micro BCA Protein 
Assay Kit (Thermo Scientific, Rockford, USA). βeta actin antibody (Abcam, UK). 4CN 
optic substrate kit and Polyvinylidene fluoride membrane (PVDF) (Bio Rad, Alfred 
Nobel Drive Hercules, CA, USA).   
Bovine serum albumin (Innovative, Peary Court Novi, Michigan, USA). Spectra 
multicolor broad range (Fermentas, Rockford, USA). Paraformaldehyde, TEMED 
(Merck, Germany). ABC staining kit and all primary and secondary antibodies (Santa 
Cruz, Delaware Avenue,CA, USA), Polylysine coated slide (Menzal, Germany). DPX 
mounting medium (Sigma, St. Louis, USA). 
Micro Amp fast 8 tube strip, Micro Amp Optical cap strip. RNAlater, Taq Man RNA to 
CT 1step, and RNA assays (Applied Biosystems,Lincoln Centre Drive, Foster City, 
USA).   Ribo pure kit, RNase away and RNAlater
®
 (Ambion, Lincoln Centre Drive, 
Foster City, USA). 
3.2 Sterilization 
Solutions, plastic and glass disposables were sterilized by autoclaving for 20 min at 1.05 
kg/cm2 (15 psi) on liquid cycle. Distilled water (dH2O) was used for analytical purposes 
throughout the study. Nuclease-free H2O was used for studies with RNA. 
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3.3 Approval by Animal Ethic Committee 
Animal studies were approved by Medicine Animal Care and Use Committee (ACUC) 
University of Malaya, the Ethic number is 14/9/2009/FIS/NS. Wistar Kyoto (WKY), 
female rats (Rattus norvegicus), approximately 2 months of age and 180-230 g weight 
were obtained from animal house of University of Malaya. Rats were caged in groups of 
4  in polycarbonate cage, 19" X 10" X 6" high with bedding in a clean and well 
ventilated animal Laboratory in animal house of the Department of Physiology, Faculty 
of Medicine, University of Malaya. Rats were maintained with a standard cycle of 12 
hours light  (light is on at 7 a.m), and 12 hours dark, room temperature kept at ± 25°C, 
and humidity of 30-70%. Animals were provided with soy-free diet (Gold Coin Pellet, 
from Altromin, Germany) and tap water ad libitum.  
3.4 Study samples 
Rats were divided into different groups (table 3.1). In-vivo uterine perfusions were 
conducted in all groups to analyze the changes in the pH, secretion rate, Na
+
, Cl
-
 and 
HCO3
-
 content of the uterine fluid.  Following perfusions, the animals were humanely 
sacrificed and the uterine horns were collected for Western blotting, 
immunohistochemistry (IHC) and quantitative real time PCR (qPCR). 
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                      Table 3.  1 Different experimental groups that have been used in this study. 
F
em
ale W
K
Y
 R
ats 
O
v
ariecto
m
ized
 rats 
Perfusion without inhibitor 
Western blot, IHC, qPCR 
Perfusion in the presence of  different inhibitors 
1- Control (3 days peanut oil) I. Control (perfusion with glibenclamide) 
II. Control (perfusion with DIDS) 
III. Control (perfusion with ACTZ) 
IV. Control (perfusion with EIPA) 
2- 0.2µg estrogen,3 days 
(0.2E) 
I. 0.2E (perfusion with glibenclamide) 
II. 0.2E (perfusion with DIDS) 
III. 0.2E (perfusion with ACTZ) 
IV. 0.2E (perfusion with EIPA) 
3- 4 mg progesterone (3 days) 
(P) 
I. P (perfusion with glibenclamide) 
II. P (perfusion with DIDS) 
III. P (perfusion with ACTZ) 
IV. P (perfusion with EIPA) 
4- 0.2µg estrogen + 4mg 
progesterone, each for 3 days, 
(E+P)* 
I. E+P (perfusion with glibenclamide) 
II. E+P (perfusion with DIDS) 
III. E+P (perfusion with ACTZ) 
IV. E+P (perfusion with EIPA) 
5- 2µg estrogen (3 days) 
6- 20µg estrogen (3 days) 
7- 50µg estrogen (3 days) 
In
tact R
ats 
8- Proestrus (Ps) I. Ps (perfusion with glibenclamide) 
II. Ps (perfusion with DIDS) 
III. Ps (perfusion with ACTZ) 
IV. Ps (perfusion with EIPA) 
9- Estrus (Es) I.  Es (perfusion with glibenclamide) 
II. Es (perfusion with DIDS) 
III. Es (perfusion with ACTZ) 
IV. Es (perfusion with EIPA) 
10- Metestrus (Ms) I. Ms (perfusion with glibenclamide) 
II. Ms (perfusion with DIDS) 
III. Ms (perfusion with ACTZ) 
IV. Ms (perfusion with EIPA) 
11- Diestrus (Ds) I. Ds (perfusion with glibenclamide) 
II. Ds (perfusion with DIDS) 
III. Ds (perfusion with ACTZ) 
IV. Ds (perfusion with EIPA) 
Perfusion was performed with and without inhibitors. In groups 5-7, in which the rats were treated with 
high doses of E, perfusions were conducted without the presence of inhibitors. Meanwhile, in other 
groups , the perfusions were conducted as follows: 1- perfusion without any inhibitor 2- perfusion with 
glibenclamide 3- perfusion with DIDS 4- perfusion with ACTZ 5- perfusion with EIPA. Six rats were 
used in each group. 
*: Another group that was used in this study is 0.2µg estrogen+ peanut oil, each for 3 days, (this treatment 
was used to specifically evaluate the inhibitory effect of progesterone on the expression of CFTR and 
SLC26A6). We were only able to load 7 groups during western blotting, thus in chapter 4 this group 
replaced 2µg estrogen for qPCR, WB and IHC. No perfusion was conducted for this group. 
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.3.5.2 Animal and surgical procedures 
3.5.2.1 Anaesthesia  
In this study animals were anaesthetized with ketamine (80 mg/kg) and xylazine 
(8mg/kg) injected intraperitoneally (IP). Ketamine is hydrochloric salt and is used for 
induction and maintenance of general anaesthesia, in combination with a sedative such 
as xylazine. Xylazine is a drug used for sedation, anaesthesia, muscle relaxation and 
analgesia in animals. The depth of anaesthesia was monitored by the loss of plantar 
reflexes while breathing movement was maintained. 
3.5.2.2 Ovariectomy 
 Rats were anesthetized prior to ovariectomy which is used to eliminate endogenous 
steroid hormones. During surgery, a heat pad was used to maintain body temperature 
and vital signs were regularly monitored. 90% ethanol was used to sterilize all surgical 
instruments to reduce contamination. 
Following anaesthesia rats were placed in left lateral position. Ovaries are located at 
caudal end of the ribs on lateral side of the animal. The area was shaved and swabbed 
with 90% ethanol to completely remove the fur. A small incision was made in the skin, 
after removing connective tissue where a second incision was made through the muscle; 
ovary can be seen between fats at the peritoneal cavity. The ovary was removed and 
remaining part of the oviduct and uterus was pushed back into peritoneal cavity. The 
incision in muscle and skin was sutured and same procedure was repeated for the left 
ovary (Parhizkar, et al., 2008). After surgery, the animals were given intramuscular 
injection of 0.1 ml of Kombitrim antibiotic to prevent any post-surgical and wound 
infection.  
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3.5.2.3 Administration of sex steroid  
10 days after ovariectomy, rats were treated with 4 mg progesterone, (1mg progesterone 
dissolved in 0.1 ml peanut oil) or 0.2 µg 17-β estradiol, (dissolved in 0.1 ml peanut oil) 
which injected subcutaneously behind the neck. Control animals were treated with same 
volume of peanut oil (vehicle) (Salleh, et al., 2005). Some experimental groups received 
higher dosage of E (2, 20 and 50µg) similar to that used in oral contraceptive pills 
(Petitti, 2003). One group was treated with 0.2µg oestradiol (3 days) +4mg progesterone 
(3 days), to roughly mimic steroid trend during oestrous cycle. Treatments were carried 
on for 3 days in all study groups. One day after treatment the rats subjected to perfusion. 
3.5.2.4 Identification of stages of the oestrous cycle  
There is fluctuation in ovarian hormone levels during the female reproductive cycle 
(Figure 3.1). The oestrous cycle is 4-5 days in the rat and includes proestrus, oestrus, 
metestrus (early diestrus), and diestrus. Table 3.2 lists the characteristics of each stage 
(Islam, et al., 2008). 
The determination of the stages of the oestrous cycle was achieved by observation of 
vaginal smear under light microscope. Vaginal secretion was collected with a plastic 
pipette filled with 10 µl normal saline (NaCl 0.9%) and smoothly inserted into the rat 
vagina. The vaginal fluid was placed on the slide after collection, unstained material 
was observed under light microscope and proportion of different cell type was used to 
determine each stage. Three types of cells could be seen: round and nucleated cells are 
epithelial cells that is in proestrus stage; irregular cells without nucleus are the cornified 
cells can be seen in oestrus; the small round ones are leukocyte which is in high amount 
at diestrus and at metestrus the proportion of three different cells are similar  (Islam, et 
al., 2008; Marcondes, et al., 2002). Following determination the stages of oestrous 
cycle, perfusion was carried out. 
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Stage of the 
oestrous cycle 
Characteristics 
proestrus 
(12-13 hours in 
rat) 
According the species one or several follicles start to grow 
Last 1days-3 weeks 
Endometrium develop 
Female is not sexually receptive 
estrus 
(25-27 hours in 
rats) 
Female is sexually receptive 
Estrogen secretion exert the biggest influence 
Ovulation 
metestrus 
(early diestrus) 
(6-8 hours in rats) 
Sign of estrogen reduce 
Corpus luteum start to form 
Progesterone secretion is very low 
1-5 days 
Diestrus 
(55-57 hours) 
Activity of corpus luteum ,secrete progesterone 
If pregnancy does not occur, uterus reorganised for next cycle 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Figure 3. 1 Hormonal profiles during the female reproductive cycle. Oestrogen 
level is high at early proestrus and estrus, while at diestrus progesterone increase. 
                                                                            Source: (Simpson & Kelly, 2012) 
 
Table 3.  2 Characteristic of different stages of the oestrous cycle, in rat this cycle is 
4 to 5 days. Adapted from (Islam, et al., 2008; Westwood, 2008) 
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3.6 Perfusion   
Uterine perfusion is used to collect uterine fluid in order to measure its pH and ionic 
content.  Uterine flushing can be used to collect the fluid, but it results in tissue damage 
and contamination of uterine fluid with interstitial fluid (Milligan & Martin, 1984), 
while the fluid volume  is low (Armstrong, 1968; Salleh, et al., 2005). 
 To perform uterine perfusion, the rats were brief anesthetized with IP injection of 
ketamine and xylazine HCl and maintained under anesthesia during the experiment. In 
this study only one horn was perfused in all groups and the other horn was collected for 
western blotting, IHC and qPCR.  After anaesthesia, a small incision was made on a 
flank to expose the distal end of the uterine horn. An inflow prefilled fine polythene 
tubing of 15cm (ID 0.38mm, OD 1.09mm) was inserted into the uterine lumen at the 
uterotubal junction and tied there. The outflow tubing, 10 cm, with same diameter was 
inserted into the uterocervical junction and tied there after the ventral incision was 
made.  
The cannula had minimal insertion into the lumen but had a slightly heat-flared ending 
to prevent them being readily pulled out by any ongoing uterine contractions. The 
Standard Infusion Harvard Pump 11 Plus Syringe (Hill Road Holliston, Massachusetts, 
USA), was used to deliver perfusion medium at constant rate of 1.3µl/min. A single 
sample of uterine fluid was collected into small, pre- weighed polythene tubes for a 
period of 3 hours as (figure 3.3). 
Figure 3. 2 Identification ofthe  oestrous cycle under light microscope. 
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3.6.1 Preparation of perfusion buffer  
The composition of uterine perfusion fluid is based on published data showing that 
uterine luminal fluid has low Na
+
 and high K
+
 and contains NaCl, Na2HCO3, Na2HPO4, 
KCl, MgSO4, HEPES, CaCl2, glucose (Aguilar & Reyley, 2005; Salleh, et al., 2005). 
The concentration of Na
+
 in the uterine fluid is approximately 124mEq/l in intact rat 
(Nordenvall, et al., 1989) and human during the follicular phase of the menstrual cycle 
(Clemeston, et al., 1970). Na
+
 content of uterine are determined to be higher under the 
influence of E (128mEq/l) compared with P (119mEq/l) and control group (100mEq/l) 
(Tantayaporn, et al., 1974).  Nordenvall (1989) reported P administration increased Na
+ 
concentration (from 124 to 134 mEq/l).  
The K
+
 concentration in uterine luminal fluid is higher than plasma and it is affected by 
the hormonal status of animal. For example, its value within the oestrous cycle is 
35.3mmol/l, in pseudopregnancy 46.2 and during implantation 46.8 (Clemeston, et al., 
1970). However Nordenvall (1989) reported that K
+
 concentration was 22.3+2.4mEq/l 
during rat oestrus cycle which is less than earlier report. These differences could be due 
to different fluid collection methods whereby Clemeston (1970) used either uterine 
flushing or ligated uterine horns, and Nordenvall used microdialysis.  
 Based on these observations the following composition of perfusate was selected:  
110.0 NaCl mmol/L, 14.3 Na2HCO3, 1.0 Na2HPO4 (total Na
+
 concentration= 125.3), 15 
KCl, 0.8 MgSO4, 10.0 HEPES, 1,8 CaCl2 and 5.5 glucose with pH=7.34 (Salleh, et al., 
2005). 
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Figure 3. 3 Procedure of uterine perfusion. Inflow tubing (a) was inserted into the uterine lumen at 
uterotubal junction, and outflow tubing (b) was put into the uterocervical junction. The uterine fluid 
was collected into the eppendorf tube (c). Infusion pump (d) delivered the buffer with constant rate 
during perfusion. 
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3. 6.2 Inhibitors 
To investigate the role of carbonic anhydrase (CA), CFTR, HCO3
-
 transporter and NHE 
on the pH, volume and ionic content of the uterine luminal fluid, a related inhibitor was 
added to perfusate solution in different experimental group in table 3.1. After 3 hours 
collection of the uterine fluid, pH, volume and ionic content (Na
+
, Cl
-
, HCO3
-
) were 
monitored and contribution of ionic channel and enzymes on the composition of the 
uterine fluid composition was determined. 
 3.6.2.1 Glibenclamide 
 5-Chloro-N-[4-(cyclohexylureidosulfonyl) phenethyl]-2- methoxybenzamide,glyburide, 
N-p-[2-(5-Chloro-2- methoxybenzamido) ethyl] benzenesulfonyl-N′-cyclohexylurea 
(Table 3.3), is CFTR inhibitor. Glibenclamide, also known as glyburide, is an anti-
diabetic drug, and is used in the treatment of type II diabetes. Glibenclamide is a 
sulfonylureas, and is able to inhibit CFTR, Cl
-
 channels in epithelial cell (Hwang & 
Sheppard, 1999; Yamazaki & Hume, 1997).  In this study,  glibenclamide with 
concentration of 200 µM (Wang, et al., 2003a) was used to inhibit CFTR activity. 
3.6.2.2 DIDS 
 4′-Diisothiocyanatostilbene-2,2′-disulfonic acid disodium salt hydrate (DIDS), (Table 
3.3), is used as an anion inhibitor, and is able to inhibit  Cl
-
/HCO3
-
 exchanger and NBC. 
DIDS is one of the most effective members of stilbene disulfonates,  which are potent 
inhibitors of inorganic anion exchanger (Poole & Halestarp, 1991). DIDS is also able to 
inhibit the voltage dependent CFTR Cl
-
 channel (Hwang & Sheppard, 1999) through the 
intracellular pathway not extracellular (Zhang, et al., 2000). DIDS concentration in this 
study was 500 µM. 
 50 
 
3.6.2.3 EIPA  
5-(N-Ethyl-N-isopropyl) amiloride (EIPA), (Table 3.3), is selective blocker of Na
+
/H
+
 
antiporter. EIPA is amiloride derivative. EIPA binding affinity for different NHE 
isoform is as follows : NHE1>NHE2>NHE5>NHE3 (Masereel, et al., 2003). EIPA 
concentration was 100µM in this study (Brown, et al., 2003). 
3.6.2.4 Acetazolamide 
 C4H6N4O3S25-Acetamido-1,3,4-thiadiazole-2-sulfonamide,N-(5-Sulfamoyl-1,3,4-
thiadiazol-2-yl) acetamide, N-(5-[Aminosulfonyl]-1,3,4-thiadiazol-2-yl) acetamide 
(ACTZ), (Table 3.3), a  membrane permeable CA inhibitor (Berg, et al., 2004). It is 
able to inhibit cytosolic CA in the uterus.  CA catalyzes the reversible reaction: 
CO2 + H2O     CA         H2CO3     CA     H
+
 + HCO3
-
 
In above reaction, CO2 and H2O produce H2CO3 and finally H
+
/HCO3
-
 which is 
reversible. All the above reactions are mediated by CA and ACTZ are able to inhibit 
this reaction. The ACTZ is known under the trade name Diamox, used for the treatment 
of different diseases such as glaucoma, epileptic seizures, benign intracranial 
hypertension (pseudotumor cerebri), altitude sickness, and it is known as a diuretic. In 
glaucoma, for example ACTZ application decreases fluid formation in the eye and 
thereby reduces intraocular pressure. In this study ACTZ was used to inhibit CA 
activity in uterus with concentration of 100 µM (Breton, et al., 1998).  
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              Table 3.  3 Formula, molecular weight (MW) and structure of different inhibitors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.6.4 Sample analysis 
3.6.4.1 pH measurement 
 The pH of collected uterine fluid was measured by HI 8424 NEW pH meter from 
Hanna instrument (Woonsocket, RI, USA). It is micro pH meter and is suitable for 
small sample size. For measuring the pH, first electrode was calibrated at pH=4 and 
pH=7, then the sample was introduced to electrode.   
 3.6.4.2 Fluid secretion rate 
 In order to measure the fluid secretion rate, the net weight of the collected fluid was 
divided by the total perfusion time (180 minutes).      
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   3.6.4.3  Measurement of HCO3
-
  
 All ionic measurement was performed by used of ADVIA Chemistry (Siemens, USA). 
HCO3
-
 was quantified by enzymatic assay with the ADVIA Chemistry Carbon Dioxide 
Liquid (CO2-L) method based on the phosphoenolpyruvate carboxylase (PEPC) 
catalyzed reaction of HCO3
- 
with phosphoenol pyruvate to produce oxaloacetate.  
Malate dehydrogenase (MDH) is used to catalyze the indicator reaction in which the 
amount of reduced nicotinamide adenine dinucleotide (NADH) analog, was oxidized 
with the decreased absorbance at 410/478 nm, while is proportional to the amount of 
CO2 in the sample. 
3.6.4.4 Measurement of Na
+
 
 The ADVIA Na
+
 method is based on an indirect potentiometric procedure using an ion 
selective electrode (ISE). The Na
+
 ISE responds selectively to Na
+
 ions according to the 
Nernst equation. The sample is mixed with ISE buffer, thereby providing a constant pH 
and a constant ionic strength solution. As the buffered sample moves through the ion 
selective electrode, changes in the electrical potential take place. These electrical 
potential changes are measured against the potential of a reference electrode in order to 
derive the correct analog value for that sample. 
3.6.4.5 Measurement of Cl
- 
  The ADVIA Cl
-
 method is based on an indirect potentiometric procedure using an ion 
selective electrode (ISE). The Cl
-
 ion selective electrode responds selectively to Cl
-
 ions 
according to the Nernst equation. 
For each ionic measurement 100µl of sample has been used. 
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3.7 Protein expression 
3.7.1 Western blotting 
 3.7.1.1 Principle of the study 
 Western blots which are known as a protein immunoblot, are performed to determine 
the molecular weight of a targeted protein and to estimate relative amounts of the 
protein present in different samples. 
The first step is to separate the proteins by gel electrophoresis (SDS-page), then antigen 
is transferred to the blotting membrane electrophoretically. Following antigen binding 
to the membrane, the remaining protein binding site on the membrane is blocked to 
reduce nonspecific protein binding. Next primary antibody is added to react with the 
protein of interest. After reaction of target by primary antibody, the membrane is 
incubated with secondary antibody linked with horse radish peroxidase, which allows 
interaction between primary and secondary antibody. Finally, the target protein is 
visualized with incubation of membrane with substrate detection reagent. The substrate 
cleaved the horse radish peroxidase linked to the secondary antibody and produce 
colorful band (Walker, 1996). 
3.7.1.2 Sample collection 
 In each study group, (described in table 3.1) after uterine perfusion, the intact horn of 
uterus was removed. The organs were immediately frozen in liquid nitrogen (-196ºC), 
samples was transferred to -80°C for long term use. 
3.7.1.3 Protein extraction 
 Protein extraction was achieved with the usage of PRO-PREP protein extraction 
solution, which is able to extract protein from whole cell, nucleus, membrane and 
cytoplasm. The buffer contain highly denaturing ionic detergent such as  sodium 
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dodecyl sulphate (SDS),  lithium dodecyl sulphate and  sodium deoxycholate that 
isolate protein as a monomeric form for western blotting and molecular weight 
analaysis;  and non-ionic detergent,  such as Triton X-100 and applied in protein –
protein interaction. It also include zwitterioninc detergent CHAPS (3-[(3-
Cholamidopropyl) dimethylammonio]-1- propanesulfonate ) that is more effective in 
disrupting protein-protein interaction.  
The work flow was as follow:  
1- 30mg of uterus was cut and soaked in 600µl of extraction solution.  
2- The tissue was homogenized with ultrasonic cell disruptor (Branson) to disrupt the 
tissue; it was placed on ice. 
3- The sample was then kept at -20°C for 30 minute to induce cell lysis, after that 
second round of homogenization was performed and sample transferred to -20°C for 30 
more minutes. 
4- The sample was centrifuged at 13000rpm, 4°C, 10minutes, and the supernatant was 
transferred to new 1.5ml tube and placed in -20°C.  
3.7.1.4 Determination of the protein concentration 
 Protein concentration was determined by Micro BCA Protein Assay Kit. The kit 
includes micro BCA reagents and albumin standard ampule which contains Bovine 
Serum Albumin (BSA) at 2mg/ml in 0.9% saline and 0.05% sodium azide. The protein 
assay kit is a detergent-compatible bicinchoninic acid formulation for the colorimetric 
detection and quantitation of total protein. Bicinchoninic acid (BCA) is the detection 
reagent for Cu
+1
, which is formed when Cu
+2
 is reduced by protein in an alkaline 
environment. A purple-colored reaction product is formed by the chelation of two 
molecules of BCA with one cuprous ion Cu
+1
. This water-soluble complex exhibits a 
strong absorbance at 570 nm that is linear with increasing protein concentrations. 
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The protein concentration was calculated from a linear plot of BSA standard 
concentration (on the x axis) of the intensity of color changes absorbance obtained from 
the reaction between BSA and BCA reagent. BSA standard was prepared at 
concentrations of 200, 40, 20, 10, 5, 2.5, 1, 0.5 and 0 µg/ml. Tissue samples were 
diluted 1 in 5 with PBS. 50 µl of sample or standard was added to 50 µl of BCA reagent 
in a 96 well plate in triplicate. The plate was incubated at 37ºC for 2 hours, after while 
the intensity of color changes in each well was qualified by a plate reader at 570nm. 
Protein standard curve was generated and the concentration (µg/ µl) of samples 
calculated from the standard curve. 
 
 
 
 
 
 
 
  
 
 
                         
                             
3.7.1.5 Principle of SDS-PAGE 
 SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) is a useful 
technique for detection, quantification, and characterization of a specific protein 
(Pettegrew, et al., 2009). Migration of protein in electrophoresis is based on its charges, 
mass, size and strength of electrical fields. 
The matrix is polyacrylamide gel which is polymer of acrylamide and bis-acrylamide 
(both from Sigma, USA). The presence of N,N,N',N'-tetramethylethylenediamine 
(TEMED), and ammonium persulfate (APS), catalyzes the gel polymerization (Walker, 
Figure 3. 4 Standard curve for protein determination. 
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2007). The separation of molecule within the gel is determined by size of the pores that 
formed within the gel. Low percentage of polyacrylamide gel is suitable for high 
molecular weight protein while increase in polyacrylamide percentage is appropriate 
matrix for low molecular weight protein. 
SDS is an ionic detergent which is used in polyacrylamide gel. SDS denatures the 
protein and makes them negatively charged. The charge is equally distributed to the 
protein molecule based on the protein length that leads to migration of protein according 
their size. 
3.7.1.6 Running Western blotting 
 3.7.1.6.a Running Polyacrylamide gel 
 Polyacrylamide consist of two different gel formulation, first is resolving gel which 
used at the bottom of gel caster with a pH at 8.8. In this study resolving gel with 12% 
(for CAXII, NHE 1, NHE2, NHE4, CFTR, SLC26A6 and NBC) and 15% (CAII) was 
used. The next gel is placed above the resolving gel is stacking gel 4% at pH 6.8 and is 
used to pack protein together after loading. Table 3.4 shows the composition of each 
gel. The gel in the gel cast was kept overnight at 4°C. 
The following day, the gel was placed inside the electrophoresis tank and bathed in 
migration buffer.  10µg protein with an equal volume of loading buffer was mixed and 
boiled for 5minutes, then centrifuged for 10 second. Samples were loaded to each well. 
Prestained protein marker was loaded into one of the empty wells to provide the protein 
size marker. Rabbit polyclonal β actin (Abcam, UK) was used as a loading control, to 
check whether all samples have been loaded in lanes carefully. In addition it was used to 
compare the expression between different samples. 
Electrophoresis carried out at constant voltage, 100 volt and the power supply was 
switched off when the front dye reached bottom of the gel. 
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                       Table 3.  4 Composition of 15% , 12% resolving gel and 4% stacking gel. 
Stock solution Resolving gel 15% Resolving gel 12% Stacking gel 4% 
Acrylamide 8.3ml 10ml 0.665ml 
4X resolving gel 4ml 4ml - 
4X stacking gel - - 1.25ml 
10% SDS 0.2ml 0.2ml 50µl 
10% APS 100µl 100µl 25µl 
TEMED 6.75µl 6.75µl 2.5µl 
Double distilled H2O 6.4ml 4.7ml 3ml 
 
3.7.1.6.b Transfer of protein to membrane for western blotting 
  After protein separation by electrophoresis, the protein must be transferred to PVDF 
membrane for immunoblotting. PVDF membranes, are hydrophobic, hence it was 
necessary to prewet the membrane in 100% methanol (2minutes) so it can be used with 
aqueous buffer. After a while, the membrane was soaked in towbin buffer (transfer 
buffer) which contain 20% methanol. The presence of methanol in the transfer buffer is 
to promote dissociation of SDS from the protein and improves adsorption of proteins 
onto membranes in the presence of SDS (Pettegrew, et al., 2009). The membrane was 
placed in contact with gel and air bobbles were removed carefully. 
The gel-membrane sandwich was placed in transfer tank for electro blotting. Blotting 
was carried out at constant voltage of 100 volts for 90minutes. Following the transfer of 
proteins to membrane, the membrane was washed for 5 minutes. 
3.7.1.6.c Blocking 
 The next step is to block the membrane which allows maximize signal noise ratio. 5% 
of BSA of 60 minute (for CAII) and 90 minutes for other target were used in this step. 
Washing with PBST (phosphate buffer saline- tween 20), was done 3 times each for 5 
minutes; it is necessary before incubation with primary antibody. 
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3.7.1.6.d Incubation with primary antibody 
 The primary antibody was diluted 1:1000 in PBST buffer. Incubation with primary 
antibody was carried out for 90minutes at room temperature (Table 3.5).  
3.7.1.6.e Incubation with secondary antibody 
 After incubation with primary antibody, the membrane was washed 3 times. The 
secondary antibody is attached to horseradish peroxidase (HRP), was diluted 1:2000. 
Incubation with secondary antibody was at room temperature for 60minutes (Table 3.5). 
3.7.1.6.f Visualizing 
 The final step in the western blotting is to visualize the proteins, which achieved by 
Opti-4CN™ Substrate Kit. This is colorimetric (HRP) substrate; detected band can be 
seen by necked eyes. 
 
                      Table 3.  5  Primary and secondary antibodies which has been used in this part. 
Target protein Primary antibody Secondary antibody 
CAII Mouse monoclonal Anti mouse, hrp 
CAXII Rabbit polyclonal Anti rabbit hrp 
NHE1 Goat polyclonal Anti goat hrp 
NHE2 Goat polyclonal Anti goat hrp 
NHE4 Goat polyclonal Anti goat hrp 
CFTR Goat polyclonal Anti goat hrp 
NBC Rabbit polyclonal Anti rabbit hrp 
SLC26A6 Goat polyclonal Anti goat hrp 
 
 
3.7.1.6.g Analysis of western blot result 
 After the visualization of target protein, the membrane was scanned by a gel 
documentation system (Vilber Lourmat, from Fisher Scientific, USA). The density of 
bands was determined by ImageJ (National Institutes of Health, USA). The ratio of 
target bands over β actin of each sample represents the relative expression of target 
proteins.  
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3.7.2 Immunohistochemistry (IHC) 
3.7.2.1 Principle 
 IHC is used to identify the specific location of antigen (target protein) in the tissue, by 
application of primary antibody and biotinylated secondary antibody, this complex 
visualized with DAB (diaminobenzidine tetrahydrochloride) staining. In this study adult 
female rats were killed by cerebral dislocation after perfusion, and intact uterine horn 
was removed and immediately immersed in 4% paraformaldehyde before tissue 
processing. 
3.7.2.2 Method 
3.7.2.2.a  Principle of tissue processing 
 Tissue processing is necessary to eliminate water from the tissue and replace it with a 
medium that allow cutting of thin sections. Fixation was carried out for 4-5 hours, as 
longer fixation time might destroy antigens in the tissue. Fixation preserves cell and 
tissue structure close to a real situation, with inhibition of autolysis and bacterial 
activity. Thus fixation that maintain tissue structure and proteins (Meyer & Hornickel, 
2010), is the first and important step in IHC. 
In this protocol, paraformaldehyde was used to fix the tissue structure. Use of 
paraformaldehyde by cross linking protein, does not destroy the protein structure and 
preserve the protein antigenicity (Meyer & Hornickel, 2010).  
After tissue fixation, post fixation and preparatory process were performed, and include 
dehydration, clearing, infiltration and embedding. 
Dehydration, dissolves various cellular component, for example water soluble protein 
dissolved in lower aqueous alcohols. To achieve dehydration, specimen goes through 
increasing alcohol concentration.  
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Next step was clearing, which is an intermediate stage from dehydration to infiltration 
and embedding. Dehydrants are usually insoluble in paraffin wax, hence it is essential to 
apply a solvent that is compatible with both dehydrant and embedding medium. 
Chloroform, is an example of a clearing agent. 
Subsequently, infiltration with wax is performed to saturate the tissue cavities and cells. 
The last step is embedding with paraffin, a medium that provides an essential 
supporting medium for microtome sectioning. 
Protocol for tissue processing  
1- Fixation in 4% paraformaldehyde for 4-5 hours. 
2- Incubation in 70%ethanol for more than 2 hours or overnight. 
3- Incubation in 90% ethanol for 2 hours. 
4- Incubation in absolute ethanol twice for 2 hours. 
5- Incubation in chloroform overnight to clear any remaining ethanol. 
6- Incubation in 4 changes of paraffin wax each 45minutes. 
7- Final step was embedding of tissue into fresh wax. The specimens can be 
maintained in 4°C until sectioning. 
3.7.2.2.b Sectioning 
 After tissue processing, tissues were cut into 5 µm section by microtome. Then sections 
were floated in water and mounted on polysine slides, finally slides were dried at 37°C 
in an oven, overnight. 
3.7.2.2.c Deparaffinization and tissue hydration 
 Before slides were stained, hydration (with decreasing ethanol grade) was carried out 
by the following steps: 
 (i) Deparaffinization with 3 changes of xylene each one 5 minutes. 
 (ii) Washing in 100% ethanol 2 times each 10 minutes. 
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(iii) Washing in 95% ethanol twice each 10 minutes. 
(iv) Washing in PBS twice each 5 minutes. 
(v) Washing in deionized water for 1 minute. 
3.7.2.2.d  Antigen retrieval 
  Antigen retrieval or antigen recovery is used to unmask antigen which masked during 
fixation. Antigen recovery increases reactivity of antigen within specimens. It was 
performed by these steps: 
(i) Preparing 10mM sodium citrate buffer, pH 6. 
(ii) Immersing slides in a container with sodium citrate buffer. 
(iii) Heating at 95°C for 5 minutes.   
(iv) Slides allowed cooling in buffer for 20 minutes. 
(v) Slides washed in deionized water, 3 times each 2 minutes. 
Prior to immunostaining, it is necessary to block the endogenous peroxidase activity 
with incubation in 0.1-1% hydrogen peroxidase in deionized water for 5-10 minutes. 
3.7.2.2.e Immunostaining 
 In this step, rat ABC staining system was used. The kit contained: 1ml normal blocking 
serum, 250µg biotinylated secondary antibody, 0.5ml avidin and 0.5ml biotinylated 
horseradish peroxidase (AB reagent), 1 ml 50x peroxidase substrate, 1 ml 50x 3,3' DAB 
chromogen, and 3 ml 10x substrate buffer. 
Preparation of working solutions: 
(i) Blocking serum: combine 75µl normal blocking serum diluted with 5 ml PBS 
(phosphate buffer saline). 
(ii) Biotinylated secondary antibody: 75µl normal blocking serum mixed with 5 ml PBS 
and 25 µl biotinylated secondary antibody. 
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(iii) AB enzyme reagent: 50 µl reagent A (avidin), plus 50 µl reagent B (biotinylated 
HRP) and 2.5 ml PBS, prepared 30 minutes before using the mixture 
(iv) Peroxidase substrate: 1.5 ml distilled H2O, and 5 drop 10x substrate buffer plus1 
drop DAB chromogen and 1 drop 50x peroxidase substrate 
The sections went through the following steps: 
(1) Incubation in 1.5% blocking serum in PBS for one hour. 
(2) Incubation with primary antibody (Table 3.5) overnight at 4°C. Optimal 
concentration of antibody was 1:100 diluted in 1.5% blocking serum in PBS. 
(3) Washing with PBS 3 times each 5 minutes. 
(4) Incubation with biotinylated secondary antibody. 
(5) Washing with PBS 3 times each 5 minutes. 
(6) Incubation with AB reagent for 30 minutes. 
(7) Washing with PBS 3 times each 5 minutes. 
(8) Incubation with 1-3 drops of peroxidase substrate for 10 minutes. 
(9) Washing with deionized H2O, 5 minutes. 
(10) Counterstaining in hematoxilyn for 5-10 seconds, then immediately washing the 
section with several changes of deionized water. 
Throughout the study, nonspecific immunoglobulin (same species with related primary 
antibody) was used as a negative control to determine the specificity of primary 
antibody. 
(11) Dehydration the specimen with 2 times 95% ethanol for 10 seconds each; 2 times 
with 100% ethanol for 10 seconds each; 3 times xylenes for 10 seconds each and wipe 
off excess xylenes. 
One to two drops of mounting medium was added and the section covered with a glass 
coverslip. 
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The slides were ready to observe by light microscope. The secondary antibody was 
according Table 3.6. 
                                
                               Table 3.  6  The secondary antibodies that has been used for IHC. 
Target protein Secondary antibody 
CAII goat anti mouse 
NHEs, CFTR, SLC26A6 bovine anti goat 
CAXII, NBC goat anti rabbit 
 
 
3.7.2.3 Evaluation of immunostaining 
The relative intensity of the products of immunoreaction at the luminal and glandular 
epithelia of the uterine sections were evaluated and graded blindly by three independent 
observers by using a light microscope (Olympus, Japan) at 10X and 100X 
magnifications. The staining intensity was estimated semi-quantitatively on a scale of 
0–3+ (+++) as: −, no detectable stain; −/+, faint; +, moderate; ++, strong; and +++, very 
intense staining, as were previously described (Perrot-Applanat, et al., 1994) 
.. 
.. 
.. 
.. 
.. 
 
.. 
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..3.7.3 Real time PCR 
3.7.3.1 Principle 
 Quantitative real time PCR (qPCR) is a sensitive technique to evaluate gene expression 
in which data is collected throughout the PCR amplification process as it occurs. It 
combines amplification and detection of the PCR product into a single step. Real time 
PCR can produce accurate data,  does not necessitate post-amplification manipulation 
such as gel agarose by use of  development of fluorogenic labelled probes, and can even 
detect a single copy of a specific transcript (Palmer, et al., 2003). It is able to detect 
small differences in gene expression between samples, and it needs less mRNA 
template in comparison with other methods. However it requires expensive equipment 
and reagents (Wong & Medrano, 2005).  
The mRNA quantification by real time PCR can be achieved in a one-step or two step 
reaction. In one step method, the whole reaction from cDNA synthesis to PCR 
amplification is performed in a single tube. This method may produce better results for 
detection of rare transcripts. In two-step reaction reverse transcription and PCR 
amplification occur in separate tubes which allow storage of cDNA for longer time 
(Wong & Medrano, 2005). In this study one step PCR was performed. 
In any of these methods, quantitation is either absolute quantitation in which serially 
diluted standards of known concentrations is used to generate a standard curve and 
determine the concentration of unknown sample; or relative quantitation, that measure 
alteration in gene expression based on external standards or reference samples (Livak & 
Schmittgen, 2001).   
Real time PCR is based on detection of fluorescence while PCR occurs. Two types of 
chemistries are used to detect the PCR: 
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1- TaqMan chemistry (known as “fluorogenic 5´ nuclease chemistry”), which uses a 
fluorogenic probe to enable the detection of a specific PCR product as it accumulates 
during PCR cycles.  TaqMan assay was used in this study. 
2- SYBR Green I dye chemistry, is a highly specific, double-stranded DNA binding 
dye, to detect PCR product as it accumulates during PCR cycles. 
Each PCR reaction is divided to 3 different phases, exponential, linear and plateau 
phase, (Figure 3.5-6) (Tichopad, et al., 2003). During the first 10-15 cycles that PCR, 
fluorescence emission has not risen above background. In exponential phase product is 
accumulated and reaction is very specific and precise thus this phase is used for data 
collection and result analysis. At the linear phase the reaction become slower due to 
consumption of components; while at plateau phase the reaction stops and no more 
product has been produced (Bustin, 2000) . 
3.7.3.2 Sample Collection 
For this study RNAlater
®
 was used to preserve tissue’s RNA prior to extraction. 
RNAlater
®   is a RNA stabilization solution that rapidly permeates into the tissue and 
protects RNA from degradation. Tissue can be preserved indefinitely in 
RNAlater
® solution at –20°C or below. To collect sample, the uterus was excised, and 
soaked in 5 volumes of RNAlater
®
. 
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Figure 3. 5 Baseline, threshold, Ct value in different view of amplification plot. 
Figure 3. 6 Baseline and Threshold. . Baseline, fluorescence cannot be 
detected by instrument and usually is between cycle 3-15. Threshold, is a level 
of normalized reporter signal that is used for C
T 
determination in real-time 
assays. The level is set to be above the baseline but sufficiently low to be 
within the exponential growth region of an amplification curve. The cycle 
number at which the fluorescence signal associated with a particular amplicon 
accumulation crosses the threshold is referred to as the C
T
.  
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3.7.3.3 Protocol for RNA Extraction 
For this study Ribo Pure kit, was used to extract RNA from the uterus. The kit contains: 
TRI Reagent, filter cartridges, collection tubes, wash solution, elution buffer. TRI 
Reagent is the improved version of the popular single-step method of total RNA 
isolation and combines phenol and guanidine thiocyanate in a monophasic solution to 
rapidly inhibit RNase activity. Before extraction, the tissue was retrieved from 
RNAlater
®
 solution with sterile forceps and excess RNAlater
®
 quickly was removed 
with an absorbent paper towel and then soaks the sample in RNA lysis buffer.  
3.7.3.3.a Homogenization 
 100 mg of uterus was powdered in liquid nitrogen, followed by addition of 1 ml of TRI 
reagent added to the tissue powder. Homogenate then was incubated at room 
temperature for 5 minutes, and centrifuged at 12000g, 10 minutes at 4 ºC. The 
supernatant transferred to a new tube. 
3.7.3.3.b RNA extraction 
 Two hundred µl chloroform was added to 1 ml of homogenate, mixed well and 
incubated for 5 minutes at room temperature (25 ºC).  It was then centrifuged at 12000g, 
for 10 minutes at 4 ºC. The centrifuging at this step, led to separation of the phase of 
mixture. The lower phase was red phenol-chloroform phase, an interphase, and a 
colorless upper part in the aqueous phase. The first two phases contain DNA and 
protein, where upper phase contains RNA. At higher temperature than 4°C the DNA 
may sequester in the aqueous phase. 400 µl of aqueous phase was transferred to a new 
1.5 ml micro centrifuge tube to proceed to RNA purification. The intermediate and 
lower phases can be used for DNA or protein extraction. 
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3.7.3.3.c Final RNA purification 
RNA precipitation was achieved by adding of 0.5ml isopropanol per 1 ml of TRI 
reagent for initial homogenization, and mixed immediately.  The mixture was incubated 
at room temperature for 10 minutes. The sample was passed through a filter cartridge 
and centrifuged at 12000g, 30 second at room temperature. The filter then was washed 
twice with 500 µl of wash buffer. Finally the cartridge was eluted with 100 µl of Elution 
buffer. Incubated at room temperature, 2 minutes and centrifuged for 30 seconds. 
3.7.3.4 RNA quality control 
3.7.3.4.a Optical density  
The extracted RNA may be contaminated by protein, DNA, EDTA and phenol that can 
act as an inhibitor of RNA downstream applications. Thus, evaluating integrity and 
quality of extracted RNA is essential. RNA was quantified by Gene Quant 1300 
spectrophotometer, from UK by diluting RNA in TE buffer. Then 2 µl of RNA was 
diluted with 78 µl of TE buffer while 80 µl of same buffer used as a blank.  Reading 
was evaluated by A260/280, A260/230. 
3.7.3.4.b Detection of genomic DNA contamination 
 Agarose gel is the most common way to evaluate RNA integrity. Gel electrophoresis is 
performed on 1% agarose in TBE buffer and 0.5µg/µl ethidium bromide for gel 
staining. After running the gel for 30 minutes in 110 V (20V/cm), gel was observed 
with a gel documentation system (Vilber Lourmat, from Fisher Scientific). Two sharp 
and clear bands at 2:1 ratio can be seen indicating 28 and 18S rRNA. Any smearing or 
shoulder of RNA indicates gross degradation. The ladder in RNA agarose gel 
electrophoresis was 1Kb DNA step ladder. 
Presence of band above 28S can indicate RNA smearing or DNA contamination. To 
assess coextraction of DNA with RNA, PCR can be run without reverse transcriptase. In 
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this case PCR amplification without RT is due to presence of genomic DNA. However 
if the assay probe spans exon-exon junction of the associated genes, it will not detect 
genomic DNA. In applied biosystem this type of assay labeled with (m) as what used in 
this research. 
 
 
 
 
 
 
 
 
 
 
 
                                                        
 
3.7.3.4.c Standard curve 
 The real-time PCR data from standard curve plots can be used to identify if inhibition 
were presented in RNA. The standard curve also used to examine PCR efficiency. The 
slope of a standard curve is commonly used to estimate the PCR amplification 
efficiency of a real-time PCR reaction. A real-time PCR standard curve is graphically 
represented as a semi-log regression line plot of Ct value vs log of input nucleic acid 
(The standard curve of different assays which has been used in this study is shown in 
appendixB). 
Thus purified RNA that is qualifying for real time PCR must contain less than 0.005% 
of genomic DNA by weight, free of inhibitors of reverse transcription and PCR, 
dissolved in PCR-compatible buffer, free of RNase activity and in nondenatured state.  
 
Figure 3. 7 RNA gel electrophoresis. 
4.7kb
p 
1.9kb
p 
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3.7.3.5 Justification for number and choice of reference genes  
Normalization of expression data is usually achieved by measuring the expression of 
several candidate reference genes (Table 3.7) in a number of representative samples, 
and selecting the gene(s) that show least variation as reference(s) for the particular 
study. To choose the best reference gene, 6 reference genes were screened for each 
group of 3 samples. GenEx, v5 (from Multid Analyses AB) used to evaluate the 
constancy or variability of reference gene expression.  
The expression of reference gene was compared with the geNorm, and NormFinder 
application model of GenEx. 
Both geNorm and NormFinder provide bar charts showing which gene are most stably 
expressed. geNorm select the pair of most stably expressed reference gene whereas 
NormFinder indicate that which reference gene might be optimal and in fact select the 
almost same order of stability as geNorm. 
NormFinder is first described by Anderson (2004), is the optimal normalization gene 
among a set of reference gene.  It ranks reference genes according to their expression 
stability in a given set of sample and given experimental design.  It estimates overall 
expression variation of the candidate normalization gene and the variation between 
sample (In this study control group vs other groups). 
geNorm uses the same data as NormFinder but all samples are treated as being from a 
single population, geNorm sequentially eliminate the genes that shows the highest 
variation relative to all of the gene based on pair expression value in all study sample, 
the variation called M-value.  
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Table 3.  7 Reference genes which has been used in this study to find out the suitable reference gene 
Reference gene 
symbol 
Gene name Assay id 
Hmbs hydroxymethylbilane synthase Rn00565886_m1 
Actb actin, beta Rn00667869_m1 
Gapd glyceraldehyde-3-phosphate dehydrogenase Rn99999916_s1 
Hprt1 hypoxanthine phosphoribosyltransferase 1 Rn01527840_m1 
B2m beta-2 microglobulin Rn00560865_m1 
Ppia peptidylprolyl isomerase A (cyclophilin A) Rn00690933_m1 
 
 
Figure 3. 9 According Normfinder, GAPD is the best reference 
Figure 3. 8 The lowest M-value belong to HPRT and GAPD 
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     3.7.3.6 Running real time PCR  
After RNA extraction and quantification, RNA was converted to cDNA for 2step real 
time PCR, or stored at -80ºC for 1step qPCR. In this study 1 step real time PCR was 
used to investigate the gene expression in different treatment groups by using of 
TaqMan® RNA-to-CT 1-Step Kit.  
This kit contains two tubes: 
1-  TaqMan® RT-PCR Mix (2✕) contains: 
– AmpliTaq Gold® DNA Polymerase, UP (Ultra Pure) 
– dNTPs (dATP, dCTP, dGTP, dTTP, and dUTP) 
– ROX™ passive reference 
– Optimized buffer components 
2-  TaqMan® RT Enzyme Mix (40✕) contains: 
– ArrayScript™ UP Reverse Transcriptase 
– RNase inhibitor 
To prepare the reaction cocktail, 50ng of total RNA in 1µl used as template. Each 
reaction tube contain 5 µl master mix, 0.25 µl reverse transcriptase, 3.25 µl RNase free 
water and 1 µl sample. Thus total volume was 10 µl per reaction. In the negative control 
well 1 µl RNase free water was used in place of sample. 
In the reaction plate, 3 replicates of each sample along with 3 replicates of endogenous 
control were used. Expression of endogenous control is not affected by different 
experimental condition thus can be used to normalize fluorescence signals for target 
assay. In this study GAPD and Hprt1 were chosen after screening different reference 
genes.  
After preparing the reaction plate, plate was loaded into Applied Biosystem Step One 
Plus thermal cycler.  
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Reverse transcription and PCR condition are shown below according TaqMan® RNA-
to-CT 1-Step Kit was: 
 
                                       
                     Table 3.  8 Real time PCR running program 
Stage Step Temp Time 
Holding Reverse transcription 48°C 15min 
Holding Activation of AmpliTaq Gold DNA 
polymerase, (Ultra Pure) 
95°C 10min 
Cycling 
(40 cycle) 
Denature 95°C 15sec 
Anneal/Extend 60°C 1 min 
 
 
 
                              Table 3.  9  TaqMan assays that were used 
 
 
 
3.7.3.7 Analysis of result  
Data was analyzed according to comparative fold changes in expression (Wong & 
Medrano, 2005) where: 
ΔCt= Ct (target gene)- Ct (reference gene) 
ΔΔCt= ΔCt (treated sample)- ΔCt (untreated sample) 
 And Fold changes= 2 
- ΔΔCt
 
 Measurements were normalized using the GenEx software. The relative quantity of 
target in each sample was determined by comparing normalized target quantity in each 
Assay ID Gene Symbol Gene Name 
Rn00570700_m1 Car 2 carbonic anhydrase 2 
Rn01418250_m1 Car12 carbonic anhydrase 12 
Rn00670440_m1 Slc4a4 solute carrier family 4 (anion exchanger), member 4 
Rn01455968_m1 Cftr 
cystic fibrosis transmembrane conductance regulator 
homolog  
Rn00561924_m1 Slc9a1 
solute carrier family 9 (sodium/hydrogen exchanger), 
member 1 
Rn00688610_m1 Slc9a2 
solute carrier family 9 (sodium/hydrogen exchanger), 
member 2 
Rn01437220_m1 Slc9a4 
solute carrier family 9 (sodium/hydrogen exchanger), 
member 4 
Rn01445892_m1 Slc26a6 solute carrier family 26, member 6 
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sample to normalized target quantity in the reference.  Data Assist v3 software from 
Applied Biosystems was used to calculate RNA folds changes. 
3.8 Statistical analysis 
Results are expressed as mean±SEM. For the functional studies n=6 per group. For real 
time PCR, western blotting n=4 per group, and each experiment was performed in 
triplicate. Statistical analysis was carried out using SPSS 19. Comparison among groups 
was by one-way ANOVA, followed by Tukey’s test. A p value <0.05 was considered 
statistically significant.  
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4.1 mRNA level, protein expression and localization of CFTR  
4.1.1 CFTR expression in ovariectomized rats 
In figure 4.1.A, the level of CFTR mRNA was significantly reduced following P 
treatment as compared to 0.2E and control. The inhibitory effect of P on CFTR mRNA 
expression could be seen in the group treated with 0.2E followed by P, in which there 
was a 13-fold reduction in the mRNA level as compared to 0.2E or E plus vehicle (0.2E 
+ vehicle). As doses increase resulted in increase in CFTR mRNA following E 
treatment. The highest amount of CFTR mRNA was observed following treatment with 
50E, which was 16-fold higher as compared to the control.  Treatment with 0.2E 
resulted in a 12-fold increase in the CFTR mRNA level, (Figure 4.1.A). 
Protein expression followed an almost similar pattern to the changes in mRNA (Figure 
4.1.B). P treatment resulted in decreased CFTR protein expression as compared to the 
control and 0.2E. There was a dose-dependent increase in the protein expression under 
E, in which treatment with 50E resulted in approximately two-times increase in protein 
expression as compared to 0.2E. As expected, E treatment followed by three days of P 
treatment (E + P) resulted in a reduction in the protein expression by about 1.5 times as 
compared to 0.2E or E plus vehicle (0.2E + vehicle). 
4.1.2 CFTR throughout the oestrous cycle 
Similar patterns of CFTR mRNA changes could be seen throughout the oestrous cycle. 
Our finding, however, indicates that CFTR mRNA was the highest at proestrus, with a 
10-fold increase, while at estrus, there was only 3-fold increase in its expression. In this 
study CFTR mRNA expression was detected even at an earlier stage of the oestrous 
cycle than the previous report (Chan, et al., 2002). During diestrus stage, however, the 
mRNA level was noted to be the lowest with only a 1.5-fold increase as compared to the 
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control (Figure 4.1.A) .The highest expression of CFTR protein was noted at proestrus 
and estrus which correlates with a high plasma E level. The amount expressed declined 
at metestrus, reaching the lowest at diestrus. This is consistent with increasing level of P 
in the circulation (Figure 4.1.B). CFTR was observed as 90kDa protein on the blot 
(Figure 1.C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 1 Real-time PCR (A) and Western blotting analysis (B) of total homogenate of the 
uterus; representative photo of western blots (C) of CFTR in ovariectomized rats and rats at 
different stages of the oestrous cycle. The photos as shown in (C) came from a same gel/blot 
that has been cut in order to arrange the different groups of treatment in sequence as to match 
the result in (A) and (B). 0.2E: 0.2µg estrogen, 20E: 20µg estrogen, 50E: 50µg estrogen, P: 
progesterone, E+P: 0.2µg estrogen + 4mg progesterone. 0.2E + vehicle: 0.2μg estrogen + 
peanut oil Ps: proestrus, Es: estrus, Ms: metestrus, Ds: diestrus.  n=4 per group (3technical 
replicate) *, P < 0.05, **P < 0.01, ***P < 0.001, data presented as mean ±SEM, compared to 
control in ovariectomized rat, however E+P compared to 0.2+ vehicle and compared to Es at 
different stages of oestrous cycle. 
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.1.3 Immunolocalization of CFTR 
An increase in CFTR expression was observed in the E treated group in dose dependent 
manner and mainly localized at the apical membrane of the luminal epithelia. CFTR 
distribution could also be seen in the glandular epithelia. No staining was seen in the 
stroma or myometrium. Meanwhile, CFTR expression was reduced following P and E + 
P treatments (Figure 4.2 & Table 4.1).  
The expression of CFTR was increased at estrus mainly at the apical membrane of the 
luminal epithelia. Enhanced expression of this protein was observed in the glandular 
epithelia with minimal expression in the stroma. At diestrus however, the amount of 
CFTR protein expression was very low compared to estrus (Figure 4.2 & Table 4.1). 
 
                 Table 4. 1 Semiquantitative of CFTR in the uterine luminal endometrium by IHC 
 group apical basal 
control + - 
0.2µg estrogen ++ - 
20 µg estrogen +++ +/- 
50 µg estrogen +++ + 
4mg progesterone +/- - 
0.2µg estrogen +4mg progesterone + - 
0.2µg estrogen+ vehicle ++ +/- 
proestrus ++ + 
estrus +++ + 
metestrus + - 
diestrus + - 
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             Control                                     0.2E                                       20E                              
                    P                                         Ps                                              Es 
                Ms                                        Ds                                    Negative control 
                50E                                        E+P                               0.2E+Vehicle 
                                    
Figure 4. 2 Immunodistribution of CFTR under the effect of exogenous and 
endogenous sex-steroid hormones. Magnifications 10X and 100X (in the upper 
right corner). 0.2E:  0.2µg estrogen, 20E: 20µg estrogen, 50E: 50µg estrogen P: 
4mg progesterone, E+P: 0.2μg estrogen +4mg  progesterone, 0.2E+vehicle: 
0.2µgoestrogen+ peanut oil, Ps: proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. 
IHC with goat nonspecific immunoglobolin is negative control to check the 
specificity of antibodies. No staining was observed in this experiment. L: lumen, G: 
Gland, arrow: luminal apical membrane, arrow head: basolateral membrane. 
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4.2 mRNA level, protein expression and localization of SLC26A6  
4.2.1 SLC26A6 mRNA and protein in ovariectomized rats 
In Figure 4.3.A, real-time PCR showed that the expression of SLC26A6 mRNA was 
under the influence of sex steroids. Under P influence, SLC26A6 mRNA level was 
increased relative to the control. The mRNA expression under P was lower than 0.2E. 
There was a dose-dependent increase in the expression of SLC26A6 mRNA under E, 
ranging between 1.5 and 5-fold increase following treatment with 0.2E and 50E, 
respectively. Treatment with E followed by P (E + P) resulted in a significant reduction 
in the mRNA level, which indicates that P acutely suppressed the expression of 
SLC26A6 mRNA induced by E. There was a significant reduction in SLC26A6 mRNA 
level following treatment with E + P as compared to 0.2E + vehicle. 
Western blot analysis of SLC26A6 protein showed similar changes to the mRNA. P 
resulted in a decrease in the expression of SLC26A6 protein as compared to E. A dose-
dependent increase in protein expression was observed following E treatment. A 0.15- 
to 0.2-fold increase in SLC26A6 protein expression was seen following treatment with 
0.2E, and 50E respectively. Administration of P after three days of treatment with 0.2E 
did not result in a significant reduction in the expression of SLC26A6 protein as 
compared to 0.2E alone or E treatment followed by vehicle (a control group for E + P), 
(Figure 4.3.B). 
4.2.2 SLC26A6 mRNA and protein throughout the oestrous cycle 
Figure 4.3.A indicated that throughout the oestrous cycle, an increase in SLC26A6 
mRNA expression by 3.2 and 3.5 fold could be seen at proestrus and estrus stages, 
respectively. The mRNA level was, however, reduced at metestrus and sharply declined 
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Figure 4. 3 Real-time quantitation PCR (A) and western blotting analysis (B) of total homogenate of 
the uterus; representative photo of western blots (C) of SLC26A6 in ovariectomized rats and rats at 
different stages of the oestrous cycle. The photos as shown in (c) came from a same gel/blot that has 
been cut in order to arrange the different groups of treatment in sequence as to match the result in (A) 
and (B).  0.2E: 0.2µg estrogen, 20 E: 20µg estrogen, 50E: 50µg estrogen, P: 4mg progesterone, E+P: 
0.2µg estrogen + 4mg progesterone. 0.2E + vehicle: 0.2μg estrogen + peanut oil Ps: proestrus, Es: 
estrus, Ms: metestrus, Ds: diestrus. n=4 *, P < 0.05, **P < 0.01, ***P < 0.001, data presented as 
mean ±SEM. 
 
at diestrus. These observations indicate that SLC26A6 mRNA expression was 
upregulated by E, while P, at diestrus, down regulates its expression. 
The highest protein expression was observed at proestrus while the lowest expression 
could be seen at diestrus, as can be seen in figure 4.3.B. 
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4.2.3 Immunolocalization of SLC26A6 
The expression of SLC26A6 was increased under E effect in a dose dependent manner, 
with the highest staining at the apical membrane of the luminal epithelia. SLC26A6 
could be seen in glandular epithelia as well as stroma following E treatment. Increased 
expression was also noted in the E + P group, however the intensity was lesser than in E 
treated group. In the P treated group however, minimal staining could be seen (Figure 
4.4 & Table 4.2). 
SLC26A6 expression was increased at proestrus and estrus, with a higher intensity at 
estrus mainly at the apical membrane of both the luminal and glandular epithelia. 
Minimal distribution could be seen at metestrus. At diestrus however, no staining was 
seen in the endometrium (Figure 4.4 & Table 4.2). 
 
             Table 4. 2 Semiquantitative of SLC26A6 in the uterine luminal endometrium by IHC 
                             group apical basal 
control + - 
0.2µg estrogen ++ + 
20 µg estrogen +++ + 
50 µg estrogen +++ + 
4mg progesterone +/- +/- 
0.2µg estrogen +4mg progesterone + - 
0.2µg estrogen+ vehicle ++ +/- 
proestrus ++ + 
estrus +++ + 
metestrus + + 
diestrus + +/- 
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              50E                                            E+P                                        0.2E+vehicle 
           Control                                         0.2E                                       20E 
                P                                                  Ps                                            Es  
            Ms                                             Ds                                     Negative control 
Figure 4. 4 Immunodistribution of SLC26A6 under the effect of exogenous and 
endogenous sex-steroid hormones. Magnifications 10X and 100X (in the upper right 
corner). 0.2E:  0.2µg estrogen, 20E: 20µg estrogen, 50E: 50µg estrogen P: 4mg 
progesterone, E+P: 0.2μg estrogen +4mg progesterone, 0.2E+vehicle: 0.2µg 
estrogen+ peanut oil, Ps: proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. IHC with 
goat nonspecific immunoglobolin is negative control to check the specificity of 
antibodies. No staining was observed in this experiment. L: lumen, G: Gland, arrow 
shows luminal apical membrane, arrow head shows basolateral membrane 
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4.3 mRNA level, protein expression and localization of NBCe1 
4.3.1 NBCe1 mRNA and protein expression in ovariectomized rats 
The qPCR assay and primary antibody that was used to evaluate SLC4A4 was for 
NBCe1. 
 Evaluating the NBCe1 mRNA level in E treated groups showed higher level of mRNA 
compared to control; however there was no difference among different E treatment.  P 
and E+P treatment presented no remarkable difference with respect to control group 
(Figure 4.5.A). 
NBCe1 showed band at 135kDa (Figure 5.4.C). NBCe1 protein expression, however 
revealed that E treatment stimulated NBCe1 protein expression in dose dependent 
manner, whereby higher NBC protein observed in 50E group compared to control rats. 
P decreased NBCe1 expression while E+P showed no difference in compare to control 
group (Figure 5.4.B). Differences between NBCe1 mRNA level and protein expression 
may indicated the presence of different NBCe1 variant as reported  by (Liu, et al., 
2012).  
4.3.2 NBC mRNA level and protein expression throughout oestrous cycle 
Investigating the alteration in NBCe1 mRNA level, showed that although NBCe1 
mRNA reduced from proestrus to diestrus, only reduction in diestrus was significantly 
vary with estrus (2.28 vs 1.31), Figure 4.5.A. 
NBCe1 protein expression was parallel to mRNA level, whereby proestrus and estrus 
showed the highest NBCe1 protein, followed by significant reduction in metestrus and 
diestrus compared to estrus.  
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Figure 4. 5 Gene expression analysis by qPCR (A) and western blotting analysis 
(B); and representative photo of western blots (C) of NBCe1 in ovariectomized 
rats and rats at different stages of the oestrous cycle. 0.2E: 0.2µg estrogen, 2E: 2 
µg estrogen, 20 E: 20µg estrogen, 50E: 50µg estrogen, P: 4mg progesterone, E+P: 
0.2 µg estrogen + 4mg progesterone. Ps: proestrus, Es: estrus, Ms: metestrus, Ds: 
diestrus.  n=4, each has 3 technical replicate,*, P < 0.05, **P < 0.01, ***P < 
0.001, data presented as mean ± SEM. In ovariectomized rats, different groups 
were compared to control, however at oestrous cycle comparison was with Es. 
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4.3.3 Immunolocalization of NBCe1 
In figure 4.6 and table 4.3 showed NBCe1 was predominantly found at the luminal and 
glandular epithelia following E treatment, with lack of expression in the stroma and 
myometrium. At higher magnification, NBCe1 could be seen at the apical and 
basolateral membrane of the luminal epithelia with a higher intensity in the former. 
NBCe1 was observed in stroma and myometrium at an increasing intensity with 
increasing doses of E. Following P treatment and in the E + P treated group, a marked 
decreased in luminal and glandular expression of NBCe1 was observed with no staining 
seen in the stroma and myometrium.  
At proestrus and estrus bilateral expression of NBCe1 was found at the luminal 
epithelia. NBCe1 was seen in glandular epithelia in addition to stromal and myometrial 
expression during proestrus and estrus. At diestrus however, minimal staining was 
observed at the luminal and glandular epithelia. 
 
              Table 4. 3 Semiquantitative of NBCe1 in the uterine luminal endometrium by IHC 
 
 
group Apical basal 
control + - 
0.2µg estrogen + + 
2 µg estrogen ++ ++ 
20 µg estrogen +++ +++ 
50 µg estrogen +++ +++ 
4mg progesterone + - 
0.2µg estrogen +4mg progesterone + + 
proestrus ++ + 
estrus ++ ++ 
metestrus ++ +/- 
diestrus + - 
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                Control                              0.2E                                        2E 
                 20E                                   50E                                         P  
                 E+P                                     Ps                                       Es 
               Ms                                      Ds                              Negative control 
Figure 4. 6 Immunodistribution of NBCe1 in steroid treated ovariectomized rats 
and at different stages of oestrous cycle. Magnifications 10X and 100X (in the 
upper right corner). 0.2E:  0.2µg estrogen, 2µg estrogen, 20E: 20µg estrogen, 50E: 
50µg estrogen P: 4mg progesterone, E+P: 0.2μg estrogen +4mg progesterone, Ps: 
proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. IHC with rabbit nonspecific 
immunoglobolin is negative control to check the specificity of antibodies. No 
staining was observed in this experiment. L: lumen, G: Gland, arrow shows 
luminal apical membrane, arrow head shows basolateral membrane. 
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4.4 mRNA level, protein expression and localization of CAII  
4.4.1 CAII mRNA and protein expression in ovariectomized rats 
Under the effect of 0.2E, CA II mRNA level was increased by 70.2 folds. Interestingly, 
in the 2E group there was a decrease in CAII mRNA expression (13 folds). Treatment 
with 20E resulted in 2 folds increase, while 4 folds increase in mRNA level of CAII was 
seen in 50E group. P treatment meanwhile caused in only 48 folds increase while 
treatment with 0.2E followed by 4 mg P led to 83 folds increase in the CAII mRNA 
level , figure 4.7.A. 
CA II protein expression followed an almost similar pattern to the changes in mRNA 
level following sex-steroid treatment. The highest expression was noted following 
treatment with E + P (7.2 folds). While it was only 6.6 folds increase in CAII protein 
expression in 0.2E group. There were no significant increase in the protein expression 
following treatment with 2 and 20E (2.8 & 2.6-folds) as compared to the control, while 
treatment with 50E resulted in a 3.05 folds increase. Treatment with P led to 5.2 folds 
increase and was significantly higher than the control, figure 4.7.B. 
4.4.2 CAII mRNA and protein expression throughout the oestrous cycle 
Throughout the oestrous cycle, the highest increase in CAII mRNA level was noted at 
estrus (32 folds), followed by proestrus (24 folds) while the lowest mRNA level was 
observed at diestrus (6 folds). At metestrus however, there was only a 5 folds increase 
in the mRNA level (Figure 4.7.A).  
At oestrous cycle, the highest CAII protein expression was noted at estrus (2 folds 
increase), while at proestrus, there was only a 1.9 fold increase. The lowest protein 
expression was occurred at metestrus (1.1 folds) and diestrus (1.2 fold), (Figure 4.7.B). 
The molecular weight of the CA II protein was detected at 29 kDa, (Figure 4.7.C). 
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Figure 4. 7 Analysis of mRNA level (A), protein expression (B) and representative blot 
(C) of CAII. 0.2E: 0.2µg estrogen, 2E: 2µg estrogen, 20 E: 20µg estrogen, 50E: 50µg 
estrogen, P: progesterone, E+P: 0.2µg estrogen + 4mg progesterone. Ps: proestrus, Es: 
estrus, Ms: metestrus, Ds: diestrus. n=4, each has 3 technical replicate, *, P < 0.05, **P 
< 0.01, ***P < 0.001, data presented as mean ± SEM. In ovariectomized rats 
comparison was done with control group, however at oestrus cycle the significance of 
the result compared with Es. 
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4.4.3 Immunolocalization of CA II 
Figure 4.8 and table 4.4 showed the immunolocalization of CAII under the influence of 
different steroid in ovariectomized rats and throughout the oestrous cycle. 
Under all treatment, CAII expression in the glandular epithelium was with much higher 
intensity than luminal epithelium. However under the effect of 0.2E it was more intense 
than other groups (Figure 4.8 and table 4.4). 
Immunolocalization of CAII showed that during all stages of the oestrous cycle, CAII 
was expressed on the glandular epithelium (Figure 4.8) CAII was highly expressed in 
the glandular epithelia, however its expression in the luminal epithelia is rather low 
(Figure 4.8). Thus glandular magnification was presented in figure 4.8 and semi 
quantification of CAII in the uterine glandular epithelium by IHC has summarized in 
table 4.4. 
 
                   Table 4. 4Semi quantification of CAII in the uterine glandular epithelium by IHC 
group Glandular epithelium 
control + 
0.2µg estrogen ++ 
2µg estrogen + 
20µg estrogen + 
50µg estrogen + 
4mg progesterone ++ 
0.2µg estrogen +4mg progesterone ++ 
proestrus +++ 
estrus ++ 
metestrus + 
diestrus ++ 
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Figure 4. 8 Immunodistribution of CAII in steroid treated ovariectomized rats and at 
different stages of the oestrous cycle. Magnifications 10X, whole uterus and 100X (in 
the upper right corner, gland). 0.2E:  0.2µg estrogen, 2µg estrogen, 20E: 20µg 
estrogen, 50E: 50µg estrogen P: 4mg progesterone, E+P: 0.2μg estrogen +4mg 
progesterone, Ps: proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. IHC with mouse 
nonspecific immunoglobolin is negative control to check the specificity of antibodies. 
No staining was observed in this experiment. L: lumen, G: Gland. 
             Control                                  0.2E                                      2E 
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4.5 mRNA level, protein expression and localization of CAXII  
 4.5.1 CAXII mRNA and protein evaluation in ovariectomized rats 
Under the effect of 0.2E, CA XII mRNA level was increased by 10.5 folds. However 
treatment with 2E reduced CA XII mRNA level to 1.5 fold. Treatment with 20E 
resulted in 2 folds increase, while 50E resulted in 8.2 folds increase. P treatment 
resulted in 8.0 folds increase while exposure to 0.2E followed by 4 mg P (E+P) resulted 
in further increase to 12.2-folds  (Fig 4.9A). 
The changes in the expression of CAXII protein are almost similar to the changes in 
mRNA level following sex-steroid treatment. The highest increase was noted following 
treatment with E+P (1.9 fold) followed by 0.2E treatment (1.3 fold). There were no 
significant changes in the protein expression following treatment with 2 and 20E as 
compared to the control. Meanwhile, treatment with 50E resulted in a significant 
increase in CAXII protein expression (1.0 fold) as compared to the control. P treatment 
resulted in 1.1 fold increase which was significantly higher than the control (Fig 4.9.B). 
CAXII showed band at 44kDa (figure 4.9.C).  
4.5.2 CAXII mRNA and protein expression throughout the oestrous cycle 
Throughout the oestrous cycle, the highest level of CAXII mRNA was noted at estrus 
(15.5 folds), followed by proestrus (10 folds) while at diestrus, there was only a 3.8 
folds increase in the mRNA level. At metestrus however, there was only a 7.5 folds 
increase in CAXII mRNA level (Figure 4.9.A).  
Throughout the oestrous cycle, the highest CAXII protein expression was noted at 
estrus (1.65 fold), while at proestrus, there was only a 1.35 fold increase. The lowest 
expression was noted at metestrus (0.9 fold) followed by diestrus (0.65 fold), figure 
4.9.B. The molecular weight of CA XII protein was observed at 44kDa, (Fig 4.9.C). 
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Figure 4. 9 Effect of exogenous and endogenous steroid hormone on CAXII gene expression 
(A), western blotting analysis (B) and respective blot (C). 0.2E:0.2µg estrogen, 2E:2µg 
estrogen, 20 E:20µg estrogen, 50E: 50µg estrogen, P: 4mg progesterone, E+P: 0.2µg 
estrogen + 4mg progesterone. Ps: proestrus, Es: estrus, Ms: metestrus, Ds: diestrus, n=4, 
each has 3 technical replicate  *, P < 0.05, **P < 0.01, ***P < 0.00, data presented as mean 
± SEM. In ovariectomized rats comparison was done with control group, however at oestrus 
cycle the significance of the result compared with Es. 
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4.5.3 Immunolocalization of CAXII 
In figure 4.10 and table 4.5, CAXII expression was the highest in the uterine luminal 
epithelia in all treatment groups and at all phases of the oestrous cycle. Under 0.2E, 
E+P, at proestrus and estrus CAXII was more intensely distributed at the basolateral as 
compared to the apical membrane. Under the effect of P and at diestrus, this protein was 
predominantly expressed at the apical membrane. Although treatment with 2E resulted 
in a predominant apical expression, higher E doses at 20 and 50E resulted in a 
predominant basolateral expression.  
 
           Table 4. 5 Semi quantitative of CAXII in the uterine luminal endometrium by IHC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
group apical basal 
control + - 
0.2µg estrogen + + 
2µg estrogen ++ ++ 
20µg estrogen +++ +++ 
50µg estrogen +++ +++ 
4mg progesterone + - 
0.2µg estrogen +4mg progesterone + + 
proestrus ++ + 
estrus ++ ++ 
metestrus ++ +/- 
diestrus + - 
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Figure 4. 10 Immunodistribution of CAXII in steroid treated ovariectomized rats 
and at different stages of THE oestrous cycle. Magnifications 10X and 100X (in the 
upper right corner). 0.2E:  0.2µg estrogen, 2µg estrogen, 20E: 20µg estrogen, 50E: 
50µg estrogen P: 4mg progesterone, E+P: 0.2μg estrogen + 4mg progesterone, Ps: 
proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. IHC with rabbit nonspecific 
immunoglobolin is negative control to check the specificity of antibodies. No 
staining was observed in this experiment. L: lumen, G: Gland, arrow: luminal apical 
membrane, arrow head: basolateral membrane 
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4.6 Discussion 
4.6.1 CFTR and SLC26A6 expression 
The actual mechanism involved in the control of uterine luminal fluid volume is still a 
matter of debate among reproductive biologists. The first evidence regarding the role of 
CFTR in the regulation of in-uterine fluid volume surfaced nearly 20 years ago when 
Rochwerger and Buchwald (1993), using in situ hybridization and protein studies, 
reported that E stimulates expression of CFTR in uterus. Forskolin-stimulated Cl
-
 
permeability was observed at the apical membrane of the endometrial cells while in 
vitro primary cultures of rat uterine epithelial cells showed high levels of CFTR 
expression under E stimulation (Rochwerger, et al., 1994). In contrast to E, Mularoni et 
al (1995), using a competitive RT-PCR technique, reported that CFTR mRNA level in 
the glandular epithelial cells of guinea-pig endometrium decreases upon treatment with 
E plus P as compared to the treatment with E in an in vitro study. 
Apart from this limited observation, the actual effect of P on uterine CFTR expression is 
still not fully elucidated. This part of the present study was undertaken to investigate the 
actual effect of P treatment alone and the effect of P following exposure to E on the 
mRNA and protein expression of CFTR as well as SLC26A6 in the uterine tissues in a 
rat model.  
A complimentary finding by Chan, et al (2002) indicates fluctuation in CFTR mRNA 
expression in adult female mouse reproductive tract at different phases of the oestrous 
cycle. In situ hybridization and semi-quantitative RT-PCR revealed abundant 
expression of CFTR mRNA in the uterine epithelium at estrus but not at other stages of 
the cycle. In contrast to Chan, et al (2002), our finding, however, indicates that CFTR 
mRNA expression is the highest at proestrus (Figure 4.1.A). These differences in the 
time of CFTR mRNA expression could probably be related to species difference, in 
which Chan, et al (2002) conducted their study in mice in contrast to our rat model. 
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Yang, et al (2004) studied CFTR expression in pregnant mice by RT-PCR, which 
showed a maximum CFTR expression at day 3 after-mating predominantly in the 
stromal cells. As can be seen from figure 4.2 CFTR is highly expressed at the apical 
membrane of rat endometrium and was up-regulated by E. Functional study showed that 
CFTR is involved in uterine Cl
-
 (Figure 6.3.B) and fluid secretion (Figure 6.2.B) under 
E stimulation. Meanwhile, Nobuzane, et al (2008) reported that treatment with 
raloxifene analogue induced CFTR expression in a study using RT-PCR. An exact 
determination of the amount of mRNA is not possible by a traditional PCR, therefore 
real time PCR (as used in this study) is the best alternative that offers an accurate 
quantification of mRNA expression as little as a twofold increase (Ben Abda, et al., 
2011). Results indicate that CFTR mRNA expression is highly increased following 
exogenous E administration and under a high level of endogenous E (Figure 4.1.A); 
therefore, CFTR could be the major anion channel expressed which may participate in 
the observed accumulation of uterine fluid under E dominance. 
In addition, the dose- dependent effect of E on CFTR mRNA expression could provide 
a fundamental basis for the observed excessive fluid accumulation under 
hyperestrogenic condition such as following consumption of oral contraceptive pills 
(Salleh, et al., 2005). To the best of our knowledge, this is the first report on the acute 
suppression by P on CFTR expression in vivo in steroid replaced ovariectomized rats as 
well as under a high endogenous E level (Fig 4.1), thus supporting the previous in vitro 
observation by Mularoni et al (1995). 
Progesterone effect on CFTR expression could be mediated via genomic pathway 
possibly via CFTR gene suppression, apart from an indirect inhibition of CFTR 
activities via the activation of ENaC as ENaC has been shown to be a negative regulator 
of CFTR (Chan, et al., 2001). This study thus provides novel information that P is 
responsible for suppression of CFTR expression in-vivo, which may explain the 
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diminished fluid secretion under a P-mediated effect. This would complement ENaC-
mediated fluid imbibition, contributing to fluid loss that initiates uterine closure. Apart 
from being a Cl
−
 channel, CFTR has also been reported to be involved in HCO3
-
 
secretion.  
 E stimulation of HCO3
-
 secretion has also been shown to occur in the duodenum via 
CFTR and Cl
-
/HCO3
-
 exchanger (Smith, et al., 2008), which is responsible for the lower 
prevalence of duodenal ulcer in premenopausal women (Tuo, et al., 2011). In addition 
to E, genistein, a phytoestrogen, has also been reported to increase duodenal HCO3
-
 
secretion in a dose-dependent manner through stimulation of CFTR (Tuo, et al., 2009). 
These observations support the notion that CFTR is the main HCO3
-
 extruder under E 
effect.  
The involvement of SLC26A6 in mediating uterine HCO3
-
 secretion has received a lot 
of attention lately. The important role of this transporter in the uterus has been 
overlooked. While He, et al (2010) has examined SLC26A6 protein expression in mice 
uteri which indicates a maximum expression of this protein under E dominance; its 
mRNA expression is, however, unknown. We have therefore provided novel 
information on the E-induced up regulation and P-induced down regulation of uterine 
SLC26A6 mRNA expression in vivo (Figure 4.3.A). In addition, we have also 
documented for the first time that SLC26A6 mRNA exhibits cyclical changes 
throughout the oestrous cycle (Figure 4.3), in which its expression is increased at 
proestrus and estrus and decreased at diestrus in apical membrane (Figure 4.4). We 
postulate that the increase in SLC26A6 expression under E influence may contribute to 
the alkalinity of uterine fluid via contributing to HCO3
-
 secretion. The stoichiometry of 
1 Cl
- 
to 2 HCO3
- 
further assists in luminal HCO3
-
 accumulation in exchange with Cl
-
, 
which needs to be recycled following its secretion through the CFTR. Cl
-
 recycling may 
prevent excessive fluid secretion under E stimulation, which perhaps plays a role in a 
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negative feedback control of uterine luminal fluid secretion. Progesterone down-
regulation of SLC26A6 resulted in a diminished HCO3
-
 secretion and together with an 
increased H
+
 secretion via the NHE1  (Salleh, et al., 2011) initiates fluid loss from the 
uterine lumen. This would therefore complement ENaC in contributing to uterine fluid 
loss under progesterone effect in order to initiate the process leading to “uterine 
closure,” sandwiching the embryo between the two opposing uterine walls. A precise 
regulation in these proteins and mRNAs expression would contribute to an accurate 
control of the uterine fluid volume and pH that are required for a successful 
implantation. 
4.6.2 NBCe1 expression 
Our result showed the changes in NBCe1 protein expression at different phases of the 
oestrous cycle which indicate that NBCe1 mRNA and protein expression was up-
regulated by E and at estrus and was down-regulated by P and at diestrus. There were 
several evidence on the presence of NBCe1 in the female reproductive tissue in which 
Liu, et al (2011) has detected two novel NBCe1 splice variants in mature mice uterus, 
while a functional study by Wang et al (2002) has document the presence of Na
+
 
dependent HCO3
- 
transport at the basolateral membrane of the endometrial epithelia.  
Hormonal and drugs influence on uterine HCO3
-
 secretion has been reported whereby 
adrenaline (Fong, et al., 1998), prostaglandin-E2 and forskolin (Fong & Chan, 1998)  
stimulate the endometrial HCO3
-
 secretion. E has been shown to stimulate the forskolin-
induced HCO3
-
 secretion in the endometrial cells in in-vitro study which was inhibited 
by DIDS, a non-specific anion exchanger inhibitor (He, et al., 2010) .  
The E-induced increase in uterine NBCe1 mRNA and protein expression (Figure 4.5.A) 
as observed in this study indicates the involvement of this protein in E-stimulated 
uterine HCO3
-
 secretion. The findings also indicate that under the effect of E, NBCe1 
protein was distributed at both the basolateral and apical membrane of the luminal and 
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glandular epithelia (Figure 4.6). This finding is in contrast with the previous report by 
Wang, et al (2002) in which NBC was believed to be distributed only at the basolateral 
membrane of the endometrial epithelia by application of short circuit current. In most 
secretory epithelia including the pancreatic duct (Satoh, et al., 2003) and gastrointestinal 
tract (Bucking & Wood, 2012; Seidler, et al., 2001), NBCe1 is localized at the 
basolateral membrane where it participates in the HCO3
-
 influx together with Na
+
 
(Abuladze, et al., 1998). However, in the salivary gland (Roussa, 2011), cornea (Diecke, 
et al., 2004) and epididymis (Jensen, et al., 1999a), the apical NBCe1 is involved in 
intraluminal HCO3
-
 secretion. Meanwhile, in the salivary ductal epithelia, luminal 
NBCe1-A with a stoichiometry of 1Na
+
: 3 HCO3
-
 acting together with the basolateral 
NBCe1-B with a stoichiometry of 1 Na
+
:2 HCO3
-
 resulting in the luminal HCO3
-
 efflux 
and transepithelial HCO3
-
 transport (Roussa, 2011). In view of this, it is possible that 
different NBCe1 variants (NBCe-1 A, B, C and D) which varies in the N and C-
terminus (Boron, et al., 2009) are expressed in the endometrial epithelial cells that 
participate in HCO3
-
 secretion. The expression of different NBCe1 splice variants in the 
uterus has been previously reported in the immature mice (Liu, et al., 2011).  
HCO3
-
 concentration in the fluid along the female reproductive tract has been reported 
to fluctuate throughout the menstrual cycle (Chan, et al., 2009). In the oviductal fluid, 
the HCO3
-
 concentration was found to be approximately 35 mM during the follicular 
phase; peaking-up to 90 mM at around the time of ovulation (Maas, et al., 1968; Maas, 
et al., 1977) in rhesus monkey (Macaca mulatta) and 40mM/l in rat under the influence 
of E (Figure 6.3.A& 6.6.A) . In order to sustain a high intraluminal HCO3
-
 secretion, 
concerted actions of multiple HCO3
- 
transporters are required which include the apical 
CFTR, Cl
-
/HCO3
-
 exchanger (SLC26A6) and NBC as well as the basolateral NBC. 
These could be similar to the mechanism underlying HCO3
-
 secretion in the pancreas 
under secretin stimulation. In pancreas, basolateral NBCe1  (Marino, et al., 1999) and 
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apical CFTR and Cl
-
/ HCO3
-
 exchanger (SLC26A6) (Ishiguro, et al., 2007) as well as 
apical NBCe1 (Thevenod, et al., 1999) are involved to sustain the high intraluminal 
HCO3
- 
concentration at 140 mmol/l (Hug, et al., 2003). Meanwhile, a more established 
mechanism involving the apical and basolateral NBC has been reported to mediate 
HCO3
-
 secretion in the cornea. NBC was found at the basolateral and apical membrane 
of the bovine and rabbit’s corneal endothelial cells. HCO3
-
 influx across the basolateral 
membrane of this cell has been reported to occur via the electrogenic NBCe1 with a 
stoichiometry of 2 HCO3
-
: 1 Na
+
, while HCO3
-
 efflux across the apical membrane 
involved the NBCe1 isoform with a stoichiometry of 3 HCO3
-
: 1 Na
+ 
(Diecke, et al., 
2004).  
In addition to extruding HCO3
-
, the apical NBCe1 may also participate in the luminal 
Na
+
 secretion. NBC could be involved in intraluminal Na
+
 secretion under E in addition 
to the movement of Na
+
 across a ‘leaky’ tight junction as has been reported in the 
pancreas (Marino, et al., 1999) and endometrium (Lindsay & Murphy, 2006). Up-to-
date, there were no reports on the apical NBC involvement in Na
+
 secretion. Another 
NBC isoform, NBC3 has been reported to be expressed at the apical membrane of the 
narrow cells in the cauda epididymidis and light (McMurtrie, et al. 2004) cells of the 
corpus and caput epididymidis which has been proposed to participate in the luminal 
Na
+
 secretion (Pushkin, et al., 2000). Our finding also indicates that following treatment 
with high E (20E & 50E), at estrus and proestrus, NBCe1 could be seen in the stroma 
and myometrium. Although NBC has been reported to be expressed in the cardiac 
(Yamamoto, et al., 2007) and skeletal muscles (Kristensen, et al., 2004), its smooth 
muscle expression is unknown. The exact role of stromal and myometrial NBCe1 
expression is unknown; although it may likely involve in pHi homeostasis.  
Under the influence of P however, minimal expression of NBCe1 mRNA and protein 
was noted, especially in the luminal and glandular epithelia (Figure 4.6). We concluded 
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that under the effect of P and at diestrus, down-regulation of NBCe1 occur which 
resulted in lower uterine fluid pH (Figure 6.2). In addition, P was also found to up-
regulate the expression of sodium proton exchanger isoform-1 (NHE1), figure 5.1.B, 
which causes an increase in H
+
 secretion. A reduction in HCO3
-
 secretion and an 
increase in H
+
 secretion under P effect which were induced by P (Figure 6.1.A & 6.3.A) 
will result in uterine luminal fluid acidification under the P influence (Salleh, et al., 
2011). In conclusion, the changes in uterine NBCe1 expression under different sex-
steroid effect and at different phases of the oestrous cycle provide a molecular basis 
underlying fluctuation in the uterine fluid pH observed under these conditions. This will 
therefore enhance our understanding on the control of HCO3
-
 secretion and the uterine 
fluid pH which is essential for successful reproduction as alteration in these parameters 
will affect sperm transport and capacitation, fertilization as well as embryo transport 
and implantation. 
4.6.3 CA expression  
The expression of CA II and XII isoforms has been reported in the humans (Karhumaa, 
et al., 2000), rats (Ge & Spicer, 1988) and mice (Ge & Spicer, 1988; Hynninen, et al., 
2004; Karhumaa, et al., 2000) endometrium. Currently, limited information in regard to 
the effect of sex-steroids on protein and mRNA expression of these two isoforms has 
been reported in the uterus, in particular in rodents. As the kidney CAXII expression 
has been reported to exhibit species-specific differences (Kyllonen, et al., 2003; 
Parkkila, 2000), the changes in the uterine expression of CAII and CAXII isoforms 
under different sex-steroid effect and at different phases of the oestrous cycle in rats was 
examined to further understand their role in rodent’s uterine fluid pH regulation. 
 In this study, the changes in CAII and XII expression throughout the oestrous cycle 
were parallel to the changes in their expression following treatment with 0.2E, P (Figure 
4.7& 4.9); which were considered to be at physiological doses (Salleh, et al., 2005). An 
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increase in CAII expression following treatment with 0.2E was consistent with an 
increase in its level at estrus. At this stage of the oestrous cycle, E was the main 
circulating sex-steroid. An enhance in the expression of CAII could be due to an 
increase in the development of the endometrial glands as this isoenzyme has been 
reported to be involved in regulating glands development in sheep (Hu & Spencer, 
2005). In addition, the observed increase in CAII expression during this oestrous phase 
could also be related to higher endometrial angiogenesis as this isoenzyme expression 
has been reported in the endometrial blood vessels (Hynninen, et al., 2004) as well as in 
the erythtrocytes (Chiang, et al., 2001). CAII was neither expressed in the stroma nor in 
the myometrium under these conditions (Figure 4.8). These observed E effects on 
uterine CAII expression has been shown to be mediated via the ER (He, et al., 2010).  
This finding indicates that CAII was present at higher amount in the glands (Figure 4.8) 
following 0.2E treatment and at estrus (Figure 4.7) further support its proposed 
function. Intracellular CAII is involved in generating HCO3
-
 from CO2 and H2O, which 
was then expelled into the lumen via the apically located HCO3
-
 transporters including 
CFTR (Chan, et al., 2002; Salleh, et al., 2005) and (Figure 4.1&4.2) and SLC26A6 
(Figure 4.3&4.4). CAII was found to interact with SLC26A6 (Vince, et al., 2000; Vince 
& Reithmeier, 1998) which will further enhance luminal HCO3
-
 secretion. In parallel, 
concomitant H
+
 production will be extruded via the basolateral NHEs; although 
interactions between CA and these transporters have yet to be documented.  
It was observed that the expression of CAII was also increased following P treatment 
and at diestrus (Figure 4.7), which suggest its participation in the reduction in uterine 
fluid pH under these conditions (Figure 6.1.A) and (Salleh, et al., 2001). This increase 
in CAII expression was supported by an increase in the activity of this enzyme under P 
effect (Lutwak-Mann, 1955; Nicholls & Board, 1967). In addition to generating H
+
, CA 
could also be involved in H
+
 secretion at the apical membrane. CAII was reported to 
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enhance the activity of sodium-proton exchanger-1 (NHE-1) (Li, et al., 2002), which 
expression was increased at the apical membrane of the luminal epithelia under P 
influence (Figure 5.1).  CAII and NHE-1 have been proposed to form a transport 
metabolon which helps in driving luminal H
+
 secretion (Purkerson & Schwartz, 2007). 
This decrease in pH of the uterine fluid was proposed to bring the blastocyst close to the 
receptive endometrium to initiate the attachment phase of implantation (Song, et al., 
2007). From the findings, it was noted that high doses of E (2, 20 &50E) exert a strong 
inhibition on CAII expression. A similar finding was reported in the uterus in rats in 
which CAII expression was reduced following administration of 4 µg/kg/day E 
(Caldarelli, et al., 2005). The significant of these effects were unknown; however it may 
explain the contraceptive effect following intake of E-only pills as well as infertility as 
observed in certain pathological conditions associated with a high E level.  
Meanwhile, the expression of membrane-bound CAXII was found to increase following 
treatment with 0.2E and at estrus. We speculate that the observed increase in this 
isoenzyme expression could be related to the rapid growth of the endometrium as 
featured by glands and blood vessels proliferation.  CAXII has been associated with 
tumor growth and progression (Hsieh, et al., 2010). In addition, the expression of this 
isoenzyme was also found to be increased under hypoxic condition (Chiche, et al., 
2009; Doyen, et al., 2013). These situations could be relevant to the uterus in which 
rapid tissue growth and proliferation may exceed growth of the blood vessels an early 
stage of the cycle, thus creating a partial hypoxic condition (Deligdisch, 2000). In view 
that hypoxia stimulates CAXII expression and activity (Maybin, et al., 2011a; Maybin, 
et al., 2011b), therefore under this situation, an increase in endometrial expression of 
this isoenzyme may occur. 
Meanwhile, under P effect and at diestrus, CAXII was high (Figure 4.9) and distributed 
mainly at the apical membrane (Figure 4.10). The apical distribution of this isoenzyme 
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was thought to be involved in uterine fluid acidification under P influence (Figure 
6.1.A). During this stage, apical CAXII catalyzes the conversion of excreted H
+
 and 
pre-existing HCO3
-
 into CO2 and H2O. CO2 will then diffuse into the cell for further 
generation of H
+
 and HCO3
-
. Intracellular HCO3
-
 will be expelled into the plasma via an 
unidentified HCO3
-
 transporter at the basolateral membrane in order to sustain the 
intracellular pH homeostasis. As a consequence of down-regulation of the apical HCO3
-
 
transporters by P (Figure 4.1,4.3&4.5)  luminal HCO3
-
 secretion diminishes, thus further 
reduce the pH of the uterine fluid as a result of a net increase in H
+
 secretion. 
Treatment with E plus P (E+P) has also resulted in an increase in CAXII expression. 
This may support the contribution of CA in change of uterine fluid pH under both E and 
P effect (figure 6.2.A &6.5.A) 
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Result & Discussion 
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5.1 Analysis of NHE1, NHE2 and NHE4 mRNA and protein expression 
5.1.1 NHE1 mRNA level and protein expression in ovariectomized rats 
In figure 5.1A, NHE1 mRNA level was the highest following P treatment (4.5 fold 
increase). There was dose-dependent increase in mRNA level with increasing doses of 
E (2.8 to 3.5 fold increase in higher E doses: 0.2 – 50E). Treatment with E followed by 
P resulted in a significant inhibition of the mRNA level to only about 1.95 fold, which 
was more than two times lesser than in the P treated group.  
In figure 5.1.B, NHE1 protein expression was significantly increased following 
treatment with P (1.7 fold increased). E treatment resulted in a dose-dependent increase 
in NHE1 protein expression (0.6 – 0.9 fold). In E + P group, the amount of protein 
expressed was significantly lower than in the P treated group. The molecular weight for 
NHE1 is 100kDa (Figure 5.1.C) 
5.1.2 NHE1 mRNA level and protein expression at oestrous cycle 
Throughout the oestrous cycle, NHE1 mRNA level was the highest at diestrus (5.9 fold 
increase), followed by proestrus and estrus (3.4 and 2.9 fold increase respectively). 
These findings suggested that NHE1 protein expression was up-regulated under P 
dominance. Thus the highest amount of NHE1 protein observed at diestrus whereas the 
lowest expression was at metestrus (1.6 fold) (Figure 5.1).  
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Figure 5. 1 Comparison of mRNA level (A), protein expression analysis (B) and related blot (C) of 
NHE1 under the influence of steroid hormone.  * compared to control group in ovariectomized rats 
and compared to estrus at different stages of the oestrous cycle. 0.2E: 0.2µg estrogen, 2E: 2µg 
estrogen, 20 E: 20µg estrogen, 50E: 50µg estrogen, P:  4mg progesterone, E+P: 0.2µg estrogen + 4 
mg progesterone. Ps: proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. n=4,  *, P < 0.05, **P < 
0.01, ***P < 0.001, data presented as mean ± SEM. In ovariectomized groups comparison was 
done with control group however at oestrous cycle comparison was done with ES. 
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5.1.3 NHE1 localization 
In figure 5.2 and table 5.1, IHC results indicate that NHE1 protein was distributed 
mainly at the apical membrane of the luminal and glandular epithelia under steroid 
treatment. Minimal staining could be seen at the apical membrane in 0.2 and 2E groups, 
and a moderate staining predominantly at the apical membrane was observed in 20E. In 
the 50E group however, intense staining could be seen. In contrast to 0.2E, P resulted in 
intense expression of NHE1 predominantly at the apical membrane of the luminal and 
glandular epithelia. In E+P group, no staining was observed.  
Meanwhile, throughout the oestrous cycle, NHE1 is minimally expressed at proestrus 
and estrus mainly at the apical membrane. At metestrus, a moderate staining could be 
seen at the apical membrane while an intense staining predominantly apical was 
observed at diestrus.  
                                      
            Table 5. 1 Semi quantification of NHE1 in the uterine luminal endometrium by IHC 
group apical basal 
control - -/+ 
0.2µg estrogen - -/+ 
2µg estrogen - + 
20µg estrogen ++ + 
50µg estrogen +++ + 
4mg progesterone +++ + 
0.2µg estrogen +4 mg progesterone - - 
proestrus -/+ - 
estrus -/+ - 
metestrus -/+ - 
diestrus +++ + 
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 Figure 5. 2  Immunodistribution of NHE1 in steroid treated ovariectomized rats and 
at different stages of oestrous cycle. Magnifications 10X and 100X (in the upper 
right corner). 0.2E:  0.2µg estrogen, 2µg estrogen, 20E: 20µg estrogen, 50E: 50µg 
estrogen P: 4mg progesterone, E+P: 0.2μg estrogen + 4mg progesterone, Ps: 
proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. IHC with goat nonspecific 
immunoglobolin is negative control to check the specificity of antibodies. No 
staining was observed in this experiment. L: lumen, G: Gland, arrow shows luminal 
apical membrane, arrow head shows basolateral membrane 
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5.2 NHE2 expression 
5.2.1 NHE2 mRNA level and protein expression in ovariectomized rats 
In figure 5.3A, NHE2 mRNA expression was the highest in the group receiving 0.2E in 
which there was a 2.3 fold increase in mRNA level. Treatment with increasing doses of 
E resulted in a reduction in mRNA level (from 2.05 to 1.2 fold with 2E and 50E 
respectively). P treatment resulted in a low level of NHE2 mRNA. Treatment with E 
followed by P (E+P) did not change mRNA level of NHE2 in respect to control group.   
NHE2 protein was the highest in the 0.2E group. Increasing E doses resulted in a 
parallel decrease in the amount of NHE2 protein expressed. P resulted in a significantly 
low expression (0.45 fold) as compared to 0.2E. Treatment with E + P however causes 
an increase in the protein amount (Figure 5.3.B). 
5.2.2 NHE2 mRNA level and protein expression at oestrous cycle 
Changes in NHE2 mRNA level throughout the oestrous cycle were consistent with its 
changes following different steroid treatment. At proestrus, NHE2 mRNA level was the 
highest with a 3.2 fold increase coincide with a high level of endogenous E, while at 
estrus; there was a 2.6 fold increase. The lowest mRNA level was noted at diestrus (2.1 
fold), when the circulating P level was high (Figure 5.3.A), however these changes in 
mRNA level are not significant.   
Throughout the oestrous cycle however, NHE2 protein was expressed the highest at 
estrus stage (2.75) and the lowest at diestrus stage (0.95). This is consistent with a high 
endogenous E at estrus and high plasma P at diestrus (Figure 5.3.B). The molecular 
weight for NHE2 is 75 kDa (Figure 5.3.C). 
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Figure 5. 3 NHE2 mRNA (A) and protein (B) analysis and representative photos of 
western blot (C). 0.2E: 0.2µg estrogen, 2E: 2µg estrogen, 20 E: 20µg estrogen, 50E: 50 
µg estrogen, P: 4mg progesterone, E+P: 0.2µg estrogen + 4mg progesterone. Ps: 
proestrus, Es: estrus, Ms: metestrus, Ds: diestrus.  *, P < 0.05, **P < 0.01, ***P < 
0.001.n=4 rats per group, data presented as mean±SEM. In ovariectomized rat 
comparison was done with control group however at oestrous cycle other groups were 
compared with Es. 
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5.2.3 Localization of NHE2 
In figure 5.4 and Table 5.2, IHC results indicate that NHE2 protein was expressed 
mainly in the luminal and glandular epithelia under different steroid treatment although 
stromal and myometrial expression could also be seen at proestrus and estrus stages. 
Treatment with E resulted in a dose-dependent increase in the intensity of staining at 
both the apical and basolateral membrane of the luminal epithelia. The staining was the 
most intense under 20E and 50E. In the P treated group however, minimal apical 
staining could be seen, while moderate to intense staining could be observed in the E + 
P group. The distribution of NHE2 throughout the oestrous cycle correlates with the 
changing level of sex-steroid. The distribution was intense at proestrus and estrus, while 
minimal distribution could be seen at metestrus and diestrus. 
 
              Table 5. 2 Semi quantification of NHE2 in the uterine luminal endometrium by IHC 
 Apical Basal 
control -/+ - 
0.2µg estrogen ++ + 
2µg estrogen ++ ++ 
20µg estrogen +++ ++ 
50µg estrogen +++ ++ 
4mg  progesterone + - 
0.2µg estrogen +4mg progesterone +++ ++ 
proestrus +++ +++ 
estrus +++ +++ 
metestrus -/+ - 
diestrus + -/+ 
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           Control                                        0.2E                                           2E 
           20E                                 50E                                P 
              E+P                                             Ps                                             Es 
                 Ms                                               Ds                          Negative Control           
Figure 5.4 Immunodistribution of NHE2 in steroid treated ovariectomized rats and at 
different stages of oestrous cycle. Magnifications 10X and 100X (in the upper right 
corner). 0.2E:  0.2µg estrogen, 2µg estrogen, 20E: 20µg estrogen, 50E: 50µg 
oestrogen P: 4mg progesterone, E+P: 0.2μg estrogen +4mg progesterone, Ps: 
proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. IHC with goat nonspecific 
immunoglobolin is negative control to check the specificity of antibodies. No 
staining was observed in this experiment. L: lumen, G: Gland, arrow shows luminal 
apical membrane, arrow head :basolateral  membrane 
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5.3 NHE4 expression 
5.3.1 NHE4 mRNA level and protein expression in ovariectomized rats 
In figure 5.5.A, NHE4 mRNA level was the highest following treatment with E. 
Following 0.2E treatment, the expression level was increased by 14-fold, while 
treatment with 20E resulted in 20 fold increase in NHE4 mRNA level. P treatment led 
to significant inhibition in mRNA level in which there was only a 1.5 fold increase. 
Treatment with E followed by P also resulted in a significantly low NHE4 mRNA level 
(3.0 fold) as compared with 0.2E.  
In figure 5.5.B, NHE4 protein was expressed the highest under E treatment. There was 
dose-dependent increase in the amount of NHE4 protein with increasing E doses (2.8 
fold with 0.2E and 5.0 fold with 50E). P however causes a significant inhibition on 
NHE4 protein expression in which there was only a 0.9 fold increase. Treatment with E 
+ P did not significantly differ from progesterone treated group. 
5.3.2 NHE4 mRNA level and protein expression at oestrous cycle 
Throughout the oestrous cycle, NHE4 mRNA level was the highest at proestrus (24 fold 
increase), followed by estrus (12 fold increase), which were consistent with a high 
endogenous E level. At metestrus and diestrus however, the level were significantly low 
which were 4.9 and 4.0 fold respectively. The expression of NHE4 mRNA at diestrus 
was 6 times lesser than at proestrus, suggesting that high endogenous P inhibits NHE4 
mRNA expression (Figure 5.5.A).  
At oestrous cycle phases however, NHE4 protein was expressed the highest at proestrus 
(6.0 fold) and estrus (4.65 fold). The lowest expression was at metestrus and diestrus 
(2.5 and 2.6 fold) respectively. The molecular weight for NHE4 is 70 kDa (Fig 5.5.C). 
In general, under E influence, NHE4 mRNA is the most abundant isoforms. NHE4 
mRNA level exceeds NHE2 mRNA by nearly 7-folds. Under P dominance however, 
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there was only a slight increase in NHE1 mRNA level as compared to E dominance 
state.  NHE4 is the main protein isoform expressed under E effect although the 
expression of NHE2 isoform is also increased. Meanwhile, NHE1 isoform expression is 
slightly increased under P dominance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 5 NHE4 mRNA and Protein analysis. Fluctuation in mRNA 
level (A), protein expression (B) and western blot photo (C) of NHE4. 
0.2E: 0.2µg estrogen, 2E: 2µg estrogen, 20 E: 20µg estrogen, 50E: 50µg 
estrogen, P: 4mg progesterone, E+P: 0.2µg estrogen + 4 mg progesterone. 
Ps: proestrus, Es: estrus, Ms: metestrus, Ds: diestrus.  *, P < 0.05, **P < 
0.01, ***P < 0.001, indicate significant changes compared to control 
group in ovariectomized rats and compared to Es at different stages of the 
oestrous cycle. .n=4 rats per group, each has 3 technical replicate.  
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5.3.3 Localization of NHE4 
In figure 5.6 and Table 5.3, NHE4 protein was seen to be distributed at both the luminal 
and glandular epithelia with intense staining observed under E treatment. Treatment 
with 50E however resulted in a moderate staining. P treatment resulted in a minimal 
staining while no staining was seen in the control group. Treatment with E + P however 
led to a mild to moderate staining. Meanwhile, throughout the oestrous cycle, the 
staining was very intense at proestrus and estrus, while a minimal staining was observed 
at diestrus.  
 
           Table 5. 3 Semi quantification of NHE4 in the uterine luminal endometrium by IHC 
group Apical Basal 
control -/+ - 
0.2µg estrogen +++ +++ 
2µg estrogen +++ ++ 
20µg estrogen +++ +++ 
50µg estrogen + -/+ 
4mg progesterone + -/+ 
0.2µg estrogen +4mg progesterone ++ ++ 
proestrus +++ ++ 
estrus +++ + 
metestrus +++ -/+ 
diestrus + -/+ 
 
 
 
 
 
 
 
  NHE4 
119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 Immunodistribution of NHE4 in steroid treated ovariectomized rats and at 
different stages of oestrous cycle. Magnifications 10X and 100X (in the upper right 
corner). 0.2E:  0.2µg estrogen, 2µg estrogen, 20E: 20µg estrogen, 50E: 50µg 
estrogen P: 4mg progesterone, E+P: 0.2μg estrogen + 4mg progesterone, Ps: 
proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. IHC with goat nonspecific 
immunoglobolin is negative control to check the specificity of antibodies. No 
staining was observed in this experiment. L: lumen, G: Gland, arrow shows luminal 
apical membrane, arrow head shows basolateral membrane 
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5.4 Discussion 
Despite the reported existence of NHE1, 2 and 4 mRNAs in the endometrial epithelia 
from immature mice uteri (Wang, et al., 2003b), the effect of sex-steroid and oestrous 
cycle phases on their expression remained largely unknown. Result showed that E up-
regulates the expression of NHE4 and NHE2 mRNAs and proteins while P causes a 
concomitant increase in NHE1 mRNA and protein expression in the uterus, (ii) 
throughout the oestrous cycle, an increase in NHE1 mRNA and protein expression 
occur at diestrus while an increase in NHE2 and NHE4 mRNAs and proteins expression 
occur at proestrus and estrus, (iii) NHE4 is the most abundant NHE isoform expressed 
in the uterus under E stimulation and (iv) NHE2 and NHE4 are expressed at both the 
apical & basolateral membranes while NHE1 is predominantly expressed at the apical 
membrane of the luminal and glandular epithelia.  
Differential expression of NHE isoforms under sex-steroid influence may explain the 
uterine fluid pH fluctuation (Figure 6.5.A) at different phases of the menstrual/oestrous 
cycle. We have shown that under E stimulation, an increase in the expression of 
basolaterally located NHE2 and NHE4 may mediate intracellular H
+
 extrusion in 
exchange with Na
+
. This is important in order to maintain the intracellular pH 
homeostasis associated with a continuous luminal HCO3
-
 secretion (Zhou, 2005). 
Intracellular Na
+
 is generally believed to be pumped-out via the basolaterally located 
Na+/K+-ATPase (Turi, et al., 1992). 
In addition to an increase in the basolateral expression, we have also shown that E up-
regulates the expression of NHE2 and NHE4 at the apical membrane of the luminal 
epithelia (Figure 5.4& 5.6). The role of apical NHE2 and NHE4 is unknown; however 
these isoforms may participate in luminal Na
+
 secretion, which has been shown to be 
enhanced under E influence in mice (Wang, et al., 2003b) and in rat (Figure 5.3 & 5.5) . 
It has long been established that E stimulates fluid and electrolytes secretion in the 
 121 
 
endometrium (Clemetson et al., 1977). Na
+
 secretion has been thought to occur 
exclusively via a leaky tight junction (Lee, et al., 2000) since no transporters 
responsible for this process has been identified at the apical membrane of the 
endometrium. Aronson (1982) demonstrated that Na
+
 efflux can be stimulated by 
intracellular H
+
. Other findings in a native or NHE transfected cells suggested that NHE 
exchange activity is dependent on internal H
+
 rather than external Na
+
 or H
+
 
concentrations (Orlowski, 1993). Wakabayashi et al (2003) reported that pHi dependent 
Na
+
 efflux from cells expressing NHE1, NHE2 and NHE3 was stimulated by 
intracellular acidification and was completely inhibited by intracellular alkalinization. 
These observations support our hypothesis that under E dominance, apical NHE2 and 
NHE4 may catalyze a reverse mode of exchange of intracellular Na
+
 for extracellular 
H
+
, thus promoting Na
+
 secretion into the uterine lumen. In addition to HCO3
-
 secretion 
via the CFTR and SLC26A6 (Figure 6.3.A& 6.6.A), which were known to be up-
regulated by E (Figure 4.1& 4.3), H
+
 reabsorption will further increased the pH of the 
uterine fluid. Meanwhile, E has also been reported to down-regulate the activity of 
basolaterally located  Na
+
/K
+
-ATPase (Davis, et al., 1978), which may further promotes 
the luminal Na
+
 secretion.    
We have also shown that NHE1 mRNA and protein expressions were up-regulated by P 
and at diestrus stage of the cycle (Figure 5.1). NHE1 was predominantly found at the 
apical membrane (Figure 5.2) supporting the view that this isoform participates in 
intraluminal fluid acidification under P influence (Figure 6.2.A). Additionally, the 
apically located NHE1 could also mediate Na
+
 reabsorption in exchange with H
+
. 
Typically, Na
+
 reabsorption has been reported to occur via the ENaC (Salleh, et al., 
2005) , however in tissues lacking of ENaC such as epididymis, Na
+
 reabsorption may 
also occur via the NHE (Leung, 2001). NHE mediated Na
+
 reabsorption and H
+
 
secretion has been reported in the kidney, pancreas, intestine, colon, stomach, biliary 
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tree and middle ear  (Arena, et al., 2012; Choi, et al., 2006; Hughes, et al., 2010; 
Kirchhoff, et al., 2003; Malakooti, 2011; Narins, et al., 2004 ; Queiroz-Leite, 2011 ; 
Roussa, 2001). In human and mouse choroid plexuses, luminal NHE1 mediates net 
proton secretion into the cerebrospinal fluid (CSF) (Damkier, et al., 2009). In addition 
to luminal fluid acidification, apical NHE has also been reported to participate in 
luminal fluid absorption driven by hypertonicity of the paracellular fluid secondary to 
Na
+
 reabsorption. The role of NHE in luminal fluid loss has been described in the 
epididymis, kidney proximal tubules and intestinal epithelia (Noel & Pouyssegur, 1995; 
Wakabayashi, et al., 1997). An increase in NHE1 expression at the apical membrane of 
the luminal epithelia could be responsible for the uterine luminal fluid acidification and 
secondary fluid loss observed under P influence (Figure 6.2& 6.5). Fluid loss may assist 
uterine closure, which brought the blastocyst in contact with the two opposing surfaces 
of the endometrium (Nilsson, 1972). The significance of P mediated increased in H
+
 
secretion is unknown; however it may help in creating an acidic environment required 
for blastocyst implantation (Nilsson, 1982). An increase in uterine fluid H
+
 
concentration may help to reduce the electrostatic repulsion force between the 
negatively charged endometrium and the blastocyst in addition to the blastocyst itself 
losing part of its negative charge at the time of implantation (Jerkinson, 1977). As 
mentioned earlier, the intracellular proton generation may occur via the action of CA. In 
order to maintain the intracellular pH homeostasis, HCO3
-
 is extruded into the plasma.  
The mechanisms underlying parallel HCO3
-
 extrusion via the basolateral membrane 
under P was not known, however it may involve the HCO3
-
 transporters such as 
SLC26A6 (Figure 4.4) and SLC26A4 (Suzuki, et al., 2002). In addition, there is a 
possibility that P may also increase the expression and activity of endometrial Na
+
/K
+
-
ATPase, which promotes luminal Na
+
 reabsorption although there is no current 
evidence to support this. In conclusion, differential expression of NHE isoforms under 
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the effect of sex-steroid and throughout the oestrous cycle may have important 
implication towards the normal regulation of the uterine fluid pH and volume. Under E 
dominance, NHE2 and NHE4 up-regulation may assist uterine fluid alkalinization and 
intraluminal Na
+
 secretion. Under P dominance however, NHE1 up-regulation may 
mediate intraluminal H
+
 secretion in exchange with Na
+
, thus facilitating secondary 
fluid loss which contributes to uterine closure that initiate the attachment phase of 
embryo implantation.  
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Chapter 6 
Result & Discussion 
FUNCTIONAL 
STUDY 
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6.1 Changes in uterine fluid milieu in ovariectomized rats and rats 
throughout the oestrous cycle 
6.1.1 Effect of exogenous sex steroid on the changes of uterine fluid 
6.1.1.1 Alteration of uterine fluid pH and volume 
Uterine luminal fluid pH in ovariectomized rats treated with peanut oil (control) was 
7.54 and it increased with all doses of E in compared to the control group. There was no 
significance difference between 0.2E (pH 8.13) and 2E (pH 8.20), however 
administration of 20E (pH 8.28) and 50E (pH 8.38) increased pH significantly with 
respect to 0.2E that was considered as a physiologic dose. The pH in P (pH 7.38) treated 
group was less than that in control and was less than that in 0.2E. Another group treated 
with 3 days E followed by 3 days P (E+P), there was no significant difference (pH 7.58) 
with control or even with P treated rats, and pH was remarkably less than that in E 
groups (Figure 6.1.A). Thus, E increased the pH and provides a more alkaline 
environment while P reduced it with respect to control rats.  
Comparison of uterine fluid secretion rate showed that in all E treated groups; the 
secretion rate was increased significantly. However, under the influence of P, secretion 
rate was less than that in the control group. The E+P group did not show any remarkable 
change with respect to the control group. 20 and 50E administration resulted in higher 
secretion rate compared to 0.2E. Furthermore secretion rate by 0.2E was noticeably 
more than P and E+P. Thus E led to higher secretion rate and increased uterine lumen 
volume, (Figure 6.1.B).  
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 Figure 6. 1 Effect of sex steroids on uterine fluid pH (A) and fluid secretion rate 
 (B) in ovariectomized rats. 0.2E: 0.2µg estrogen, 2E: 2µg estrogen, 20E: 20µg 
estrogen, 50E: 50µg estrogen, P: 4mg progesterone, E+P: 0.2µg estrogen+ 4mg 
progesterone. *,† p<0.05, **,†† p<0.01 and *** p<0.001 with respect to control 
group. n=6 rats per group, data presented as mean ± SEM. * compared to control, 
† compared to 0.2E. 
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6.1.1.2  Effect of different inhibitors on the uterine fluid pH  
To evaluate the involvement of different proteins in uterine fluid changes under the 
influence of E, 0.2E was chosen as this dose consider as the physiologic dose (Salleh, et 
al 2005). Thus in following functional studies E treatment refers to 0.2E group.  
The pH increases following E treatment was significantly inhibited by glibenclamide 
(CFTR inhibitor), DIDS (inhibitor of HCO3
-
 transporter) and ACTZ (CA inhibitor).  
EIPA (NHE inhibitor) however did not inhibit E-induced increase in uterine fluid pH. P 
treatment caused pH decrease which was antagonized by ACTZ and EIPA. In the E + P 
treated group however, the pH was significantly lower than the E-treated animals, 
however EIPA causes a significant increase in the pH (p<0.01), (Figure 6.2.A).  Thus, 
HCO3
-
 transporter such as CFTR, Cl/HCO3
-
 exchanger and CA are involved in the 
changes of uterine fluid pH under the influence of E, while NHE and CA play a role in 
lower uterine fluid pH under the P influence. 
6.1.1.3 Effect of different protein inhibitors on the uterine fluid secretion rate 
E treatment resulted in an increase in the rate of fluid secretion (Figure 6.2.B). This 
increase was inhibited by glibenclamide, DIDS and ACTZ while EIPA administration 
resulted in a significant increase in fluid secretion rate. On the other hand, P treatment 
resulted in a decrease in fluid secretion. The increase was significantly inhibited by 
EIPA and ACTZ. In the E+P group there was no difference in the rate of fluid secretion 
as compared to the control with only DIDS administration significantly reducing the 
rate of fluid secretion. 
These results showed that under the influence of E, CFTR, CA and Cl
-
/HCO3
-
 
exchanger contributed in higher uterine fluid volume; in contrast NHE and CA are 
responsible for fluid changes under the influence of P.  
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Figure 6. 2 Effect of different inhibitors on the pH and fluid secretion rate of 
uterine fluid in ovariectomized rats. E: 0.2µg estrogen, P: 4mg progesterone, E+P: 
0.2µg estrogen + 4mg progesterone. G: glibenclamide, ACTZ: acetazolamide, 
EIPA: 5-(N-Ethyl-N-isopropyl) amiloride, DIDS: 4,4'-Diisothiocyano-2,2'-
stilbenedisulfonic Acid, Disodium Salt.  * p<0.05, ** p<0.01 and *** p<0.001. n=6 
rats per group, data presented as mean±SEM. 
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6.1.1.4 Changes in HCO3
-
, Cl
-
 concentration in ovariectomized rats 
There was an increase in HCO3
- 
secretion following E treatment (Figure 6.3.A), which 
was inhibited by glibenclamide, DIDS and ACTZ. P treatment however resulted in a 
significant reduction in uterine fluid HCO3
- 
concentration, which was antagonized by 
ACTZ and EIPA. No significant changes in HCO3
- 
concentration was seen in the E + P 
treated group as compared to the control or even following administration of inhibitors.  
An increase in Cl
-
 concentration following E treatment is inhibited by glibenclamide, 
DIDS and ACTZ (Figure 6.3.B). P treatment resulted in a lower Cl
-
 content as 
compared to E. This was antagonized by ACTZ and EIPA. In the E + P group however, 
the Cl
-
 concentration was significantly lesser than the E treated group. The addition of 
inhibitors however did not cause any significant effect on the Cl
-
 concentration.  
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Figure 6. 3 Changes in the HCO3
-
 (A) and Cl
-
 (B) concentration, in the steroid 
replaced ovariectomized rats. E: 0.2µg estrogen, P: 4mg progesterone, E+P: 
0.2µg estrogen + 4mg progesterone. G: glibenclamide, ACTZ: acetazolamide, 
EIPA: 5-(N-Ethyl-N-isopropyl) amiloride, DIDS: 4,4'-Diisothiocyano-2,2'-
stilbenedisulfonic Acid, Disodium Salt.  * p<0.05, ** p<0.01 and *** p<0.001, as 
compared with respected control group in each treatment. † compare between E, 
P and E+P with control group. n=6 rats per group, data presented as mean±SEM. 
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6.1.1.4 Na
+
 concentration in the steroid treated ovariectomized rats 
Na
+
 concentration was increased under E treatment. This enhancement was inhibited by 
glibenclamide and DIDS. P treatment resulted in a decrease in Na
+
 concentration, which 
was inhibited by EIPA and ACTZ. In the E + P group, EIPA antagonized the reduction 
in Na
+
 concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. 4 Changes in the Na
+
 level of the uterine fluid in ovariectomized 
rats. E: 0.2µg estrogen, P: 4mg progesterone, E+P: 0.2µg estrogen + 4mg 
progesterone. G: glibenclamide, ACTZ: acetazolamide, EIPA: 5-(N-Ethyl-
N-isopropyl) amiloride, DIDS: 4,4'-Diisothiocyano-2,2'-stilbenedisulfonic 
Acid, Disodium Salt. * p<0.05, ** p<0.01 and *** p<0.001, as compared 
with respected control group in each treatment. † compare between E, P and 
E+P with control group. n=6 rats per group, data presented as mean±SEM. 
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6.1.2 Uterine fluid environment throughout the oestrous cycle 
6.1.2.1 Fluctuation in the pH of uterine fluid throughout the oestrous cycle  
Throughout the phases of oestrous cycle, high pH was observed at proestrus (7.93) and 
estrus (7.95) consistent with a high circulating E concentration, while low pH was seen 
at diestrus (7.67) and metestrus (7.75) consistent with a high circulating P 
concentration. The high uterine fluid pH at proestrus and estrus phases was inhibited by 
glibenclamide, DIDS and ACTZ (Figure 6.5.A).  At diestrus however, a reduction in the 
pH was significantly antagonized by ACTZ and EIPA. The pH reduction seen at 
metestrus was significantly antagonized by EIPA (p<0.01), (Figure 6.5.A). 
6.2.2 Effect of endogenous steroid on secretion rate of uterine fluid 
There was an increase in the rate of fluid secretion at proestrus and estrus stages of the 
cycle. The reduction in the rate of fluid secretion was inhibited by glibenclamide, DIDS 
and ACTZ; while EIPA causes an increase in fluid secretion at both proestrus and 
estrus.  A lower fluid secretion rate was observed at diestrus and metestrus and this was 
antagonized by ACTZ as well as EIPA and EIPA alone respectively (Figure 6.5.B). 
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Figure 6. 5 Changes in the pH (A) and fluid secretion rate, (B) at different 
stages of the oestrous cycle and effect of different protein inhibitors. Ps: 
proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. G:glibenclamide, ACTZ: 
acetazolamide, EIPA: 5-(N-Ethyl-N-isopropyl) amiloride, DIDS: 4,4'-
Diisothiocyano-2,2'-stilbenedisulfonic Acid, Disodium Salt.. * p<0.05, ** 
p<0.01 and *** p<0.001. * shows the comparison with respected control in 
each stages of the oestrous cycle, † shows the comparison among Ps, Ms 
and Ds with Es.  n=6 rats per group, data presented as mean± SEM. 
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6.1.2.3 Alteration in the HCO3
-
 and Cl
-
 content of the uterine fluid during oestrous 
cycle  
There was an increase in HCO3
- 
concentration at proestrus and estrus stages, and this 
increase was significantly inhibited by glibenclamide (CFTR inhibitor), DIDS and 
ACTZ. HCO3
- 
concentration was lowest at diestrus, and this was antagonized by ACTZ 
and EIPA. At metestrus however, the decrease in HCO3
- 
concentration was inhibited by 
EIPA, (Figure 6.6A).  
Chloride concentration was highest at proestrus and estrus, and lowest at diestrus. At 
metestrus however, Cl
-
 concentration was significantly lower than at proestrus. Addition 
of glibenclamide resulted in a significant decrease in Cl
-
 content at proestrus and estrus, 
while DIDS administration resulted in an increase in Cl
-
 concentration. ACTZ and EIPA 
meanwhile caused an increase in Cl
-
 content at diestrus, but not at metestrus.  
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 Figure 6. 6 HCO3
-
 (A) and Cl
-
 (B) changes throughout the oestrous cycle 
Ps: proestrus, Es: estrus, Ms: metestrus, Ds: diestrus. G:glibenclamide, 
ACTZ: acetazolamide, EIPA: 5-(N-Ethyl-N-isopropyl) amiloride, DIDS: 
4,4'-Diisothiocyano-2,2'-stilbenedisulfonic Acid, Disodium Salt. * p<0.05, 
** p<0.01 and *** p<0.001,  * shows the comparison with respected control 
in each stages of the  oestrous cycle, † shows the comparison among Ps, Ms 
and Ds with Es.  n=6 per group, data presented as mean ±SEM. 
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6.1.2.4 Effect of different inhibitors in Na
+
 content of the uterine fluid at oestrous 
cycle 
In figure 6.7, Na
+
 concentration was the highest at proestrus and estrus which was 
inhibited by glibenclamide and DIDS. Na
+
 concentration was relatively lower at diestrus 
and metestrus, which is antagonized by EIPA and ACTZ and EIPA alone respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. 7  Na
+
 concentration in the uterine fluid during different 
stages of the oestrous cycle. Ps: proestrus, Es: estrus, Ms: metestrus, Ds: 
diestrus. G:glibenclamide, ACTZ: acetazolamide, EIPA: 5-(N-Ethyl-N-
isopropyl) amiloride, DIDS: 4,4'-Diisothiocyano-2,2'-stilbenedisulfonic 
Acid, Disodium Salt. * p<0.05, ** p<0.01 and *** p<0.001, * shows the 
comparison with respected control in each stages of the  oestrous cycle, † 
shows the comparison among Ps, Ms and Ds with Es. n=6 per group, data 
presented as mean±SEM 
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6.2 Discussion 
Many methods have been employed for collection of uterine fluid, including 
cannulation in which a cannula is installed by surgery in the uterine tube. This method 
is suitable for big animals such as cow, ewe, rabbit and monkey. The uterine fluid can 
be collected over the time of few days up to a few months (Aguilar & Reyle, 2005; 
Grippo, et al., 1995). The most commonly method used in rat and mouse is uterine 
flushing, however in this method fluid probably get contaminated by plasma and 
interstitial fluid (Milligan &martin, 1984). Another method to observe the changes of 
uterine fluid is cultured endometrial cell (He, et al., 2010; Wang, et al., 2002) whereby 
protein expression or function maybe lost during cell culture (Downing, et al., 1997).  
Thus in this study the uterus was perfused and the fluid was collected at the cervical end 
of uterus as has been described before (Salleh, et al., 2005), whereby the uterine fluid 
has less chance of manipulation during sample collection. 
This study reveals the participation of multiple proteins in uterine fluid pH regulation 
under different effect of sex-steroid and at different phases of oestrous cycle in in-vivo 
model. We have shown that uterine fluid pH control is linked to the regulation of 
uterine fluid volume and electrolytes. Changes in uterine fluid pH and volume were 
observed under higher dose of E (Figure 6.1). Although uterine fluid pH was found to 
be alkaline at around the time of ovulation (Murdoch & White, 1971). There is currently 
lack of information on the pH status in the post-ovulatory period as well as at early 
phase of the cycle. We have therefore provided the first direct evidence on uterine fluid 
pH fluctuation throughout the oestrous cycle, being the highest at proestrus and estrus 
and the lowest at diestrus (Figure 6.5A), consistent with an increasing E and P level 
respectively. This pH changes is parallel with the observed changes in HCO3
- 
concentration under different effect of sex-steroid and at different phases of the cycle 
(Figure 6.5.B). The highest HCO3
-
 concentration observed under E, was approximately 
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40 mmol/l (Figure 6.3.A & 6.6.A) is consistent with the reported HCO3
-
 concentration 
at the follicular phase (35 mmol/l) in rhesus monkey (Macaca mulatta) which peaks-up 
to more than 90 mM at around the time of ovulation (Maas, et al., 1977). E dependent 
HCO3
- 
secretion has also been reported in mice and human duodenum (Smith, et al., 
2008; Tuo, et al., 2011). In addition to the changes in HCO3
-
, uterine fluid volume, Cl
-
 
and Na
+
 content (Figure 6.3&4 and 6.6&7) have also been found to be reduced 
following P treatment and at diestrus as oppose to an increase in their level under the 
effect of E and at estrus and proestrus phases.  
This study indicates that CFTR is involved in uterine fluid alkalinization under the 
influence of E (Figure 6.2.A& 6.3.A). In addition to being a Cl
-
 channel, CFTR has 
been shown to transport HCO3
-
  (Hug, et al., 2003). Indeed a parallel reduction in the 
uterine fluid pH, HCO3
-
 and Cl
-
 concentrations was observed following glibenclamide 
administration (Figure 6.2-4). This is confirmed the notion that CFTR participates in 
uterine fluid secretion (Chan, et al., 2009), as a  reduction in uterine fluid volume 
occurred following glibenclamide administration (Figure 6.2.B). CFTR activation 
resulted in luminal Cl
-
 efflux which then drives fluid secretion (6.3.B). CFTR mediated 
fluid secretion has been reported in the airway (Shan, et al., 2012) and kidney epithelial 
cells (Wallace, et al., 1996). Apart from stimulating fluid secretion via CFTR, E has 
also been reported to induce the formation of a leaky tight junction, through which 
paracellular fluid movement occurs, thus contributing to the intrauterine fluid 
accumulation (Lindsay & Murphy, 2006).  
As mentioned above, glibenclamide inhibition on HCO3
-
 secretion indicates CFTR 
involvement in uterine HCO3
-
 transport. This may resemble the mechanism in the 
pancreas, where CFTR has been reported to function together with the Cl
-
/HCO3
-
 
exchangers (SLC26A6) in mediating HCO3
-
 secretion, which contributes to pancreatic 
fluid alkalinization (Hug, et al., 2003; Wang, et al., 2006). As a major Cl
- 
channel, 
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CFTR has been reported to mediate Cl
-
 secretion under E stimulation (Salleh, et al., 
2005). A high uterine fluid Cl
-
 concentration has been reported at around the time of 
implantation in rats (Nilsson & Ljung, 1985). CFTR may be involved indirectly in 
luminal Na
+
 secretion under E, which is electrogenically driven by a high intraluminal 
Cl
–
 concentration (Crowell, 2009). Immunohistochemistry confirmed CFTR distribution 
in the luminal and glandular epithelia following E treatment and at estrus (Figure 4.2), 
consistent with the previous findings (Chan, et al., 2009; Chan, et al., 2002; Salleh, et 
al., 2005). Yang, et al  (2004) meanwhile reported a stromal CFTR expression prior to 
implantation in rats. While stromal CFTR could be involved in decidualization, 
epithelial CFTR plays an important role in uterine fluid volume, pH and Cl
-
 regulation 
(Figure 6.2& 6.3). Following P treatment and at diestrus, CFTR expression was found 
to be reduced (Figure 4.1), which explains a decrease in the volume, Cl
-
 and HCO3
-
 
concentrations of the uterine fluid. Additionally, lack of glibenclamide inhibition 
confirmed this.  
The observed effects of DIDS suggest the involvement of either Cl
-
/HCO3
-
 exchanger 
(SLC26A6) or NBC (SLC24A4) in the pH increase following E treatment, at estrus and 
proestrus (Figure 6.1.A) as DIDS is a non-specific inhibitor of these proteins (Chen, et 
al., 2008; He, et al., 2010; Shahidullah, et al., 2009). A reduction in the pH following 
DIDS administration was lesser than that observed following glibenclamide 
administration (Figure 6.2.A), suggesting that CFTR is the main protein involved in 
uterine fluid alkalinization. In view of this, SLC26A6 and/or SLC4A4 may complement 
CFTR function in the uterus. Following DIDS administration, uterine HCO3
-
 
concentration was found to be reduced (Figure 6.3.A & 6.6.A) under the influence of E 
and during estrus, which indicates HCO3
-
 secretion occur via these anion exchangers 
(SLC4A4 and/or SLC26A6) under these conditions.  Meanwhile, SLC26A6 has been 
reported to mediate uterine HCO3
- 
secretion in an in vitro study in endometrial cells 
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obtained from mice treated with E and at estrus (He, et al., 2010). Our findings which 
indicate that SLC26A6 was present in the luminal and glandular epithelia under E 
dominance (Figure 4.4) confirmed the involvement of this protein in uterine HCO3
-
 
secretion. Meanwhile, SLC26A6 has also been reported to be involved in mediating 
HCO3
-
 secretion in other tissue such as pancreatic duct (Ishiguro, et al., 2007). Other 
than SLC26A6, the involvement of apical SLC4A4 cannot be excluded (Figure 4.6). 
An inhibition of the volume (Figure 6.2.B& 6.5.B), Cl
-
 (Figure 6.3.B& 6.6.B) and Na
+
   
(Figure 6.4& 6.7) increase following DIDS administration under E and at estrus suggest 
the involvement of SLC26A6 or SLC4A4 in mediating this effect. The involvement of 
the former is more likely than the latter since its uterine expression of SLC26A6 has 
been reported to be influenced by sex-steroid. Although SLC26A6 does not directly 
involved in fluid and Cl
-
 secretion, these effects may occur via CFTR inhibition. CFTR 
activity can be affected by SLC26A6 (Ko, et al., 2004). Interactions between these two 
proteins are likely as they have been found to be co-expressed in the uterus under E and 
at estrus (Figure 4.1& 4.3). Interactions between CFTR and SLC26A6 have been 
reported in the pancreas (Lohi, et al., 2003), salivary glands, airways, vas deferens and 
intestine (Wang, et al., 2006).  SLC26A6 inhibition will result in a decreased CFTR 
activity (Ko, et al., 2002) which may explain a reduction in volume (Figure 6.2.B& 
6.5.B), Cl
-
 (Figure 6.3.B& 6.6.B) and Na
+
   (Figure 6.4& 6.7) concentrations following 
E treatment and at estrus and proestrus. Meanwhile, lack of DIDS inhibition on the 
volume, pH, HCO3
-
, Na
+
 and Cl
-
 decrease following P treatment and at diestrus (Figure 
6.2-6.7) confirmed that the expression and activity of this protein was reduced under 
these conditions (Figure 6.3).   
Administration of EIPA in the E-treated group and at estrus did not have any effect of 
the uterine fluid pH (Figure 6.2.A& 6.5.A), however it is resulted in a significant 
increase in volume (Figure 6.2.B& 6.5.B) which suggests that other transporter apart 
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from NHE is involved in mediating this effect. EIPA has been shown to inhibit the 
ENaC (Masereel, et al., 2003), that explain the excessive increase in uterine fluid 
volume under these conditions.  ENaC is a negative regulator of CFTR (Stutts, et al., 
1995). ENaC inhibition will augment CFTR activity, resulting in an increase in fluid 
secretion. EIPA did not affect HCO3
-
 concentration (Figure6.3.A& 6.6.A) although a 
reduction in Na
+
 (Figure 6.4&6.7) and Cl
-
 (Figure 6.3.B&6.6.B) concentrations could be 
seen, possibly due to increase in volume of uterine fluid (Figure 6.2.B&6.5.B). Lack of 
EIPA effect on HCO3
- 
secretion under E could be due to the basolateral NHE 
localization in mouse (Wang, et al., 2003b) and rat (Figure 5.4&5.6), which participates 
in the exchange of external Na
+
 with internal H
+
 (Dunham, et al., 2004; Orlowski & 
Grinstein, 2004).  
Meanwhile, EIPA-related increase in uterine fluid pH following P treatment (Figure 
6.2.A) and at diestrus (Figure 6.5.A) indicates the involvement of NHE in uterine fluid 
acidification. This was confirmed by IHC in which NHE-1 expression was increased 
under the influence of P and at diestrus, mainly at the apical membrane (Figure 5.2), 
which mediates H
+
 secretion. In addition, CFTR (Figure 4.1&4.2) and SLC26A6 
(Figure 4.3&4.4) expressions were also found to be markedly reduced under these 
conditions, resulting in decrease in HCO3
-
 secretion, which will further contribute to a 
reduction in the uterine fluid pH (Figure 6.1A&6.5.A). EIPA has also been shown to 
inhibit a reduction in the volume, HCO3
-
, Cl
-
 and Na
+
 concentrations under the effect of 
P (Figure 6.2.B, 6.3& 6.4) and at diestrus (Figure 6.5.B, 6.6&6.7). EIPA-related 
increase in fluid volume suggesting that P-induced fluid loss may occur via ENaC 
and/or NHE. Progesterone-induced fluid absorption secondary to Na
+
 reabsorption has 
been documented in the uterus (Naftalin, et al., 2002), which is mediated via ENaC 
(Chan, et al., 2002; Salleh, et al., 2005). Although ENaC serves as a major pathway for 
uterine fluid reabsorption under the P effect (Salleh, et al., 2005) NHE could provide an 
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alternative pathway for fluid loss as has been reported in the epididymis (Leung, 2001). 
Na
+
 reabsorption via ENaC or/and NHE will drive electrogenic Cl
- 
influx, creating an 
osmotic gradient necessary for H2O absorption (Naftalin, et al., 1999). This may explain 
the observed reduction in Na
+
 and Cl
-
 concentrations under P (Figure 6.3.B&6.4) and at 
diestrus (Figure6.6.B&6.7). Meanwhile, P has also been reported to up-regulate the 
expression of aquaporin (AQP) channel in the endometrium (Lindsay & Murphy, 2007) 
as well as inducing the formation of a “tight” tight junction which would further 
prevents paracellular fluid movements (Li, et al., 1994; Lindsay & Murphy, 2006).  
Results also showed that ACTZ administration antagonized the pH changes in both E 
and P treated groups (Figure 6.2.A). ACTZ inhibits both intracellular CAII and 
membrane-bound CAXII isoforms (Berg 2004). Intracellular CA II catalyzes the 
conversion of CO2 and H2O to H2CO3, which result in the  generation of H
+
 and HCO3
– 
(Boron, 2010). Meanwhile, membrane bound CA XII catalyzes the conversion of 
extracellular H
+
 and HCO3
–
 to CO2 and H2O (Karhumaa, et al., 2001a). The effect of 
ACTZ on uterine fluid pH following E treatment, at estrus and proestrus suggest the 
involvement of CA in uterine fluid alkalinization (Figure 6.2.A& 6.5.A).  A slight 
decrease in the pH following ACTZ as compared to DIDS and glibenclamide 
administration suggest that CA play a less important role in pH increase as compared to 
SLC26A6 and CFTR under the same conditions. These findings also conclude that the 
plasma-derived HCO3
- 
is a major contributor to uterine fluid HCO3
-
 rather than the 
intracellular HCO3
- 
generation involving CA.  
Intracellular CA II catalyzes the reaction that results in HCO3
- 
synthesis (Karhumaa, et 
al., 2001a), which will then be secreted via CFTR and SLC26A6 (Figure 4.2&4.4). 
Meanwhile, concomitant H
+
 production will be secreted via the basolateral NHE (Chan, 
et al., 2009; Wang, et al., 2003b) in order to maintain the intracellular pH homeostasis. 
In addition to participating in the pH control, CA may also be involved in uterine fluid 
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secretion. The involvement of CA in anion and fluid secretion has been reported in the 
cerebrospinal fluid (Maren & Broder, 1970). This increase in uterine fluid secretion may 
occur indirectly via CFTR. The inhibitory effects of ACTZ on E-stimulated increase in  
Na
+
 and Cl
-
 concentrations also indicates indirect involvement of CA in electrolytes 
regulations (Figure 6.3.B&6.4). In this study, CA II isoform is present mainly in the 
glandular epithelia under the effect of E and at estrus (Figure 4.8). 
In addition to participating in uterine fluid alkalinization under the influence of E, CA 
also participates in the uterine fluid acidification under P effect and at diestrus (Figure 
6.2.A&6.5.A). This may involve the intracellular CA II and a membrane bound CA XII. 
The latter isoenzyme participates in intraluminal HCO3
- 
buffering, resulting in H2CO3 
generation, which ultimately formed CO2 and H2O (Ivanov, et al., 2001). CO2 will then 
diffuse into the cell and is converted into H2CO3 by intracellular CAII, which ultimately 
dissociates into H
+
 and HCO3
-
 (Boron, 2010). H
+
 will then be secreted into the lumen 
via NHE-1, which expression is increased under the influence of P and at diestrus 
(Figure 4.7). Meanwhile, basolateral HCO3
-
 secretion may occur via the basolaterally 
located anion exchanger such as NBC (SLC4A4) and SLC26A6 to maintain the 
intracellular pH homeostasis (Table 4.2&4.3). These processes are required to maintain 
a continuous H
+
 secretion which results in uterine fluid acidification as observed under 
P influence.  
An increase in the volume (Figure 6.2.B), Na
+ 
(Figure 6.4), Cl
-
 and HCO3
-
 (Figure 6.3) 
concentrations following ACTZ administration under P suggested that CA is involved 
in mediating these changes. A decreased in HCO3
-
 concentration following P treatment 
and at diestrus is a direct consequence of an increased in H
+ 
secretion. The mechanism 
underlying an increase in uterine fluid volume following ACTZ administration is 
however unknown, although there is a possibility that ACTZ may inhibit the AQP 
channels (Berg, et al., 2004) may inhibit fluid reabsorption induced by P, thus resulting 
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in a volume increase. The observed increase in Na
+
 concentration following ACTZ 
administration indicates that CA may indirectly involve in Na
+
 reabsorption via the 
NHE, which will then induced electrogenic Cl
-
 absorption, thus explaining the increased 
in luminal Cl
-
 concentration following ACTZ administration (Figure 6.3.B&6.6.B).  The 
presence of CA isoforms following P treatment and at diestrus was confirmed by 
immunostaining, in which CA II was found mainly in the glandular epithelia (Figure 
4.8) while CA XII was present mainly in the luminal as well as glandular epithelia 
(Figure 4.10). 
Treatment with E followed by P did not result in any significant changes in the uterine 
fluid parameters as compared to the control. The results obtained following 
administration of various proteins inhibitors could not conclude the involvement of 
CFTR, SLC4A4/SLC26A6 and CA apart from a limited observation which indicate that 
NHE or ENaC may participate in regulating the uterine fluid pH and Na
+
 concentration. 
In view of this, a more complex mechanism may be involved under this condition.  
Meanwhile, the changes seen at metestrus reflect the transitions between estrus to 
diestrus phases.  Our findings which indicate that EIPA inhibits the changes at 
metestrus suggest the participation of NHE and/or ENaC in these processes. In 
conclusion, the present study provides an insight into the possible mechanisms 
underlying the concomitant changes in the pH, volume, and electrolytes content of the 
uterine luminal fluid. By using an in-vivo model, we have successfully provided 
evidence on the relationship between the uterine fluid pH, volume and electrolytes 
concentration changes under different sex-steroid influence. This understanding is 
important for normal reproduction as any deviation from these parameters could have a 
significant impact on fertility.  
In this study expression of protein channel that involved in uterine fluid changes has 
been investigated under high estrogen doses that used in birth control pills (Petitti, 
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2003). According our result expression of HCO3
-
 transporter increased under higher 
estrogen treatment (Figure 4.1-4.6) that resulted in higher HCO3
-
 and consequently fluid 
secretion (Figure 6.2) into the lumen. Similar effect has been reported by genistein, 
whereby CFTR expression was more under higher dose of genistein (Tuo, et al., 2009). 
Under the same condition expression of NHE2 (Figure 5.3) and CA (Figure 4.7-4.10) 
was down regulated at higher E dose, that probably led to rapid passage of fluid into the 
uterine lumen and affect the ionic content(Chan, et al., 2009). Increase in uterine fluid 
volume has been reported in ovarian hyperstimulation syndrome (OHSS) or in HSP. In 
OHSS animals, inhibition of CFTR resulted in alleviation of the symptoms, whereas 
enhanced CFTR mRNA levels reported in HSP patients (Ajonuma, et al., 2005). Due to 
interaction between CFTR and Cl
-
/HCO3
-
 exchanger, probably these channels together 
are responsible for OHSS or HSP. Furthermore increase in HCO3
-
 transporter that led to 
higher uterine fluid resulted in discrepancy in electrolyte content of uterus  or rapid 
passage of fluid into the uterine lumen (Chan, et al., 2009) would be the pathologic 
effect of hyper estrogenic condition on uterine content.     
 Hence, this results could provide a fundamental basis for the observed excessive fluid 
accumulation under a hyper-estrogenic state such as in the use of oral contraceptive pills 
(Salleh, et al., 2005).  
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Chapter 7 
CONCLUSION  
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7.1 Possible mechanism in the regulation of uterine fluid pH under the 
effect of E 
Taken together, our results indicate that under the of influence E, HCO3
-
 transporters 
play a major role in making the uterine fluid alkaline via stimulation of HCO3
-
 
secretion. The alkaline environment of uterine fluid is associated with higher secretion 
rate and increase in HCO3
-
 and Cl
-
 content of the uterine lumen.  On the other hand 
NHE isoform involved in higher Na
+
 concentration. The possible mechanism could be 
(Figure 7.1):  
CAII which is responsible for the generation of H
+
 and HCO3
-
 is up regulated by 0.2E 
and at estrus. HCO3
-
 is extruded into the lumen via the apically located SLC26A6 and 
CFTR, in which both up-regulated by E and at estrus. In order to maintain the pHi 
homeostasis, H
+
 is expelled via the basolaterally located NHE2 and NHE4 in exchange 
with Na
+
. Na
+
 is then pumped back into the blood via the basolaterally located Na
+
/K
+
 
ATPase. The apically located NHE2 (and NHE4) may be involved in Na
+
 secretion in 
exchange with H
+
, thus further contributing to alkalinization of the luminal fluid by 
removing H
+
. The up-regulation of a membrane bound CAXII under this condition is 
responsible for conversion of H
+
 to H2CO3 that involved in HCO3
-
 absorption from the 
blood in addition to  basolaterally located NBCe1 (Figure 7.1). 
 7.2 Possible mechanism in regulation of uterine fluid pH under the 
effect of P 
Under the influence of P, increased membrane-bound CA activity and up regulation of 
NHE1 in addition to down regulation of other HCO3
-
 transporter, might be an important 
factor which contributes to observed decrease in the uterine fluid pH and volume. 
However, ENaC, well known Na
+
 channel which up-regulated under the influence of P 
and involved in Na
+
 absorption should not be neglected in the changes of uterine fluid  
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Figure 7. 1 Proposed mechanism for regulation of uterine fluid pH under the influence  
of E. 
Figure 7. 2 Possible mechanism of regulation of uterine fluid pH under the influence 
of P 
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secretion rate. Thus, the mechanism that involved in this condition could be (Figure 
7.2): 
CAII involves in intracellular generation of H
+
 and HCO3
-
. H
+
 will be then extruded 
into the lumen via the apically located NHE1. Other NHE isoforms that expressed at the 
apical membrane at a much lower level than NHE1 may also participate in luminal H
+
 
secretion. Apically located CAXII reabsorb HCO3
-
 from the lumen. HCO3
-
 may be 
expelled into the plasma via the basolaterally located SLC26A6 or other HCO3
-
 
transporter such as SLC26A4 (Suzuki, et al., 2002) in order to maintain the pHi 
homeostasis. Na
+
 that accumulated in the cell (via ENaC and NHE1) will be extruded 
into the blood via the basolateral Na
+
/K
+
 ATPase (Figure 7.2). 
7.3 Conclusion 
1- E enhances pH of uterine luminal fluid and uterine fluid volume in a dose dependent 
manner. 
2- E increase Na
+
, Cl
-
 and HCO3
-
 concentration of the uterine luminal fluid. 
3- P reduces uterine fluid pH, volume and ionic content. 
4- Alkaline environment under the influence of E is antagonized by inhibition of to 
HCO3
-
 transporter and CA. 
5- E up-regulates expression of CFTR, SLC26A6, NBCe1, NHE2, NHE4, CAII and 
CAXII. 
6- Higher E dose inhibit expression of CA and NHE2.  
7- P down-regulates expression of CFTR, SLC26A6 and NBCe1 as compared to E. 
8- Except CAII which expressed mainly in the uterine glandular epithelium, other 
transporter located in glandular and luminal epithelium. 
9- CAXII and NBCe1 are mostly located on the basal membrane in luminal epithelium 
under the influence of E. 
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10-  Bilateral localization of NBCe1 could be due to presence of other SLC4A4 isoform 
in the uterus. This one can be evaluated by application of specific antibody for 
different variant. 
 In pancreas, it has been reported that HCO3
-
 secretion by SLC26A6 is stimulated by 
CFTR through phosphorylation of the CFTR R domain by PKA (Chappe, et al., 2005; 
Chávez, et al., 2011; Simpson, et al., 2005). This interaction may be mediated by NHE-
RF (NHE- regulatory factor), whereby its expression up-regulated by E (Masereel, et 
al., 2003). Thus expression of PKA and NHE-RF can be investigated to further evaluate 
the exact mechanism of regulation of uterine fluid pH. 
Due to importance of uterine closure in implantation, expression and localization of 
other HCO3
-
 transporter at this condition need to be assessed. 
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Appendices Appendix A: Real time PCR Ct value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CFTR 
Sample Ct Sample Ct Sample Ct 
control 31.9015 50E3 28.0268 Ms1 29.1222 
control 31.6286 50E3 28.3313 Ms1 28.5703 
control 31.674 P1 31.8707 Ms1 28.9428 
control 31.0504 P1 32.0703 Ms2 28.185 
control 31.1688 P1 31.6384 Ms2 28.1633 
control 30.5102 P1 31.7574 Ms3 30.2277 
control 30.7448 P2 30.7388 Ms3 29.8638 
control 32.4022 P2 29.9379 Ms3 30.5245 
control 33.0592 P2 30.3265 Ds1 30.0412 
0.2E1 27.1989 P2 30.0985 Ds1 29.602 
0.2E1 26.9723 P3 31.4994 Ds1 29.4032 
0.2E1 26.7201 P3 31.5347 Ds1 29.9124 
0.2E1 26.9093 P3 32.0332 Ds2 29.3987 
0.2E2 26.0996 E+P1 30.8615 Ds2 28.9585 
0.2E2 26.1226 E+P1 31.1524 Ds2 29.5122 
0.2E2 25.9807 E+P1 30.8919 Ds3 30.22 
0.2E2 26.2609 E+P2 31.1611 Ds3 29.6678 
0.2E3 26.0046 E+P2 31.42 
  0.2E3 25.555 E+P2 30.9516 
  0.2E3 26.1854 E+P3 32.4022 
  0.2E+vehicle 24.7983 E+P3 32.0292 
  0.2E+vehicle 24.7218 E+P3 32.4204 
  0.2E+vehicle 24.7404 E+P3 31.975 
  0.2E+vehicle 26.7331 Ps1 25.1447 
  0.2E+vehicle 26.2812 Ps1 25.0988 
  0.2E+vehicle 25.3335 Ps1 undetermined 
 20E1 26.4973 Ps2 24.6482 
  20E1 26.5899 Ps2 25.0917 
  20E1 26.3811 Ps2 25.6074 
  20E1 26.4995 Ps3 26.5197 
  20E2 25.7303 Ps3 26.4474 
  20E2 25.4378 Ps3 26.4559 
  20E2 25.4343 Es1 27.1074 
  20E2 25.7835 Es1 27.2524 
  20E3 27.5348 Es1 26.9835 
  20E3 26.973 Es1 26.9836 
  20E3 26.7478 Es2 26.2777 
  50E1 26.5021 Es2 26.0815 
  50E1 26.6329 Es2 26.252 
  50E2 25.8623 ES2 25.9633 
  50E3 27.9472 ES3 29.9602 
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SLC26A6 
Sample Ct Sample Ct Sample Ct 
control 31.1835 50E2 29.975 Es1 30.3145 
control 30.8251 50E2 29.9864 Es1 30.0326 
control 30.7587 50E2 30.1259 Es1 29.5062 
control 30.3858 50E2 30.5371 Es2 29.5086 
control 30.562 50E3 30.6219 Es2 29.1185 
control 30.589 P1 30.869 Es2 29.4152 
control 30.7754 P1 30.5448 Es1 29.5983 
control 32.677 P2 30.808 Es1 30.076 
control 32.4306 P2 30.5031 Es1 30.1295 
0.2E1 27.7949 P2 30.6009 Es3 30.6818 
0.2E1 27.7141 P2 30.4042 Ms1 30.4693 
0.2E1 30.7357 P3 30.8102 Ms1 30.4601 
0.2E1 28.1924 P1 30.769 Ms1 29.9677 
0.2E2 28.3217 P1 30.6448 Ms1 30.1936 
0.2E2 28.5499 P2 30.708 Ms2 29.5769 
0.2E2 28.5349 P2 30.4031 Ms2 30.082 
0.2E2 27.5384 P2 30.6009 Ms2 29.4131 
0.2E3 27.2079 P2 30.4042 Ms2 29.67 
0.2E3 27.6286 P3 30.7102 Ms3 30.6521 
0.2E+vehicle 28.933 E+P1 30.0978 Ms3 30.91 
0.2E+vehicle 28.9941 E+P1 30.8054 Ms3 30.2704 
0.2E+vehicle 28.9477 E+P1 30.4702 Ds1 30.5535 
0.2E+vehicle 29.6745 E+P1 30.7059 Ds1 30.3764 
0.2E+vehicle 29.6181 E+P2 30.953 Ds1 30.6439 
0.2E+vehicle 29.5542 E+P2 30.7587 Ds2 30.5156 
0.2E+vehicle 30.5872 E+P2 30.6393 Ds2 29.9692 
0.2E+vehicle 29.8505 E+P2 30.6065 Ds2 30.6279 
0.2E+vehicle 30.4159 E+P3 30.1591 Ds2 30.3479 
20E1 28.9004 E+P3 29.8647 Ds3 30.4281 
20E1 29.3884 PS1 29.1637 Ds3 31.3658 
20E1 28.8976 Ps1 29.3241 Ds3 31.2427 
20E1 29.256 Ps1 28.828 
  20E2 30.6818 Ps1 29.3353 
  20E2 30.2459 Ps2 28.8893 
  20E2 30.2136 Ps2 28.8123 
  20E2 30.4229 Ps2 29.1978 
  20E3 30.5814 Ps2 29.0491 
  50E1 30.0662 Ps3 29.8456 
  50E1 29.7083 Ps3 29.9153 
  50E1 30.2812 Ps3 29.9229 
  50E1 30.0201 Es1 30.0156 
  
 181 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NBC 
Sample Ct Sample Ct Sample Ct 
control 28.9334 50E1 29.8024 Es3 28.8414 
control 28.6953 50E2 32.1264 Es3 28.9701 
control 28.0809 50E2 30.8004 Es3 28.5158 
control 31.1386 50E2 32.6676 Ms1 29.2509 
control 30.0613 50E2 31.7307 Ms1 27.9742 
control 30.0201 50E3 29.8609 Ms1 28.2524 
control 29.0334 50E3 29.3987 Ms1 27.9275 
control 29.6953 50E3 29.6642 Ms2 28.9623 
control 28.0809 P1 29.053 Ms2 28.8536 
control 30.1386 P1 28.4818 Ms3 29.6669 
control 30.0613 P1 28.3093 Ms3 29.0588 
control 30.0201 P1 28.2577 Ds1 29.2791 
0.2E1 29.7761 P2 30.2327 Ds1 28.6651 
0.2E1 29.4084 P2 29.1942 Ds1 28.4894 
0.2E1 29.2151 P3 31.1693 Ds2 27.9746 
0.2E1 29.3037 P3 31.4261 Ds2 27.8964 
0.2E2 31.1454 E+P1 27.9967 Ds2 28.2347 
0.2E2 31.2088 E+P1 27.9639 Ds3 28.8078 
0.2E2 31.1943 E+P1 27.6556 
  0.2E2 31.1726 E+P1 27.7538 
  0.2E3 30.0175 E+P2 30.0352 
  0.2E3 30.2067 E+P2 30.2931 
  0.2E3 29.8915 E+P2 29.9642 
  2E1 29.6624 E+P2 29.4863 
  2E1 29.5196 E+P3 37.4499 
  2E2 31.6703 Ps1 28.7853 
  2E2 31.3923 Ps1 28.4415 
  2E2 31.6432 Ps1 28.5665 
  2E3 30.5415 Ps1 28.7581 
  2E3 30.4117 Ps2 29.6145 
  2E3 30.2287 Ps3 29.7335 
  20E1 28.969 Ps3 29.6663 
  20E1 28.1744 Ps3 30.2403 
  20E2 31.0385 Es1 27.6045 
  20E2 32.3063 Es1 27.8897 
  20E3 28.982 Es1 28.1475 
  20E3 28.9525 Es1 27.8334 
  20E3 29.1722 Es2 28.0321 
  50E1 30.0151 Es2 28.4545 
  50E1 29.767 Es2 27.8712 
  50E1 30.2743 Es2 28.0588 
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CAII 
Sample Ct Sample Ct Sample Ct Sample Ct 
control 28.2679 20E1 31.2772 P4 26.8866 Es4 28.721 
control 28.2107 20E1 31.1867 P4 26.8323 Es4 28.8547 
control 28.3196 20E1 31.3612 P4 26.9738 Ms1 26.5654 
control 28.2298 20E1 31.4239 E+P1 27.8114 Ms1 26.1724 
control 28.2394 20E2 31.4512 E+P1 27.8971 Ms2 26.3647 
control 28.5558 20E2 31.6003 E+P1 27.8293 Ms2 28.9699 
control 28.7825 20E2 31.5137 E+P1 27.9305 Ms2 28.0001 
control 30.1979 20E2 31.7894 E+P2 27.6075 Ms3 29.8332 
control 30.3265 20E3 31.9996 E+P2 27.3918 Ms3 29.7226 
control 30.2764 20E3 31.2669 E+P2 27.8193 Ms3 29.4831 
control 24.3881 20E4 30.7898 E+P2 27.8061 Ms4 28.9696 
control 28.119 20E4 30.3832 E+P3 24.4116 Ms4 26.8632 
control 27.9459 20E4 30.8577 E+P3 24.6783 Ms4 26.1936 
control 27.7153 20E4 30.8845 E+P3 24.0766 Ms4 26.115 
0.2E1 27.2391 50E1 30.0799 E+P4 25.8203 Ms4 25.983 
0.2E1 27.0746 50E1 30.1009 E+P4 25.0847 Ds1 26.3435 
0.2E1 27.3827 50E1 30.2181 E+P4 25.3682 Ds1 27.7674 
0.2E1 27.2604 50E1 30.2676 E+P4 25.3267 Ds1 26.1811 
0.2E2 26.6379 50E2 30.2733 Ps1 30.9134 Ds2 27.1631 
0.2E2 26.5561 50E2 29.9926 Ps1 30.7086 Ds2 27.6077 
0.2E2 26.9409 50E2 30.4742 Ps1 30.9289 Ds3 27.4959 
0.2E2 26.7298 50E2 30.9928 Ps1 31.7425 Ds3 28.668 
0.2E3 24.4044 50E3 30.6027 Ps2 31.4734 Ds3 28.4471 
0.2E3 23.8725 50E3 31.1739 Ps2 33.2987 Ds3 27.8064 
0.2E4 25.92 50E4 30.4099 Ps2 32.869 Ds4 29.7655 
0.2E4 25.6138 50E4 29.8855 Ps3 33.2955 Ds4 29.1365 
0.2E4 25.2992 50E4 30.2091 Ps3 33.0235 Ds4 29.3703 
2E1 31.4511 50E4 30.3196 Ps4 25.5769 Ds4 29.1353 
2E1 31.5556 P1 28.0885 Ps4 25.1413 
  2E1 31.5284 P1 28.2547 PS4 25.5641 
  2E1 31.643 P1 28.1536 PS4 25.3968 
  2E2 31.6621 P1 28.2807 Es1 30.0273 
  2E2 31.8508 P2 27.8672 Es1 29.3934 
  2E2 31.2588 P2 28.2058 Es1 29.382 
  2E2 31.7426 P2 28.0182 Es2 29.3048 
  2E3 34.2972 P2 28.5833 Es2 30.1382 
  2E3 33.9064 P3 25.9421 Es3 30.7831 
  2E4 31.5737 P3 25.8146 Es3 29.9246 
  2E4 30.4765 P3 25.0276 Es3 29.6427 
  2E4 30.8759 P3 26.4022 Es3 30.9783 
  2E4 31.1569 P4 26.3936 Es4 28.4791 
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CAXII 
Sample Ct Sample Ct Sample Ct Sample Ct 
control 30.2081 20E2 34.5517 E+P4 28.176 Ds5 30.2689 
control 30.8125 20E2 34.0706 E+P4 27.7224 Ds5 30.2145 
control 31.9892 20E4 33.26 E+P5 28.0313 
  control 32.0002 20E4 32.5324 E+P5 28.4701 
  control 32.0502 20E4 32.4647 Ps1 26.9754 
  control 30.1542 20E4 33.1973 Ps1 26.2996 
  control 29.6599 20E5 30.9109 Ps2 30.9901 
  control 30.5014 50E1 31.3271 Ps2 30.61 
  control 30.54 50E1 31.3421 Ps2 30.6932 
  control 31.1065 50E1 31.5531 Ps4 29.6364 
  control 30.891 50E2 29.9323 Ps4 29.4148 
  0.2E1 29.3373 50E2 29.3354 Ps4 28.8025 
  0.2E1 28.3606 50E2 30.2349 Ps5 29.7825 
  0.2E1 28.3374 50E2 30.2347 Ps5 29.7744 
  0.2E1 28.5341 50E4 31.6841 Es1 28.9185 
  0.2E2 30.6091 50E4 31.9743 Es1 28.4727 
  0.2E2 30.5731 50E4 31.5505 Es2 29.4952 
  0.2E2 30.625 50E4 31.796 Es2 29.7939 
  0.2E2 30.3877 50E5 31.1539 Es2 29.8288 
  0.2E4 29.0693 P1 29.6102 Es4 28.5944 
  0.2E4 29.0233 P1 29.5497 Es4 28.3899 
  0.2E4 28.9804 P1 29.6752 Es4 28.2577 
  0.2E4 28.9316 P1 29.4537 Es4 27.5976 
  0.2E5 29.7644 P2 30.9331 Es5 29.3155 
  0.2E5 29.0719 P2 30.6292 Es5 28.8347 
  2E1 31.6667 P2 30.3682 Ms1 25.0265 
  2E1 31.1326 P2 30.5905 Ms1 25.8499 
  2E1 31.9002 P4 28.6689 Ms2 28.0943 
  2E2 33.2263 P4 28.4583 Ms2 28.2743 
  2E2 33.3832 P4 28.3674 Ms4 25.6164 
  2E2 33.0165 P4 29.0698 Ms4 25.4701 
  2E2 32.7147 P5 30.2735 Ms4 25.331 
  2E4 31.9221 P5 30.0563 Ms5 29.0287 
  2E4 31.629 E+P1 28.5262 Ms5 29.0148 
  2E4 31.6471 E+P1 28.9006 Ms5 28.8836 
  2E4 31.6461 E+P1 28.9858 Ms5 29.2481 
  2E5 31.5841 E+P1 28.6941 Ds1 26.7869 
  2E5 30.9218 E+P2 28.3653 Ds2 26.8963 
  20E1 32.1441 E+P2 28.8986 Ds4 30.7868 
  20E2 33.9486 E+P2 28.1332 Ds5 30.6949 
  20E2 33.7868 E+P2 28.5732 Ds5 30.0137 
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NHE1 
Sample Ct Sample Ct Sample Ct Sample Ct 
control 33.1894 20E2 31.3288 E+P3 31.0064 Ps2 30.8882 
control 32.9647 20E2 31.4635 E+P1 31.8185 Ps2 30.6622 
control 32.9364 20E2 31.3898 Ds1 31.2772 Ps2 30.7596 
control 32.8661 20E3 31.8133 Ds1 31.1674 Ps3 30.7568 
control 32.648 20E3 31.5256 Ds2 31.3232 
  control 32.757 20E3 32.0134 Ds2 31.371 
  control 32.8904 20E3 31.3695 Ds2 31.1783 
  control 32.7693 50E1 32.4515 Ds2 31.5101 
  control 34.3002 50E1 32.4616 Ds3 31.4876 
  control 34.1813 50E1 32.1818 Ds3 31.3438 
  control 33.931 50E1 32.5398 Ds3 31.3245 
  control 34.592 50E2 32.3945 Ps3 31.7165 
  0.2E1 31.3524 50E2 32.6985 Ps3 31.9707 
  0.2E1 31.4177 50E2 32.527 Ps3 31.5092 
  0.2E1 31.5215 50E2 32.5913 Es1 30.7796 
  0.2E1 31.5278 50E3 33.2574 Es1 30.9681 
  0.2E2 31.1644 50E3 32.8268 Es1 31.0861 
  0.2E2 31.2552 50E3 32.9937 Es2 31.0853 
  0.2E2 31.4378 50E3 33.34 Es2 30.7376 
  0.2E2 31.5962 P1 30.7122 Es2 31.3899 
  0.2E3 32.1292 P1 30.9372 Es2 31.3846 
  0.2E3 31.9896 P1 30.9861 Es3 32.943 
  0.2E3 32.0228 P1 31.0724 Es3 31.9289 
  0.2E3 32.2199 P2 30.4617 Es3 34.0672 
  2E1 31.3532 P2 30.8639 Ms1 31.9721 
  2E1 31.3586 P2 30.9978 Ms1 32.3528 
  2E1 31.4406 P2 30.8415 Ms1 32.494 
  2E1 29.685 P3 31.8462 Ms1 32.4893 
  2E2 31.6679 P3 31.8072 Ms2 32.1553 
  2E2 31.0806 P3 31.896 Ms2 32.2341 
  2E2 31.5304 P3 31.9865 Ms2 32.7934 
  2E2 31.5097 E+P1 32.2429 Ms2 32.4451 
  2E3 31.2431 E+P1 31.9739 Ms3 32.6173 
  2E3 31.381 E+P1 31.9529 Ms3 undetermined 
 2E3 32.273 E+P2 32.0333 Ms3 32.7455 
  2E3 31.6992 E+P2 32.1193 Ms3 32.7995 
  20E1 31.0884 E+P2 32.0645 Ps1 30.2726 
  20E1 31.2836 E+P2 32.1115 Ps1 30.6041 
  20E1 31.0549 E+P3 32.7758 Ps1 30.2618 
  20E1 31.2398 E+P3 32.8616 Ps1 30.5414 
  20E2 31.0169 E+P3 31.3622 Ps2 30.8077 
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NHE2 
Sample Ct Sample Ct Sample Ct Sample Ct 
control 28.9538 2E2 25.3833 Ps1 23.9102 Ds3 25.1142 
control 29.2016 2E2 25.4876 Ps1 24.1631 Ds3 24.4766 
control 28.9961 2E3 25.9315 Ps1 23.8182 Ds3 24.583 
control 29.1017 2E3 25.9763 Ps1 23.9106 
  control 27.9248 2E3 25.8194 Ps2 25.3056 
  control 27.7736 2E3 26.1783 Ps2 25.2337 
  control 27.744 50E1 26.7049 Ps2 24.9755 
  control 27.821 50E1 26.8698 Ps2 24.8795 
  control 28.341 50E1 27.0755 Ps3 25.6904 
  control 28.7064 50E2 26.3389 Ps3 25.3988 
  control 28.4364 50E2 26.3049 Es1 24.0915 
  control 28.7292 50E2 26.5863 Es1 24.1368 
  0.2E1 26.4695 50E2 26.7784 Es1 24.169 
  0.2E1 26.4219 50E3 26.8399 Es1 24.3714 
  0.2E1 26.3692 50E3 26.6336 Es2 25.5321 
  0.2E2 25.777 50E3 26.9937 Es2 25.3591 
  0.2E2 25.8963 50E3 27.1758 Es2 25.4399 
  0.2E2 25.7404 P1 27.9624 Es2 25.3031 
  0.2E2 25.8298 P1 28.0712 Es3 25.1658 
  0.2E3 26.8376 P1 27.8805 Es3 26.0536 
  0.2E3 26.8628 P1 27.8948 Es3 25.1214 
  0.2E3 26.951 P2 27.1695 Es3 24.9694 
  0.2E3 26.7595 P2 27.2529 Ms1 24.5594 
  20E1 26.4292 P2 27.2443 Ms1 24.6494 
  20E1 27.1423 P2 27.0331 Ms1 24.2509 
  20E1 26.8819 P3 27.3706 Ms1 24.7786 
  20E1 26.8099 P3 27.4442 Ms2 25.4297 
  20E2 26.4414 P3 27.7007 Ms2 25.5702 
  20E2 26.5803 P3 27.6869 Ms2 25.2167 
  20E2 26.5774 E+P1 25.0707 Ms2 26.1943 
  20E2 26.7292 E+P1 24.9785 Ms3 25.0447 
  20E3 26.9461 E+P1 24.9806 Ms3 25.2591 
  20E3 26.9373 E+P1 25.08 Ms3 25.3231 
  20E3 27.0965 E+P2 27.3137 Ms3 25.0592 
  20E3 26.9871 E+P2 27.2076 Ds1 23.6869 
  2E1 25.2248 E+P2 26.4233 Ds1 23.9748 
  2E1 25.4744 E+P3 26.9729 Ds1 24.353 
  2E1 25.6352 E+P3 27.289 Ds2 24.4904 
  2E1 25.5101 E+P3 26.6391 Ds2 24.5849 
  2E2 25.3247 E+P3 26.9679 Ds2 24.5829 
  2E2 25.5102 Ps 25.8575 Ds3 24.4364 
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NHE4 
Sample Ct Sample Ct Sample Ct Sample Ct 
control 33.6234 20E2 25.926 Ps1 25.4975 Ds1 31.1866 
control 33.5436 20E2 25.4631 Ps1 25.411 Ds1 30.9156 
control 33.6663 20E2 25.6824 Ps1 25.4669 Ds1 31.1049 
control 33.6782 20E2 25.0543 Ps2 26.1654 Ds1 31.1749 
control 34.1034 20E3 26.2973 Ps2 26.2551 Ds2 30.743 
control 33.6796 20E3 26.4499 Ps2 26.1324 Ds2 30.742 
control 33.7697 20E3 26.5481 Ps3 26.8152 Ds2 30.7438 
control 33.412 20E3 26.9121 Ps3 26.4604 Ds4 30.0759 
control 35.7163 50E1 27.359 Ps3 26.5356 Ds4 30.753 
control 35.2921 50E1 27.3596 Ps4 22.8118 Ds4 30.2611 
control 35.9995 50E1 
 
Ps4 22.9023 Ds4 29.7968 
control 32.8001 50E2 26.8152 Es1 27.7344 
  0.2E2 27.7431 50E2 26.8224 Es1 27.0139 
  0.2E2 27.6593 50E2 26.9273 Es1 26.8576 
  0.2E2 27.7824 50E2 26.9637 Es1 26.9307 
  0.2E2 27.6754 50E3 27.7773 Es2 27.7622 
  0.2E3 28.6306 50E3 27.6994 Es2 27.4307 
  0.2E3 28.4341 50E3 27.7564 Es2 27.4879 
  0.2E3 28.5148 50E4 26.2485 Es3 28.9572 
  0.2E3 28.2534 50E4 26.5713 Es3 28.5003 
  0.2E4 27.4236 50E4 26.4618 Es3 28.2573 
  2E1 26.8517 50E4 26.2356 Es4 27.6089 
  2E1 26.3874 P2 33.3527 Es4 27.5645 
  2E3 26.8069 P2 33.7573 Es4 25.8207 
  2E3 26.4578 P2 34.0978 Es4 25.7856 
  2E3 26.4963 P2 34.4683 Ms1 29.9491 
  2E3 26.516 P3 34.9144 Ms1 29.9597 
  2E3 27.4246 P3 34.9754 Ms1 30.0001 
  2E3 27.0372 P4 34.5708 Ms1 29.7231 
  2E3 26.9647 P4 34.7531 Ms2 
 
 
 2E3 27.1539 E+P2 31.3012 Ms2 30.7288 
  2E4 26.8172 E+P2 31.1248 Ms2 30.3549 
  2E4 26.435 E+P2 31.49 Ms2 30.9639 
  20E 24.1435 E+P2 31.6834 Ms3 31.251 
  20E 24.3839 E+P3 33.5476 Ms3 31.4511 
  20E 24.5227 E+P3 33.851 Ms3 31.3559 
  20E 24.5441 E+P3 33.3093 Ms3 31.3715 
  20E1 24.6201 E+P4 30.9481 Ms4 28.9033 
  20E1 24.3622 E+P4 30.7745 Ms4 27.5496 
  20E1 24.5361 E+P4 30.3817 Ms4 27.2053 
  20E1 25.8531 Ps1 25.7578 Ms4 27.7589 
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Selection of endogenous control (housekeeping gene) for qPCR 
 
Hmbs Ppia B2m GAPD Hprt1 Actb 
control 28.8217 24.5373 26.8878 25.1455 24.9574 22.2005 
control 28.4682 24.5062 28.0638 25.1835 25.0702 22.1091 
control 28.7383 25.8173 27.381 25.1474 24.8792 20.1237 
control 29.5682 26.6854 27.9453 25.5378 24.9492 19.8938 
control 29.5911 25.3983 28.3458 25.7282 24.9565 21.1436 
control 29.5675 25.8186 27.381 25.1455 24.9141 21.2144 
control 30.2205 25.3983 27.9453 25.1835 24.8981 22.65 
control 30.2719 26.4503 26.8878 25.1474 24.5234 20.31 
control 29.9501 25.2207 28.0638 25.7282 24.363 21.9518 
0.2E 28.475 23.9113 21.9523 23.9088 25.7612 19.6279 
0.2E 29.3247 22.85 22.4394 23.9762 25.5497 19.8397 
0.2E 28.9561 24.0476 22.3467 23.9772 25.5774 19.9223 
0.2E 29.4017 23.0651 23.5385 24.79 24.9252 20.2523 
0.2E 29.0716 23.02 25.0266 25.0797 25.1928 20.7 
0.2E 29.4017 23.9681 25.0763 25.126 25.2629 20.62 
0.2E 27.4533 22.9609 21.2665 25.92 
 
21.5401 
0.2E 27.9344 23.0778 21.4065 24.5437 24.8573 20.9459 
0.2E 27.4549 25.2074 21.9522 25.0418 25.3446 20.575 
50E 27.4533 22.492 21.2665 25.0588 25.8687 20.3837 
50E 27.9344 22.9609 21.4065 25.6819 25.0262 20.0633 
50E 27.4549 23.0778 21.9522 25.8245 25.445 21.2834 
50E 27.4533 22.9609 21.2665 25.6819 25.9272 19.71 
50E 27.9344 23.0778 21.8358 25.8245 24.5186 20.67 
P 30.113 24.1907 28.1427 24.6192 25.2964 20.627 
P 29.935 24.2252 28.1112 24.7995 25.2202 21.4676 
P 29.5614 24.9641 27.6804 24.585 25.6477 19.9555 
P 29.5549 24.332 28.7949 24.6921 25.892 20.1709 
P 29.2282 24.1907 28.1427 24.8493 25.5331 20.4692 
P 30.4091 24.2252 28.7248 25.3582 25.3747 20.627 
P 29.2685 24.9641 28.8364 25.4805 25.3168 20.45 
P 30.7544 24.332 28.6877 25.54 26.6302 21.12 
P 30.2335 23.8972 28.7248 24.8493 25.5082 20.82 
P 30.2793 24.138 28.8364 25.3582 25.742 21.312 
P 30.0926 24.8879 28.6877 25.4805 25.9633 20.627 
E+P 25.9802 24.6961 24.9756 24.3172 24.8285 20.11 
E+P 25.6827 25.8511 23.97 24.7265 24.6262 22.1351 
E+P 25.2595 22.6726 25.2382 24.6041 24.7402 22.3243 
E+P 25.5081 25.9599 24.9794 24.6095 24.8552 19.3506 
E+P3 26.5934 23.6207 25.9438 25.95 25.5524 21.9262 
E+P 25.8233 24.6762 25.2382 24.6041 25.4762 21.123 
E+P 26.1657 24.6509 24.9794 24.6095 25.901 21.35 
E+P 26.2576 23.234 25.2382 24.7265 25.645 20.1341 
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Appendix B: Real time assays standard curve 
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Appendix C: buffer preparation 
SDS-page: 
1. Acrylamide (Acrylamide, MW: 71.08 kDa and bisacrylamide, MW 154.17 kDa) 
 
Stock concentration of acrylamide: 30% 
Stock concentration of bisacrylamide: 0.8%  
Acrylamide (30g) and bisacrylamide (0.8g) was dissolved in double distilled water. The 
solutions were topped up to 100ml with double distilled water and stored in dark at 4ºC. 
 
2. 4 x resolving buffer (pH 8.8) (Tris, MW: 121.1 kDa) 
 
Stock solution (1.5M):  18.17g of tris was dissolved in double distilled water and volume 
topped up to 100ml, after adjusting of pH. The solution was stored at 4ºC. 
 
3. 4 x stacking buffer (pH 6.8) (Tris, MW: 121.1 kDa) 
 
Stock solution (0.5M): 3.03g of tris was dissolved in double distilled water and volume 
topped up to 50ml. pH was adjusted at 6.8. The solution was stored at 4ºC. 
 
4. 10% SDS (MW: 288.38 kDa) 
 
5g of sodium dodoceyl sulphate was dissolved in double distilled water and volume topped 
up to 50ml. Keep at room temperature. 
 
5. 10% APS (MW : 228.2 kDa) 
 
0.1g of ammonium persulphate was dissolved in double distilled water and volume topped 
up to 1ml.  
 
6. 2 x treatment buffer 
 
Stock concentration of tris: 0.125M (ph 6.8) 
Stock concentration of SDS: 4% 
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Stock concentration of glycerol: 20% 
Stock concentration of dithiothreitol: 0.2M 
Stock concentration of bromophenol blue: 0.02% 
Glycerol (2ml), dithiothreitol (0.31g), bromophenol blue (0.002g), SDS (4ml of 10% SDS) 
and tris (2.5ml of 0.5M tris) was dissolved in double distilled water. The solution were 
topped up to 10ml with double distilled water and stored at 20ºC. 
 
7. Tank buffer (Tris, MW: 121.1 kDa and glycine, MW 75.07 kDa) 
 
Stock concentration of tris: 0.025M (pH 8.3) 
Stock concentration of glycine: 0.192M 
Stock concentration of SDS: 0.1% 
Tris (3.03g), glycine (14.41 g) and SDS (1g) was dissolved in double distilled water. The 
solution were topped up to 1000L with double distilled water and stored at room 
temperature. 
 
Reagent used for Coomassie blue staining 
Coomassie blue solution 
 
Stock concentration of coomassie: 0.025% 
Stock concentration of methanol: 40% 
Stock concentration of acetic acid: 7% 
Coomassie (0.05g), methanol (80ml) and acetic acid (14ml) was topped up to 200ml 
with double distilled water and stored at RTºC. 
 
Destain solution ǀ 
 
Stock concentration of methanol: 40% 
Stock concentration of acetic acid: 7% 
Methanol (80ml) and acetic acid (14ml) was topped up to 200ml with double distilled 
water and stored at RTºC. 
 
Destain solution ǁ 
 
Stock concentration of methanol: 40% 
Stock concentration of acetic acid: 7% 
Methanol (10ml) and acetic acid (14ml) was topped up to 200ml with double distilled 
water and stored at RTºC. 
 
Reagent used for western-blotting 
Towbin buffer 
 
Stock concentration of tris: 25mM 
Stock concentration of glycine: 192mM 
Stock concentration of glycine: 192mM 
Tris (3.03g) and glycine (14.4g) was dissolved in double distilled water. The solution 
were topped up to 1L with double distilled water and stored at RT. 
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Phosphate buffer saline-tween (PBST) 
 
Stock concentration of bovine serum albumin (BSA): 1% 
Stock concentration of tween: 0.1% 
Bovine serum albumin (2.5ml) and tween (250µl) was dissolved in double distilled 
water. The solution were topped up to 250ml with double distilled water and stored at 
4ºC. 
 
Phosphate buffer saline 
 
Potassium phosphate (0.12g), sodium phosphate (0.72g), sodium chloride (4.0g) and 
potassium chloride (0.1g) was dissolved in double distilled water. The solution were 
topped up to 500ml with double distilled water and stored at 4ºC. 
 
Perfusion buffer:  
Stock concentration (mmol/l): 110 NaCl, 143NaHCO3, 1 NaHPO4, 20 KCl, 0.8 
MgSO4, 1.8 CaCl2, 5.5 glucose, 10 HEPES 
NaCl (6.43g), NaHCO3 (1.2g), NaHPO4 (0.15g), KCl (1.5 g), MgSO4 (0.096g), CaCl2 
(0.2g), glucose (0.99g), 0.22g all mixed and dissolved in dH2O and pH was then 
adjusted to 7.34. 
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